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“Don't worry - so what if there is no life after death? 
There is life after Garp, believe me.”  
― John Irving, The World According to Garp   
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Abstract 
During the symptomatic asexual stage of its life cycle, the malaria parasite P. 
falciparum exports proteins into the host erythrocyte to modulate its properties. 
Many exported proteins are targeted to the cell periphery where they affect cell 
deformability, adhesion, and nutrient import. These changes are implicated in 
causing severe manifestations of the disease. We have identified novel protein 
modules which are capable of targeting to the periphery of the red blood cell 
and which may be involved in modulating these important changes. These were 
all composed of lysine-rich repetitive sequences, which were shown to be 
functional in ten proteins altogether, including one protein from the zoonotic P. 
knowlesi species. Some were found in proteins known to modulate erythrocyte 
rigidity and cytoadhesion while others were previously uncharacterised.  
One protein, the glutamic acid-rich protein (GARP), contains three lysine-rich 
repeating sequences with a peripheral-targeting function. Such repetitive 
sequences are highly enriched in P. falciparum yet very few have been shown 
to be functional. Targeting efficiency was shown to be directly affected by the 
number of repeats present; suggesting that expansion of short non-functional 
lysine-rich sequences can lead to the de novo formation of localisation 
sequences. This is observed by comparing the protein sequences of closely 
related Plasmodium species where repeat expansion has led to functional 
targeting sequences in some but not others. Additionally, we show that the 
length of many functional repetitive sequences is highly variable between 
parasite isolates. Repeat expansion and contraction may allow the parasite to 
rapidly adapt to selective pressure. 
Another domain was identified in proteins involved in modulating cytoadhesion 
and rigidity of host cells in P. falciparum and is conserved across primate-
infecting Plasmodium species. Identifying the roles of these novel modules will 
expand our understanding of parasite-induced erythrocyte modifications and the 
underlying mechanisms responsible for severe malaria. 
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Chapter 1: Introduction 
1.1 History of Malaria 
1.1.1 Origins of the Parasite 
Malaria is one of the most widespread and destructive diseases experienced on 
Earth, with nearly half the world’s population currently at risk. Its dominance is a 
result of millennia of evolution by one of the most prolific parasite species on the 
planet, the unicellular eukaryotic organisms of the genus Plasmodium.  
Plasmodium parasite species are transmitted between vertebrate hosts by 
Anopheles mosquito vectors. They belong to the phylum apicomplexa, which is 
defined by a distinct apical structure in the invasive stage and includes the 
parasites responsible for diseases such as toxoplasmosis and babesiosis 
(Levine, 1971). Most apicomplexan parasites contain a plastid-like organelle 
called the apicoplast which likely originated from a secondary endosymbiosis 
event from red algae (McFadden et al., 1996, Kohler et al., 1997).  Plasmodium 
parasites have been discovered in amber-preserved insects believed to date 
back thirty million years (Poinar, 2005); in the intervening years the parasite has 
diversified to infect most land-based vertebrates including birds, reptiles, 
rodents and primates. Human-infecting malaria parasites are believed to have 
originated from a crossover event from chimpanzee or gorilla-infecting parasites 
in Africa (Liu et al., 2010, Escalante and Ayala, 1994). 
Five species of Plasmodium infect humans: P. falciparum, P. vivax, P. knowlesi, 
P. malariae, and P. ovale. Infection with Plasmodium falciparum causes the 
most severe form of malaria and is responsible for the majority of deaths 
attributed to the disease. The symptoms of P. falciparum infection can vary with 
disease severity and include fever, severe anaemia, breathing difficulty, and 
cerebral malaria which can lead to coma and is often fatal. Many malaria cases 
outside Africa are caused by P. vivax; the symptoms of infection are not as 
severe as those of P. falciparum, with mild anaemia and fever commonly 
reported with few fatalities, although instances of severe disease have also 
been documented (Anstey et al., 2012). P. vivax parasites can remain dormant 
and cause disease relapse when triggered, making treatment difficult. P. 
knowlesi is a zoonotic malaria parasite which primarily infects macaques in 
Southeast Asian countries, but can cause severe malaria if transmitted to 
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humans (Cox-Singh et al., 2008). Developments in diagnostic techniques have 
demonstrated that P. knowlesi is far more common than first thought, and is 
increasing in prevalence due to deforestation leading to increased contact with 
macaques (Singh et al., 2004a). The other human-infecting malaria parasites, 
P. ovale and P. malariae are less common and typically cause mild symptoms 
(Collins and Jeffery, 2005, Collins and Jeffery, 2007). Individuals in many 
malaria endemic regions are often infected by more than one parasite species 
at a time, complicating diagnostic efforts (Snounou et al., 1993). 
 
1.1.2 The Influence of Malaria on Human History 
As malaria has evolved to survive within a human host, it has also had a 
significant influence on the evolution of the human genome. Genetic mutations 
which protect against malaria are common in populations historically affected by 
malaria as they confer a selective advantage. For example, sickle cell trait, 
thalassaemia, and glucose-6-phosphate dehydrogenase deficiency can all 
result in severe complications and are usually under negative selection, but are 
selected for in malaria endemic regions as they protect from the severe 
manifestations of the disease (Kwiatkowski, 2005). Indeed, P. vivax has nearly 
disappeared from West Africa due to the loss of the Duffy antigen from the red 
blood cells of the population, which is required for the parasite to invade (Miller 
et al., 1976). 
Malaria has also had a significant influence on human history. Malaria-like 
symptoms have been recorded in patients at least 10,000 years ago, and many 
ancient civilizations such as the ancient Egyptians and Greeks were plagued by 
the disease (Neghina et al., 2010).  It has been implicated in shaping historical 
events by causing mass-fatalities in armies (Landers, 1998) and is believed to 
have contributed to the deaths of numerous historical figures such as Alexander 
the Great (Atkinson and Truter, 2009). Malaria, translated as ‘bad air’, was 
previously believed to be associated with pollution or fumes from swamps. Only 
in 1880 did the French physician Alphonse Laveran identify the parasite in the 
blood of infected patients, a discovery which led to the British medical doctor 
Ronald Ross attributing its transmission to mosquitoes in 1897. Both were 
eventually awarded the Nobel Prize in medicine for their work. 
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Figure 1.1 – Distribution of malaria infection and number of fatalities caused by 
the disease per year. Map was created using the ‘build a map’ tool on the World 
Health Organisation website. 
 
Today, P. falciparum malaria results in more than 400,000 deaths per year 
(WHO, 2015). Most of these occur in sub-Saharan Africa in children under the 
age of five who have not developed immunity to the disease (Fig 1.1). Severe 
malaria also occurs in pregnant women due to the build-up of infected 
erythrocytes in the placenta (Matteelli et al., 1997). Tropical regions are most 
heavily affected by malaria as they provide an ideal habitat for the Anopheles 
mosquitoes responsible for transmission. In addition to the high number of 
fatalities, all species of malaria also cause a severe burden on the resources of 
countries where it is endemic, with loss of working hours, impaired school 
performance and the cost of medicines being particularly prohibitive in the 
poorer countries most severely affected (Hotez et al., 2014, Vitor-Silva et al., 
2009). As many malaria-endemic countries lack the infrastructure necessary to 
overcome these problems, eradication of malaria is considered a particularly 
difficult challenge in world health. However, significant gains have been made in 
reducing fatalities from the disease in recent years (WHO, 2015). 
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1.1.3 Treating the Disease 
The current front-line treatment against P. falciparum malaria is a combination 
of drugs including the compound artemisinin and its derivatives (Artemisinin-
based combination therapy –ACT) (WHO, 2015) (Fig 1.2). This compound is 
derived from the Artemisia annua plant, which was used in traditional Chinese 
medicine for centuries as a remedy against the intermittent fevers typical of 
malaria. Only in 1977 did Professor Youyou Tu discover the active compound, 
and was jointly awarded the Nobel Prize for medicine in 2015 (Tu, 2011). The 
first drugs used against malaria was quinine and other related alkaloids derived 
from the chinchona tree (Fig 1.2). The synthesis of quinine is particularly 
complex and the compound is still derived from its natural source, limiting 
manufacturing capacity (Woodward and Doering, 1944). A related but easily-
synthesised compound, chloroquine, was synthesised in 1930, and was widely 
used against malaria worldwide until the emergence of widespread resistance 
less than 20 years following its deployment (Payne, 1987). Other compounds 
such as mefloquine, doxycycline and atavaquone/proguanil are used for 
prophylaxis for travellers to endemic regions (Fig 1.2), however due to growing 
resistance these are not used alone in antimalarial treatment regimens (WHO, 
2015). 
 
Figure 1.2 – Antimalarial compounds and their structures. Structures were made 
using Chemdraw (Clark, 2010). Names of Artemisinin-derived compounds are coloured 
purple and quinine-based compounds coloured green. 
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Resistance to antimalarial treatment is a growing concern for the future. The 
first cases of reduced clearance rates for artemisinin-based treatments were 
reported on the Thai-Cambodian border in 2008 (Noedl et al., 2008), where 
resistance to chloroquine and many other compounds also originated (Payne, 
1987). It is believed that an unregulated drug market distributing artemisin 
monotherapy as well as sub-theraputic levels of partner drugs, as well as the 
specific genetic background of P. falciparum parasites all contribute to creating 
a drug-resistance hot-spot in this region. Resistance to artemisinin has been 
linked to point mutations in the kelch13 gene, which is believed to be involved in 
protein turnover (Ariey et al., 2014). Artemisinin is activated by the Fe2+ ion in 
heme and is believed to kill the parasite by covalently binding to numerous 
essential proteins and resulting in increased oxidative stress within the cell 
(Wang et al., 2015, Becker et al., 2004). The low half-life of the compound in the 
body, however, means that other longer lasting drugs must be administered at 
the same time. By affecting protein turnover the parasite may be able to 
withstand the short efficacy window of artemisinin, while resistance to the other 
drugs is able to take hold. 
A vaccine against malaria would be highly advantageous in overcoming the 
threat of artemisinin resistance. After several decades, a vaccine has now 
passed through stage 3 clinical trials and is being distributed in selected African 
countries (Tinto et al., 2015). This vaccine is composed of the circumsporozoite 
protein which surrounds the invasive sporozoite stage of the parasite, as well as 
the hepatitis B surface antigen. A highly-repetitive region of the protein has 
previously been shown to be highly antigenic and antibodies against this region 
block invasion of the liver (Stewart et al., 1986). Additionally, a non-repetitive 
region of the protein is included in the vaccine as the repetitive domain is not 
capable of forming T-cell epitopes. This vaccine, called RTS,S has been shown 
to protect against severe malaria in vaccinated children in approximately 30% of 
cases (Mian-McCarthy et al., 2012). This reduction in severe cases may bring 
malaria control to a manageable level in endemic countries; however there is 
some concern that the variability of the CSP protein sequence will allow 
resistance to develop against the vaccine (Neafsey et al., 2015). A vaccine 
composed of irradiated whole sporozoites has also entered clinical trials; 
however there are some practical difficulties in extraction of these invasive 
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stages from mosquitoes which may hinder widespread use (Seder et al., 2013). 
Early indications of high protection rates are promising, however.  
The most practical malaria eradication schemes used to date have involved 
vector control. Distribution of insecticide-treated bed-nets to malaria endemic 
countries is at an all-time high, and has been shown to be one of the most 
effective methods of lowering infection rates (WHO, 2015). The use of DDT 
insecticide saw large gains in malaria eradication but these have been partly 
reversed since the widespread use of the compound was banned for 
environmental reasons (Mabaso et al., 2004). While some countries still rely on 
DDT insecticide treatment, resistance in the mosquito population is spreading. 
Methods for preventing mosquito breeding have contributed to malaria 
eradication in some countries; mosquito larvae develop while floating on open 
water, and blocking access to standing water or adding detergent to disrupt 
surface tension can be effective in lowering insect populations. This has an 
added advantage of reducing the cases of other diseases transmitted by insects 
such as dengue fever and zika disease. Genetic methods for creating infertile 
mosquitoes have also been developed and may be deployed in the near future 
(Gantz et al., 2015, Hammond et al., 2016). 
 
1.2 The parasite life cycle 
1.2.1 Sporozoites 
The malaria parasite undergoes several morphological changes as it completes 
its life cycle, with multiple differentiation steps within both insect and vertebrate 
hosts (Fig 1.3). Sporozoites are injected into the host as the female Anopheles 
mosquito takes a blood meal. These are elongated motile forms of the parasite 
which are able to glide through the dermis into the bloodstream and migrate to 
the liver (Fig 1.3A) (Amino et al., 2006). Sporozoites actively penetrate the liver 
and invade hepatocytes, where they grow and multiply into tens of thousands of 
haploid merozoite forms (Fig 1.3B) (Frevert et al., 2005). These are released 
into the bloodstream as the hepatocytes burst, where they are able to invade 
erythrocytes. While most Plasmodium species invade mature erythrocytes, P. 
vivax invades undifferentiated reticulocytes (Moreno-Perez et al., 2013). Both P. 
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vivax and P. ovale may also form dormant hypnozoites in the liver, which form 
merozoites once re-activated (Mueller et al., 2009). 
 
 
 
 
Figure 1.3 - The Plasmodium falciparum life cycle. A) Sporozoites are injected from 
the salivary glands of the Anopheles mosquito into the human circulatory system. B) 
These migrate to the liver cells where they multiply asexually into merozoites, which 
are released into the bloodstream as the cells rupture. C) Merozoites insert themselves 
into the host erythrocytes to enter the asexual blood phase. D) Ring stage - parasites 
start exporting proteins into the red blood cell, and structures called ‘knobs’ become 
visible on the surface. E) Early trophozoite – the parasite grows inside its 
parasitophorous vacuole and new organelles such as Maurer’s clefts and 
tubulovesicular networks are formed. F) Late trophozoite – the parasite replicates its 
DNA within the confines of the original cell. G) Schizont stage – the cell segments into 
roughly 16-20 separate membrane-bound merozoites. H) The red blood cell ruptures to 
release the merozoites which then go on and infect new cells. I) A small proportion of 
cells will leave the asexual cycle and differentiate into the sexual stage where male and 
female gametocytes are formed. J) The mosquito phase - The gametocytes are 
ingested into the mosquito’s gut as it takes a blood meal, where they sexually 
reproduce into zygotes which then form ookinetes which leave the gut and develop into 
oocysts. These then rupture to release sporozoites from the salivary glands into a new 
host. 
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1.2.2 Invasion 
The invasion of erythrocytes is a multi-step process (Fig 1.4). First, the 
merozoite attaches itself to the surface of the erythrocyte, an interaction 
believed to be mediated by the coat of merozoite surface proteins (MSP) which 
cover the parasite (Moss et al., 2012). The polar merozoite must then reorient 
itself so that the apical end is in contact with the erythrocyte surface (Gilson and 
Crabb, 2009). Many proteins involved in this process are stored in organelles 
within the merozoite such as the rhoptries, micronemes, and dense granules, 
and are secreted and trafficked to the surface when required (Singh et al., 
2010). For example, two families of merozoite surface proteins, the PfRH and 
erythrocyte binding antigen (PfEBA) families, are released from the rhoptries 
and micronemes, respectively (Tham et al., 2012, Triglia et al., 2001, Sim et al., 
1992). Many of these bind to erythrocyte surface receptors; EBA-175 binds 
glycophorin A and PfRH5 binds to basigin, for example (Orlandi et al., 1992, 
Bartholdson et al., 2013). The storage of these proteins within the merozoite 
until required is thought to limit exposure to the host immune system, while the 
exposed MSP proteins are variable suggesting they are under selective 
pressure (Wright and Rayner, 2014).  
 
Figure 1.4 – Invasion of merozoites into erythrocytes. Attachment is mediated by 
the MSP coat. Secretory organelles (e.g. micronemes) release receptors to mediate 
reorientation and moving junction formation.  Proteins are released into the host cell 
upon invasion, as the protein coat is shed and the parasitophorous vacuole is formed. 
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Once the merozoite is orientated correctly, additional parasite proteins are 
involved in forming a moving junction composed of an actin and myosin motor 
which drives invasion into the host cell (Fig 1.4) (Baum et al., 2006). A complex 
of rhoptry proteins known as the RON complex is inserted into the erythrocyte 
membrane, where its interaction with the apical membrane antigen (AMA1) on 
the merozoite surface is believed to contribute to the formation of a tight moving 
junction (Riglar et al., 2011). Additional rhoptry proteins are released into the 
host cell at this point, which are involved in essential erythrocyte modifications 
(Counihan et al., 2013, Ling et al., 2004, Nguitragool et al., 2011, Vincensini et 
al., 2008). As the merozoite enters the host cell, the merozoite surface proteins 
are shed and the erythrocyte membrane forms a vacuole around the parasite, 
known as the parasitophorous vacuole (Lingelbach and Joiner, 1998). This 
remains intact as the parasite develops. 
 
1.2.3 Erythrocyte Stages and Egress 
Within the erythrocyte the parasite undergoes several morphological changes 
(Fig 1.3C-H). The early asexual stage is referred to as the ring stage due to its 
appearance with giemsa staining. The parasite then enters the trophozoite 
stage, where it continues to grow by ingesting and digesting haemoglobin from 
the cytosol of the erythrocyte for protein production (Goldberg et al., 1990). The 
parasite enters the schizont stage and asexually replicates its genome before 
dividing to form 16-20 daughter merozoites to complete the 48 hour cycle 
(Bannister et al., 2000).  
Egress from the erythrocyte is mediated by a complex cascade of 
phosphorylation and proteolysis events where a number of proteins are 
activated in turn and lead to rupture of the host cell (Alam et al., 2015). Many 
key players in this process have recently been elucidated; protein kinase G 
triggers the secretion of the subtilisin-like protease 1 (SUB1) from the 
exonemes of merozoites (Collins et al., 2013) which leads to the subsequent 
release of proteins from the micronemes. Additionally, the calcium dependent 
protein kinases PfCDPK1 and PfCDPK5 respond to the calcium influx observed 
prior to egress and also contribute to secretion of proteins from the micronemes 
(Dvorin et al., 2010, Bansal et al., 2013). Several proteases lead to lysis of the 
parasitophorous vacuole and the erythrocyte membrane, likely through a 
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mechanical disruption of the spectrin cytoskeleton by activated MSP1 (Das et 
al., 2015). Once egress is triggered, the rupture of the host cell is an explosive 
event, with merozoites propelled outwards to invade uninfected erythrocytes 
and continue the cycle. 
 
1.2.4 Sexual Development 
During schizogony, a fraction of the parasite population becomes committed to 
differentiate into gametocytes, the sexual stage of the parasite life cycle. 
Morphological differences become apparent after the ring stage of the 
subsequent cycle, where male and female gametocytes begin to form and 
become increasingly elongated. These stages mature over a period of about a 
week in P. falciparum , and are sequestered within the bone marrow of the host 
until they reach maturity and are released into the blood stream to be picked up 
by a mosquito during a blood meal (Fig 1.3I). Once within the mosquito midgut 
changes to the pH and temperature and the presence of xanthurenic acid 
(Billker et al., 1998) trigger egress from the erythrocyte and exflagellation of 
male gametocytes to form gametes which fertilize female gametes to form a 
diploid zygote form (Kuehn and Pradel, 2010). The zygote subsequently 
differentiates into motile ookinetes, which are able to penetrate the mosquito 
midgut and form an oocyst (Fig 1.3J). Oocysts burst to release thousands of 
sporozoites, which must then travel to the salivary glands in order to be injected 
into the host. The cycle restarts once the mosquito bites a new host. 
 
1.3 The Unusual Genome of P. falciparum  
1.3.1 AT-Bias and Amino Acid Enrichment 
The first genome sequence of Plasmodium falciparum was completed in 2002 
(Gardner et al., 2002); since then the sequences of many other Plasmodium 
species and field strains have become available, allowing greater insight into 
the evolution and variation of the parasite. The P. falciparum genome encodes 
5777 gene products, of which 2209 are annotated as ‘proteins of unknown 
function’ with little homology to other eukaryotic proteins. One striking 
observation of the genome is that it is extremely rich in A-T base pairs, with an 
overall A/T composition of 80.6% (Gardner et al., 2002), and 76.2% within 
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coding regions. The only other sequenced genome containing a comparable 
bias belongs to the slime mold Dictyostelium discoideum with an AT 
composition of 77% (Szafranski et al., 2005); why and how the two unrelated 
eukaryotes independently evolved such extreme genome compositions is not 
known. As well as a bias towards adenine or thymine at the third position of 
codons encoding the same amino acids, P. falciparum is also enriched in 
residues encoded by AT-rich codons such as lysine, isoleucine and asparagine, 
with a resulting reduction in GC-rich residues such as Glycine, alanine and 
arginine (DePristo et al., 2006). 
 
1.3.2 Protein Repeats 
The P. falciparum genome is also highly enriched in tandemly repeated protein 
sequences. At the DNA level, trinucleotide repeats are believed to form from 
strand slippage during DNA replication in the mitotic cycle, or unequal crossover 
of chromosomes during meiosis (DePristo et al., 2006). This is a dynamic 
process with repetitive sequences often expanding and contracting at a greater 
rate than that of single nucleotide mutation (Fig 1.5) (Gemayel et al., 2012). 
Repeating sequences are relatively common in eukaryotes; single amino acid 
repeats such as glutamine and asparagine tracts are mainly known for their 
tendency to aggregate and are often associated with neurodegenerative 
disorders such as Huntington’s disease (Nelson et al., 2013). Tandemly 
repeated sequences with longer unit lengths, on the other hand, often form 
modular arrays of folded domains, as seen in solenoid protein domains such as 
ankyrin repeats (Andrade et al., 2001). These structural tandem repeats often 
mediate protein-protein interactions across diverse protein families. While many 
studies illustrate the importance of these two classes of repeats, little is known 
about sequences containing short repetitive motifs which have no defined 
secondary structure. These are particularly enriched in P. falciparum, with over 
30% of proteins containing repetitive sequences (Mendes et al., 2013). 
The lack of amino acid diversity in tandemly repeated short motifs characterises 
them as low complexity sequences. Generally, hydrophobic residues are 
underrepresented in the repeating sequences of P. falciparum proteins, and 
many are therefore also predicted to be intrinsically disordered (Verra and 
Hughes, 1999). These extended flexible sequences may be inserted into folded 
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protein domains which are otherwise highly conserved with homologues in other 
species, while other proteins are composed almost entirely of short repeats. 
Notably, long tracts of asparagine are present in a quarter of P. falciparum 
proteins (Singh et al., 2004b); in other eukaryotes such sequences are prone to 
prion-like aggregation which can be highly disadvantageous to the cell, however 
additional chaperones are encoded by the parasite to attenuate this effect 
during febrile episodes (Muralidharan et al., 2012). The fact that the parasite 
has needed to evolve to compensate for the negative impacts of trinucleotide 
repeat propagation suggests there may be some selective advantage to such 
sequences.  
 
Figure 1.5 – Tandem repeats are highly variable sequences. During DNA 
replication, dissociation of the strands may result in the formation of secondary 
structure such as DNA loops in either the template or the newly synthesised strand. In 
the case of repetitive sequences, the new strand may re-anneal in the incorrect 
position, leading to extension or contraction of the repetitive sequences. 
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1.3.3 The Function of Low complexity repeating Sequences 
Many perceive repetitive sequences to be ‘junk DNA’ with no function, and they 
are often excluded from genomic analysis as they are difficult to resolve 
(Gemayel et al., 2012). However, deletion of the repetitive sequences of two P. 
falciparum genes results in a clear phenotype; the ‘NANP’ repeats of the 
circumsporozoite protein (CSP) are required for invasion of liver cells, while 
removal of repeats from the REX1 protein affects the separation of Maurer’s 
clefts  (Ferguson et al., 2014, McHugh et al., 2015). Additionally, a poly-histidine 
sequence has been shown to target the knob-associated histidine-rich protein 
(KAHRP) to Maurer’s clefts and the erythrocyte membrane (Wickham et al., 
2001). The precise role of the repeats in these cases are unknown, however, 
and deletion of asparagine repeats from the essential proteasome protein RPN6 
had no discernible effect on protein function (Muralidharan et al., 2011).  
One prominent hypothesis is that repetitive sequences play a role in immune 
evasion. Many repetitive sequences are highly antigenic, with antibodies found 
in the sera of infected individuals against many different repetitive epitopes 
(Kaur et al., 1990). Notably, the NANP/NVDP repeat region of the 
circumsporozoite protein (CSP1) now forms the basis of the malaria vaccine 
RTS, S, and the merozoite surface protein (MSP1) is a vaccine candidate due 
to protection offered by antibodies against its repetitive region (Conway et al., 
2000, Moss et al., 2012, Ferguson et al., 2014). However, the majority of 
antibodies against repeated regions are not protective, leading many to 
hypothesise the proteins are instead contributing to the lack of long-term 
protection against malaria within previously-infected individuals. Atypical 
memory B-cells have been associated with malaria; these are impaired in 
proliferation, cytokine production and antibody secretion, suggesting the 
parasite may actively suppress the host immune response (Portugal et al., 
2015).  
One theory is that the parasite may flood the immune system with highly-
antigenic cross-reactive epitopes to overload B-cells and from a smokescreen 
to prevent affinity maturation of B-cells towards more protective epitopes (Kemp 
et al., 1987). Alternatively, it has been shown that highly repetitive sequences 
may crosslink B-cell receptors and activate the cell in a T-cell independent 
manner which is less protective (Schofield, 1991, Guy et al., 2015). This is 
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supported by a computational analysis indicating repetitive sequences are 
excellent B-cell epitopes, but that the lack of hydrophobic residues in disordered 
sequences leads to reduced MHC binding and thus weak T-cell stimulation 
(Guy et al., 2015). These more general roles may explain why such diverse 
protein families contain repetitive sequences, including many cell-surface 
proteins which are exposed to the immune system (Mendes et al., 2013). The 
dynamic expansion and contraction of repeats may therefore allow the parasite 
to rapidly adapt to selective pressure from the host immune system (Mendes et 
al., 2013).  
 
1.4 Erythrocyte Modifications 
1.4.1 Protein Export 
The red blood cell is terminally differentiated and contains no organelles of its 
own, and so provides an ideal environment for the malaria parasite to reside 
undetected. The parasite compensates for the lack of protein-making machinery 
within the erythrocyte by exporting its own set of proteins to perform essential 
tasks such as nutrient uptake and immune evasion (Haldar and Mohandas, 
2007, Nguitragool et al., 2011). These proteins affect mechanical properties 
such as erythrocyte deformability and adhesion to the vascular system, which 
contribute to disease severity (Marti and Spielmann, 2013, Spillman et al., 2015, 
Boddey and Cowman, 2013). 
To enter the host cell, proteins must cross both the plasma membrane of the 
parasite as well as the membrane of the parasitophorous vacuole which 
surrounds it (Fig 1.6) (Marti and Spielmann, 2013). Proteins destined for export 
must therefore first enter the secretory pathway; N-terminal signal peptides 
direct many exported proteins to the endoplasmic reticulum (ER), while others 
contain transmembrane domains. Within the ER, proteins which are to be 
exported into the host cell must be differentiated from those to be retained 
within the parasitophorous vacuole. A host targeting (HT) motif, otherwise 
known as the Plasmodium export element (PEXEL), has been shown to be 
sufficient for enabling proteins to cross the parasitophorous vacuole (Hiller et 
al., 2004, Marti et al., 2004). This motif, which has the canonical sequence 
RxLxE/D/Q, is cleaved after the third leucine by the ER-resident protease 
29 
 
Plasmepsin V (Boddey et al., 2010, Russo et al., 2010, Chang et al., 2008). The 
new N-terminus of the protein is then N-acetylated by an unidentified N-acetyl 
transferase. Formation of the cleaved N-terminus by a capsid protease is also 
sufficient for export (Tarr et al., 2013, Gruring et al., 2012), indicating that 
Plasmepsin V cleavage is not coupled to the transfer of proteins to the export 
pathway but that the Ac-xE/D/Q N-terminus is instead recognised by 
components of the export machinery. A significant number of PEXEL-negative 
exported proteins (PNEPs) have also been identified, which contain 
transmembrane domains but do not have a clear conserved signal for export 
(Heiber et al., 2013, Spielmann and Gilberger, 2010). 
 
Figure 1.6 – Protein Export in P. falciparum. On insertion into the endoplasmic 
reticulum (ER) Signal Peptidase (red) and Plasmepsin V (orange) cleave the signal 
sequence (SS) and HT/PEXEL motif (RxLxE), respectively. The cleaved acetylated 
protein is trafficked via vesicular transport to the parasite plasma membrane, then 
exported into the host cell across the parasitophorous vacuole membrane (PVM) via 
the Plasmodium translocon of exported proteins (PTEX). 
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Once mature exported proteins have passed through the golgi and entered the 
parasitophorous vacuole, they must traverse the PVM to enter the host cell. A 
complex termed  the Plasmodium translocon of exported proteins (PTEX) has 
been implicated in this process (de Koning-Ward et al., 2009). Within this 
complex, the EXP2 protein is thought to form a pore within the parasitophorous 
vacuole membrane (Kalanon et al., 2016, Mesen-Ramirez et al., 2016), while 
the AAA+ ATPase protein HSP101 is believed to function as a chaperone and 
may be involved in unfolding proteins to feed them through the pore (Beck et 
al., 2014). Disulphide bonds must be broken for efficient export, and a 
thioredoxin-like protein TRX2 is also thought to be involved in the complex 
(Matthews et al., 2013). HT/PEXEL proteins fused to a DHFR domain, which is 
stabilised by the addition of WR and cannot be unfolded, were trapped in the 
PV and immunoprecipitated putative components of the PTEX translocon 
(Mesen-Ramirez et al., 2016). Additional pull-down experiments and spatial 
association in cells have indicated the PTEX complex is composed of EXP2, 
HSP101, TRX2, and two proteins of unknown function named PTEX150 and 
PTEX88 (Riglar et al., 2013, de Koning-Ward et al., 2009). EXP2, HSP101, and 
PTEX150 are all refractory to gene disruption in P. berghei (Matthews et al., 
2013), and a conditional knockdown of the proteins results in a block of protein 
export for both PEXEL-positive proteins and PNEPs (Elsworth et al., 2014). 
Other proteins have recently been associated with the PTEX complex, although 
their roles have not been elucidated (Elsworth et al., 2016). 
Some have hypothesised that proteins destined for export are trafficked to 
segregated compartments of the PV which contain the PTEX translocon, as 
suggested by the ‘necklace of beads’ conformation observed in the PV for 
fluorescently tagged exported proteins (Wickham et al., 2001). Others believe 
the translocon itself confers selectivity for PEXEL proteins or PNEPs by 
recognising signals such as the cleaved HT/PEXEL N-terminus. Altogether, 
more than 400 proteins have been shown to contain a signal sequence and 
PEXEL/HT motif at the N-terminus or to belong to known families of PNEPs 
(Hiller et al., 2004, Marti et al., 2004, Heiber et al., 2013).  Evidence that the fifth 
position of the HT/PEXEL motif may tolerate other residues other than E/D/Q 
suggests an even greater proportion of proteins are exported into the host cell 
(Schulze et al., 2015, Tarr et al., 2013, Boddey et al., 2013).  
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Within the erythrocyte cytoplasm new structures called Maurer’s clefts are 
formed soon after parasite invasion (Fig 1.7). These membranous structures 
are hypothesised to behave as an external secretory pathway so that the 
parasite has the capability to sort proteins outside the confines of its own cell 
(Bhattacharjee et al., 2008, Hanssen et al., 2008, Przyborski et al., 2003). 
Vesicles have been observed surrounding these organelles and it is 
hypothesised that membrane proteins may be trafficked in this fashion between 
the parasite, the clefts and the erythrocyte membrane (Cyrklaff et al., 2011, 
Hanssen et al., 2008). Many proteins have been observed in electron-dense 
clusters in the erythrocyte cytosol, including dots associated with HSP70 and 
HSP40 proteins, indicating that chaperones may instead be responsible for 
trafficking proteins within the host cell (Botha et al., 2007, Kulzer et al., 2012). A 
‘tubovesicular network’ extending from the parasitophorous vacuole is also 
observed in some cells; it may be involved in trafficking proteins or nutrients into 
or out of the parasite (Fig 1.7). Many exported proteins are then inserted into 
the erythrocyte membrane, while others interact with the unique cytoskeleton of 
the host cell. Many are associated with the ‘knob’ protrusions which form of the 
erythrocyte surface soon after infection (Fig 1.7). However, the function and 
localisation of the majority of predicted exported proteins is yet to be revealed, 
with many likely to play roles in immune evasion and nutrient import which are 
essential for parasite survival. 
 
Figure 1.7 – Modifications to the parasite-infected erythrocyte. Membranous 
structures called Maurer’s clefts appear in the host cell cytosol soon after infection, and 
‘knob’ structures form on the cell surface. Additionally, a ‘tubovesicular network’ 
extends from the parasitophorous vacuole of the parasite. 
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1.4.2 The Erythrocyte Cytoskeleton 
Erythrocytes are highly specialised for their role in circulating oxygen throughout 
the body. Their concave structures are highly deformable in order to facilitate 
their passage through narrow capillaries and splenic sinusoids, many of which 
have a diameter smaller than that of the erythrocytes themselves (Fig 1.8A). 
This flexibility is conferred by the unique cytoskeleton of the cell, which is 
composed of a network of spectrin filaments (Fig 1.8B) (Mankelow et al., 2012). 
Alpha and beta-spectrin are large (>250 KDa) proteins composed of a chain of 
folded domains known as spectrin repeats, of which there are 22 in alpha and 
17 in beta spectrin. These repeats each form a three-helix bundle in a coiled-
coil conformation, and the repeat domains of the alpha and beta filaments 
associate to form a heterodimer. The dimers then interact in a head to head 
manner to form spectrin tetramers. At the tetramerisation site, Ankyrin and Band 
4.2 connect spectrin to the membrane pore protein Band 3, while at the other 
end of the filament, the junctional complex forms a hub of spectrin filaments 
connected to transmembrane glycophorin proteins (Mohandas and Gallagher, 
2008). This is composed of short actin filaments with adducin, dematin, band 
4.1, p55, tropomodulin, and tropomyosin (Fig 1.8C) (Mankelow et al., 2012). 
The composition of the red blood cell cytoskeleton has been extensively studied 
due to the simplicity of the organelle-free erythrocyte, and there exist many 
protocols for extracting the various different fragments (Black et al., 2008). It is 
believed that the relatively weak interaction between spectrin dimers at the 
tetramerisation site contributes to the deformability of the cell, as they may 
dissociate under shear stress (An et al., 2002). The filaments themselves may 
also alternate between a tightly-coiled ‘chinese finger trap’ conformation and an 
elongated form (Brown et al., 2015).  
 
1.4.3 Modification of the Cytoskeleton 
Upon infection with Plasmodium falciparum, the erythrocyte cytoskeleton 
becomes increasingly rigid and cannot deform through narrow openings (Nash 
et al., 1989). Several parasite proteins have been implicated in rigidifying the 
host cell; the ring-infected erythrocyte surface antigen (RESA) has been shown 
to associate with spectrin and its deletion results in a decrease in cell rigidity 
(Foley et al., 1991, Pei et al., 2007b). Interestingly, this effect is accentuated 
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when cells are heated to 41 °C, suggesting that RESA may stabilise the 
cytoskeleton during febrile episodes induced by malaria disease (Mills et al., 
2007). Erythrocytes remain rigid once the temperature is decreased, indicating 
that RESA permanently modifies the cytoskeleton, possibly with the assistance 
of other heat-activated proteins.  
 
Figure 1.8 – The erythrocyte cytoskeleton and membrane. A) Erythrocytes form a 
concave sphere which can easily deform through narrow openings. B) The 
cytoskeleton forms a hexagonal network below the membrane surface. C) Alpha and 
beta spectrin filaments form tetramers which are connected to the membrane bilayer by 
two junctional complexes: the Ankyrin complex is composed of the transmembrane 
protein Band 3 linked to spectrin by Ankyrin, while the junctional complex is composed 
of short actin filaments capped by various components and linked to the membrane by 
glycosylated glycophorin proteins. Inset: each spectrin repeat forms a coiled-coil 
bundle. 
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Other proteins which have been implicated in modifying cell deformability 
include PfEMP3 and Pf332, which interact with spectrin and actin, respectively 
(Waller et al., 2010, Waller et al., 2007a). There is conflicting evidence on 
whether PfEMP3 destabilises or stabilises the cytoskeleton; deletion of the gene 
results in a decrease in rigidity (Glenister et al., 2002), however when a short 
fragment of the protein is incorporated into the cell, the shear resistance is 
reduced (Pei et al., 2007a). Deletion or truncation of the megadalton protein 
Pf332 resulted in an increase in cell rigidity and abnormal Maurer’s cleft 
structures, suggesting it may be involved in protein trafficking (Glenister et al., 
2009). The mature erythrocyte infected surface antigen (MESA) interacts with 
protein 4.1, which is present at both the junctional complex and Ankyrin 
complex (Bennett et al., 1997). This interaction with protein 4.1 may disrupt its 
binding to p55, however a clear phenotype for MESA has not been established 
(Waller et al., 2003). Other proteins were shown to contain a motif similar to the 
MEC motif and also interact with protein 4.1 in vitro (Kilili and LaCount, 2011).  
Electron microscopy of infected cells has indicated that the actin filaments of the 
cytoskeleton may be repurposed by the parasite (Cyrklaff et al., 2011). Short 
capped actin filaments are present in the junctional complex, however much 
longer filaments are observed extending from the cytoskeleton in infected cells. 
These may stabilise Maurer’s clefts at the cell periphery (Rug et al., 2014); the 
organelles are motile for the early stages of the parasite but become fixed 
adjacent to the plasma membrane in later stages (McMillan et al., 2013). 
Alternatively, these filaments may provide a means of trafficking vesicles 
between these structures and the plasma membrane. The molecular basis for 
the reorganisation of actin is unclear, however mutations in haemoglobin which 
are protective against malaria reduced actin polymerisation (Cyrklaff et al., 
2011). The protein MAHRP2 which is localised to Maurer’s clefts has also been 
implicated in tethering the organelles to the erythrocyte cytoskeleton (Pachlatko 
et al., 2010). 
 
1.4.4 Nutrient Import 
The parasite acquires many of the lipids, proteins and nutrients required for 
growth from the host cell. These are acquired from the erythrocyte cytosol by 
means of double-membrane invaginations in the PVM and PV called 
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cytostomes (Lazarus et al., 2008). These fill with haemoglobin and other 
proteins then fuse with the parasite food vacuole, where proteases break down 
the haemoglobin to leave toxic heme which is polymerized into pigmented 
crystals of hemozoin (Goldberg et al., 1990). The amino acids released by the 
degradation of haemoglobin and other proteins are recycled for protein 
synthesis. 
Some small molecules required by the parasite cannot be acquired from the 
erythrocyte, however. New permeation pathways are therefore established in 
the erythrocyte plasma membrane in order for the parasite to import sugars, 
amino acids, nucleosides, and ions from the blood plasma (Desai, 2014). It is 
unclear whether the parasite modifies endogenous erythrocyte membrane 
channels or creates its own pores in the membrane. The cytoadherence-linked 
asexual gene 3 (CLAG3) is the only protein identified to date which contributes 
to nutrient import; it is released into the host cell from the rhoptries upon 
merozoite invasion, where it localises to the erythrocyte plasma membrane 
(Nguitragool et al., 2011). An inhibitor of membrane channel conductance was 
found to be selective for DD2 parasites, and was attributed to a divergent 
CLAG3 sequence (Nguitragool et al., 2011). The protein may form a novel 
channel in the membrane or may play a modulatory role.  
Others have suggested that known anion channels in the erythrocyte are 
modified by the parasite. The patch-clamp technique, which directly measures 
conductance across a membrane, was used to evaluate the properties of 
uninfected and malaria infected erythrocytes, indicating that the anion selectivity 
and conductance observed for activated endogenous channels were very 
similar to those of infected cells (Decherf et al., 2004). The erythrocyte kinase 
PKA was able to activate the channel by phosphorylation, suggesting that the 
parasite may activate erythrocyte PKA or directly phosphorylate the 
endogenous anion channel (Decherf et al., 2004). The balance of Na+ and K+ 
cations is also disrupted in erythrocytes infected with Plasmodium , with a 
greater concentration of sodium in infected cells (Ginsburg et al., 1986). The 
implications of such changes to the cell composition for the parasite are yet to 
be established, and it is likely that many more proteins are involved in 
internalizing required lipids and nutrients into the parasite. 
 
36 
 
1.4.5 Cytoadhesion 
It is believed that the reduction in erythrocyte deformability allows the spleen to 
detect infected cells, and the parasite has therefore developed a strategy to 
avoid the organ altogether. In addition to the sequestration of infected 
erythrocytes in narrow capillaries through increased rigidity, the parasite also 
expresses adherent proteins on its surface which can interact with receptors on 
endothelial cells in various organs (Baruch et al., 1996). Infected erythrocytes 
can also adhere to uninfected erythrocytes and cluster together in ‘rosettes’, 
further impeding their journey though the microvasculature (Ho et al., 1991). 
The sequestration of infected erythrocytes in the circulatory system is believed 
to be a main factor in the pathogenesis of severe malaria. 
Cytoadhesion is mainly mediated by the PfEMP1 family of proteins encoded by 
var genes (Crabb et al., 1997, Watermeyer et al., 2016, Baruch et al., 1996). 
There are 60 genes within the family, with only one expressed at a time. Sub-
populations of the parasite may switch between expression of PfEMP1 
antigens, which bind to different receptors and may contribute to different 
manifestations of the disease. For example, the VAR2CSA gene encodes a 
PfEMP1 variant capable of binding to the CSA receptor on placental cells, and 
results in severe malaria in pregnant women (Viebig et al., 2005). Sequestration 
of parasites within the brain by association to brain endothelial receptors can 
result in cerebral malaria, which is a leading cause of death from the disease 
(Craig et al., 2012b). Variation of the surface antigen protects the parasite from 
detection by the immune system. 
In order to maximise the avidity of binding between PfEMP1 antigens and their 
respective receptors, the protein is clustered in protrusions known as knob 
structures on the erythrocyte membrane (Fig 1.9) (Crabb et al., 1997). Electron 
microscopy of these knob protrusions has indicated that they are composed of a 
spiral-shaped structure lying under the membrane surface, surrounded by 
electron dense material (Fig 1.9B-G) (Watermeyer et al., 2016). The best-
studied protein known to be involved in the formation of this structure is the 
knob-associated histidine rich protein (KAHRP); deletion of KAHRP results in a 
knobless phenotype (Fig 1.9B-C), and results in a significant reduction in 
adherence to endothelial receptors under flow conditions (Crabb et al., 1997). 
Other proteins also play a role in the trafficking and stabilising of the variable 
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surface antigen, as it appears to be transported via the Maurer’s clefts before 
insertion into the cell membrane. Deletion of Maurer’s cleft proteins such as 
MAHRP1 and SBP1 result in decreased PfEMP1 on the erythrocyte surface 
(Cooke et al., 2006, Spycher et al., 2008). 
 
Figure 1.9 – Cytoadhesion of infected erythrocytes is mediated by the PfEMP1 
surface antigen presented on knob structures. A) A schematic of cytoadhesion in 
cerebral malaria; PfEMP1 binds brain endothelial cell receptors, or rosettes form 
through adhesion to other erythrocytes. These sequester infected cells in the 
microvasculature. B-C) Scanning electron microscopy (SEM) of KAHRP+ and KAHRP- 
infected cells; deletion of KAHRP abolishes knob structures (Rug et al., 2006). D) 
Freeze fracture EM of knobs on the erythrocyte surface. Membrane protein foci are 
excluded from the area directly surrounding the knobs (Horrocks et al., 2005). E) TEM 
of knob structures from cytoplasmic side, indicating a spiral structure below membrane 
(Watermeyer et al., 2016). F) TEM cross-section of an infected erythrocyte, with the 
electron dense knob structure clearly seen below the membrane (Watermeyer et al., 
2016). G) TEM of PfEMP1 presented on the knob structures of an infected cell 
interacting with receptors on an endothelial cell surface. M = Maurer’s cleft (Horrocks et 
al., 2005). Electron micrographs have been truncated from the original versions by Rug 
et al., Watermeyer et al., and Horrocks et al. 
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Another protein family called the Poly-helical interspersed sub-telomeric 
(PHIST) proteins which contain a Plasmodium RESA-like domain (PRESAN) 
have been implicated in anchoring PfEMP1 to the erythrocyte surface (Oberli et 
al., 2016). This family is divided into the PHISTA, PHISTB and PHISTC groups 
based on their sequence motifs (Oakley, 2006, Sargeant et al., 2006). A large 
number of PHISTB proteins were shown to target the erythrocyte cytoskeleton 
by an extended PRESAN domain which is not present in the other subgroups 
(Tarr et al., 2014). One PHISTb protein, known as the lysine-rich membrane-
associated PHISTb protein (LYMP) has been shown to directly interact with 
various PfEMP1 proteins via its PRESAN domain, and to interact with the 
cytoskeletal component Band3 with its C- terminus, suggesting an anchoring 
role (Oberli et al., 2014, Oberli et al., 2016). Deletion of LYMP resulted in a 
decrease in cytoadhesion (Proellocks et al., 2014). A PHISTc protein was also 
shown to interact with the ATS domain of the same PfEMP1 protein as LYMP 
but with a much lower affinity (Oberli et al., 2014). While the cytosolic ATS 
domain is largely conserved between PfEMP1 proteins it is possible that 
different PRESAN domains may exhibit affinities for different surface antigens. 
Interactions between other PHIST proteins and PfEMP1 are yet to be 
confirmed, however. 
Other families of parasite proteins are displayed on the erythrocyte surface. Like 
PfEMP1, the RIFIN and STEVOR family proteins are clonally variant (Abdel-
Latif et al., 2002, Niang et al., 2009); however their roles are not as well 
established. Both families have however been shown to mediate rosetting of 
infected cells to uninfected erythrocytes (Niang et al., 2014, Goel et al., 2015). 
RIFINS preferentially bind to blood group A receptors while STEVORs bind 
glycophorin C and may also be involved in invasion of erythrocytes (Goel et al., 
2015, Niang et al., 2014).  Increased expression of STEVOR proteins also 
decreases the deformability of the erythrocyte in the late gametocyte stages of 
the parasite (Naissant et al., 2016). Some members of the SURFIN family are 
also surface exposed, although little is known about their role in the erythrocyte 
(Alexandre et al., 2011). 
Other proteins may modulate rigidity or cytoadhesion without directly 
associating with the cytoskeleton or membrane. Members of a unique family of 
21 exported kinases known as FIKK kinases have also been shown to modulate 
39 
 
mechanical properties of the erythrocytes (Schneider and Mercereau-Puijalon, 
2005). Deletion of FIKK7.1 and FIKK12 resulted in differential phosphorylation 
of cytoskeletal components (Nunes et al., 2010), while deletion of FIKK4.2 
resulted in decreased rigidity and abnormal knob structures with reduced 
cytoadhesion (Kats et al., 2014). Most FIKK kinases studied to date are 
localised to the Maurer’s clefts, although FIKK12 also associates with the cell 
periphery (Nunes et al., 2007). The extent of post-translational modifications 
modifying the erythrocyte is yet to be established; several cytoskeletal 
components such as spectrin, band 3, and protein 4.1 are differentially 
phosphorylated in infected erythrocytes (Doerig et al., 2015, Pantaleo et al., 
2011, Wu et al., 2009). Phosphorylation may regulate the timing of erythrocyte 
modification in different life stages; cytoskeleton-targeting proteins such as 
MESA and KAHRP contain many phosphorylation sites, for example. Other 
post-translational modifications such as myristoylation and palmitoylation are 
known to occur in P. falciparum yet very little is known about the functional 
significance of these changes (Doerig et al., 2015). 
It is clear that a complex network of proteins is involved in erythrocyte 
modification. These may be directly associated with the cytoskeleton or are 
involved in trafficking via Maurer’s clefts or regulation though post-translational 
modification. Very few exported proteins have been studied in detail, and 
elucidating the key players in modulating cell rigidity, cytoadhesion and nutrient 
import remains an important challenge in elucidating the cause of severe 
malaria. 
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1.5 Project Aims and Objectives 
The aim of this project was to further our understanding of how the malaria 
parasite modifies its host erythrocyte. Host cell rigidification and cytoadhesion to 
endothelial cells leads to the sequestration of infected cells in the 
microvasculature and contributes to a severe manifestation of the disease. 
While sequestration allows the parasite to evade the host immune system, 
changes to the nutrient permeability of host cells are necessary for parasite 
survival and growth. Greater insights into these processes may therefore lead to 
new vaccine candidates or drug targets for antimalarial treatment.  
It is likely that most proteins directly involved in modulating cytoskeleton rigidity, 
surface adhesion or the formation of new membrane channels are localised to 
the periphery of the host cell. Identifying proteins with domains capable of 
targeting this area is therefore an important first step in explaining the molecular 
basis of these modifications. A binding interaction with cytoskeletal components 
has been elucidated for only a handful of proteins to date; these were mostly 
validated in vitro and confirmation of targeting within the cell is required to 
ensure these interactions are biologically relevant. We aimed to find new 
proteins involved in modifying the host cell by identifying novel protein domains 
capable of targeting the erythrocyte periphery. Previously, other conserved 
peripherally-targeting domains have been identified across exported proteins, 
such as the PRESAN domain of PHISTb proteins or the MESA erythrocyte 
cytoskeleton-binding (MEC) motif. It is therefore possible that other 
uncharacterised binding motifs are used by large groups of proteins with 
previously unidentified roles in erythrocyte modification.  
This project will mainly focus on proteins from P. falciparum as it is responsible 
for the most severe form of malaria. However other Plasmodium species such 
as P. knowlesi present an increasing threat to world health and there is 
currently little understanding of this neglected parasite. Comparisons between 
Plasmodium species will therefore be made to identify conserved mechanisms 
for survival, as well as to gain insights into the evolution of the species.  
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Chapter 2: Materials and Methods 
2.1 Cloning GFP-tagged constructs of Malaria Proteins 
2.1.1 Primer Design 
The gene sequences for all malaria proteins used were amplified by PCR from 
P. falciparum strain 3D7 gDNA (catalogue number MRA845 from Bei 
Resources (Adjalley et al., 2010)), P. reichenowi gDNA or P. knowlesi gDNA 
(from strain A1H.1 (Moon et al., 2013)). Primers for restriction ligation cloning 
were designed to anneal at a temperature of between 55 and 65 °C where 
possible, with a 3’ G or C base. NETPRIMER was used to check for possible 
primer-dimer formation. Primers were ordered from Integrated DNA 
Technologies (IDT). To clone repetitive fragments, primers were designed to 
bind the closest unique sequence to the repetitive DNA sequence to ensure the 
primers did not anneal at the wrong position in a repeating array (Fig 2.1A). 
Alternatively, an additional homologous sequence was included 5’ to the 
restriction site to target the primer to the end of the repetitive sequence, without 
including the flanking sequences in the final construct (Fig 2.1B). Overlap PCR 
was used to fuse two sequences together before ligation (Fig 2.1C). For the 
short GARP repeats and the P. gaboni GARP fragment where no genomic DNA 
was available, the sequence was built up by multiple overlapping primers in 
sequential PCR reactions (Fig 2.1D). All primer sequences are presented in 
Appendix Table 4. 
 
2.1.2 Polymerase Chain Reaction 
PCR was performed using phusion DNA polymerase (NEB) in high fidelity 
Phusion buffer with 200 µM dNTP mix (NEB), 0.5 µM forward and reverse 
primers and 250 ng template DNA in a 50 µL volume mix. Thirty cycles of 
denaturation at 97 °C, annealing at 50-65 °C, and extension at 68 °C were 
performed in a typical PCR reaction. Lower extension temperatures were used 
for particularly AT rich sequences, as low as 60 °C if necessary, with a longer 
extension time used to compensate for any effect on polymerase activity. The 
amplified DNA was purified with Promega DNA cleanup kit according to the 
manufacturer’s instructions. 
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Figure 2.1 – Primer design for restriction-digestion cloning. (A-D) Primers are 
represented with arrows in matching colours to homologous DNA sequences. 
Restriction sites are in orange. (A and B) DNA repeats are shown in blue. (C) Overlap 
PCR. (D) Gene synthesis using primer building blocks. 
 
2.1.3 Restriction-Ligation into expression vectors 
Restriction digestion was performed on PCR products and vectors using 
restriction endonucleases from either New England Biolabs (NEB) or Promega. 
DNA fragments encoding full-length proteins were inserted into P. falciparum 
expression vector PA446 upstream of a GFP tag and C-terminal strep tag, 
replacing the Rex3 sequence already present in the plasmid (Fig 2.2). 
Restriction sites AvrII and AatII or BglII were used for full-length genes. For the 
initial GARP truncations, fragments containing the Rex3 N-terminus and 
segments of the GARP gene were fused using overlap PCR and ligated into 
AvrII and BglII sites. For expression of exported protein fragments fused C-
terminal to the GFP tag with an N-terminal Rex3 sequence, the PA446 plasmid 
was modified to remove the linker between Rex3 and GFP and add a NheI site 
for the insertion of gene fragments after GFP. An extended linker and an AatII 
site was added between the GFP and the protein fragments (sequence: 
LESGSGTGASDV) for all but the initial GARP truncations (those shown in Fig 
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3.3). Expression was controlled by pfCAM 5′ and pbDT 3’ regions and plasmids 
contained a Blasticidin resistance gene. An attP site within the plasmid allowed 
for specific integration into the parasite genome at attB sites, mediated by a 
Bxb1 integrase (see 2.1.4) (Adjalley et al., 2010). The PfCAM promoter was 
replaced by the endogenous promoter for some proteins by cloning the 
promoter into the BlpI and AvrII sites or inserting both the promoter and full-
length gene into the BlpI and BglII sites. Digested vectors were either purified 
by gel extraction in 1% agarose or treated with calf intestinal alkaline 
phosphatase, followed by purification with Promega gel extraction cleanup kit in 
either case. DNA fragments were ligated into their respective vectors using T4 
DNA ligase. 
Five constructs were partly or fully cloned by Andrew Osborne: the original full-
length GARP gene; the full-length gene for PF3D7_0402000; and the 
endogenous promoter sequences for GARP, PF3D7_1102300 and 
PF3D7_1476200. 
 
Figure 2.2 – Construct design for expression of recombinant genes by P. 
falciparum parasites. Plasmid map for PA446 is represented on the left with key 
components highlighted. Examples of final plasmids are shown on the right: full length 
genes, gene fragments 5’ to GFP, gene fragments 3’ to GFP and genes expressed 
under their endogenous promoters. 
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2.1.4 Purification of DNA 
E. coli NEB 10-beta cells were used for ligation as they are particularly suited 
for large constructs. They were made electro-competent by growing up a single 
colony in 250mL super optimal broth (SOB containing 20 g/L Tryptone, 5 g/L 
Yeast Extract, 2.4 g/L MgSO4, 0.5g/L NaCl, 0.186 g/L KCl, from SIGMA) to an 
optical density of 0.6, then centrifuging at 2300 x g and washing three times in 
10% glycerol before storing at -80 °C. These cells were transformed with 5 µL 
of ligation reaction mix by electroporation with the following settings: 25µF, 
200ohms, 2.5KV. After 1 h of outgrowth in SOB, cells were plated on LB agar 
plates. A single colony was selected and grown overnight in LB broth 
(containing 10g/L Tryptone, 5 g/L Yeast Extract, 5 g/L NaCl, from SIGMA), 
before plasmid purification using a miniprep kit according to the manufacturer’s 
instructions (SIGMA). DNA yields were analysed using a Nanodrop 
spectrophotometer. Correct integration of inserts was confirmed by restriction 
digest or colony PCR; plasmids were then sequenced by Source Biosciences or 
GATC sequencing services.  
E. coli NEB DH5alpha cells were selected for midiprep as they are well-suited to 
routine cloning. Like 10-beta cells they are depleted in endonucleases 
preventing plasmid degradation and cannot utilise homologous recombination 
so genes can’t be easily lost. The cells were made chemically competent cells 
were made by growing 250 mL of E.coli to OD 0.45 then washing with 100 mM 
MgCl2 for 10 mins followed by 100 mM CaCl2 for 2 h, on ice. Cells were frozen 
in 100 mM CaCl2 with 10% glycerol. Plasmids were transformed into these cells 
by heat-shock for 30 s at 42 °C, before plating on LB-agar plates. Single 
colonies were picked and grown overnight in LB broth to saturation, then 
purified using Promega midi or maxiprep kits according to the manufacturer’s 
instructions. The final plasmids were then co-precipitated with a pINT no 
Neomycin plasmid (Adjalley et al., 2010, van Ooij et al., 2013); 10 µg each for 
transfection using the AMAXA kit and 100 µg of each for BIORAD pre-loaded 
erythrocyte transfection. The pINT plasmid encoded a Bxb1 integrase, which 
integrates the plasmid attP site into an attB site in the parasite genome (Adjalley 
et al., 2010).   
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2.2 Protocols for working with Plasmodium falciparum  
2.2.1 Culture of P. falciparum in Red Blood Cells 
P. falciparum 3D7 strain MRA845 attB parasites (Adjalley et al., 2010) were 
grown in human red blood cells of various blood groups at approximately 2.5% 
haematocrit in RPMI containing 0.5% albumax (Trager and Jensen, 1976)(From 
ThermoFisher). The MRA845 parasite strain contains an attB site for integration 
of plasmids using Bxb integrase; this is selected for by the hDHFR gene which 
confers resistance to WR. Media was therefore supplemented with 2.5 nM WR. 
Parasite cultures were kept in chambers gassed daily for 4 minutes with 5% O2, 
5% CO2 and balanced N2 in 37 ˚C incubators (BOC). Parasitemia levels were 
regularly determined by examination of giemsa stained parasites; a drop of 
parasite culture was deposited on glass slides and smeared, before being fixed 
for 30s in 100% methanol and stained with Giemsa stain (15% Giemsa stain in 
10 mM phosphate buffer, pH 7.4) (From SIGMA). Parasites were viewed using 
a 100x oil immersion lens. 
 
2.2.2 Transfection of Plasmids into P. falciparum cells  
For AMAXA transfection, the parasites were synchronised by overlaying 5 mL of 
culture onto a 3mL 65% percoll/sorbitol gradient (65% percoll, 3% sorbitol in 
PBS) and centrifuged at 2300 x g for 10 minutes to give ~95% segmenting 
schizont stage parasites. These were allowed to invade fresh erythrocytes for 2 
h before an additional percoll step to remove schizonts which did not egress in 
this time. This process was repeated at the point of egress over several days to 
acquire tightly synchronised parasites. The pINT and expression plasmids were 
combined and resuspended in miliQ water and transferred to chilled cuvettes 
with percoll-purified parasites (segmenting schizonts) and AMAXA nucleofactor 
solution.  Parasites were transfected by electroporation with the Amaxa 
Nucleofector II kit using program U33 before being added to complete media 
with 2% erythrocytes. 
For BIORAD transfection, the expression plasmid and pINT plasmid were 
rehydrated in 30 µL H2O and 30 µL cytomix solution (containing 120 mM 
KCl0.15 mM CaCl2, 2 mM EGTA, 5 mM MgCl2, 10 mM K2HPO4/KH2PO4 pH 
7.6, and 25 mM HEPES). 1 mL of uninfected erythrocytes were pelleted and 
46 
 
resuspended in 10mL of cytomix, before a second centrifugation step (1800 x 
g). 400 µL of the compacted red blood cells were added to the plasmids and 
cuvettes were chilled on ice for 30 minutes before electroporation with the 
BIORAD GenePulser Xcell kit set at 0.31KV and 950 μF. The pre-loaded 
erythrocytes were resuspended in complete media and mixed-stage parasites 
were added to a parasitemia of approximately 1%. 
For both transfection methods, drug treatment with 2 μg/ml BSD was applied 
after 24 h to select for successfully transfected cells.  
 
2.2.3 Microscopy of GFP-tagged fluorescent Proteins within the Parasite 
Parasites were cultured to around 5% parasitemia, and fresh RPMI was added 
a day prior to imaging. A drop of the iRBC/RPMI media mix was placed onto 
glass slides and kept in place with a coverslip. Coverslips were sealed in place 
with 15% pig skin gelatin. A Zeiss Axiovert 200M microscope equipped with a 
HBO100 lamp and a 100X oil lens with a numerical aperture of 1,30 was used 
to observe the GFP-tagged parasites, with phase contrast and fluorescent 
images taken at room temperature with an AxioCam MR camera using 
AxioVision software release 4.8.2. Fluorescent trophozoite parasites were 
selected by eye, and photographed with an exposure time of 1 second for all 
fluorescent images and 0.1 seconds for phase contrast. Z-stacks of images 
were collected and deconvolved by iterative restoration (confidence limit: 95%, 
iteration limit: 10) using Volocity; a single image from the Z-stack is presented. 
Automatic brightness and contrast settings were applied to all images using 
ImageJ.  
 
2.2.4 Quantification and Statistical Analysis of Images 
Deconvolved images of fluorescent malaria parasites were analysed to 
establish the fluorescence intensity at the erythrocyte periphery relative to the 
erythrocyte cytosol for each parasite line (Tarr et al., 2014). A 40-pixel plot 
profile was taken across the erythrocyte membrane from the outside of the cell 
into the erythrocyte cytosol, with the cell membrane at the midpoint. Twenty 
images were quantified for each construct, taken from at least two imaging 
sessions on different days. The background and cytoplasmic signals were taken 
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as the average intensity of the first 5 pixels and pixels 30-35, respectively. 
Peripheral fluorescence was determined as the maximal signal intensity 
between pixels 15-25. The background signal was subtracted from both 
cytoplasmic and peripheral signal and the ratio of the normalised membrane to 
cytosolic signal was calculated to give the relative peak height for fluorescence 
intensity at the periphery, and the standard deviation (See Fig 3.5 for an 
example and Appendix Table 1 for quantification of all parasite lines).  
To establish whether relative fluorescence intensity at the periphery was 
significantly enhanced relative to control protein, statistical analysis was 
performed on each parasite line by comparison to the GFP-tagged REX31-61 
construct, which is efficiently exported and remains cytosolic. One-way ANOVA 
analysis with multiple comparisons was performed, with no correction for 
multiple comparisons and assuming a Gaussian distribution. Significance is 
indicated by asterisks, with a P-value < 0.0001 being extremely significant (****) 
a P-value of 0.0001 to 0.001 is extremely significant (***), P-value of 0.001 to 
0.01 is very significant (**) and P-value 0.01 to 0.05 is significant (*). P-values 
above 0.05 are not considered to be significant (ns). Pairs of constructs were 
also compared in the same way to establish significant differences (e.g. for 
GARP truncations). See Appendix Table 1 for statistical analysis of all parasite 
lines. 
 
2.2.5 Western Blotting of Transfected proteins 
Percoll-purified schizonts were prepared and resuspended in SDS-PAGE 
sample buffer before heating to 95 ˚C for 5 minutes. Approximately 2 x 10 6 
schizonts were loaded onto each well before running the gel in running buffer 
composed of 25 mM Tris, 192 mM Glycine, and 0.05% SDS (SIGMA). The gel 
was transferred to a nicrocellulose membrane (ThermoFisher) at 100 V for 1 h 
with transfer buffer containing 25 mM Tris, 192 mM Glycine, 0.05% SDS and 
10% methanol. The membrane was blocked with a 3% milk suspension in 50 
mM Tris, 150 mM NaCl with 0.1% TWEEN for 1 hour, before adding either 
rabbit α-GFP monoclonal antibody (Torrey Pines, Catalog Number: TP401, Lot 
Number: 071519)  at a dilution of 1:4000 or mouse α-histoaspartic protease 
(HAP – Monoclonal Antibody 3F10-6, catalogue number MRA-811A) diluted 
1:10000 (Liu et al., 2005) followed by three washes with milk solution, then the 
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addition of goat α-rabbit (ThermoFisher, Catalog number: 35568, Lot number: 
OK195926) or goat α-mouse secondary antibodies (ThermoFisher, Catalog 
number: 35521, Lot number: LB143097) containing a fluorescent tag, at a 
dilution of 1:10,000, with subsequent washing. The membrane was imaged with 
a LI-COR Odyssey imager with excitation at 700 nm or 800 nm depending on 
the antibody used. All western blots which are not shown in the main text are 
shown in Appendix Figure 1. 
 
2.2.6 Extraction of Proteins from Erythrocytes by their Solubility Profile 
Parasites were synchronised using a 65% percoll gradient to enrich for 
schizonts. To make red blood cell ghosts and remove the soluble components 
of the erythrocyte, the schizonts were resuspended in 50 μL  7.5 mM sodium 
phosphate pH 7.4 with 1 mM EDTA (SIGMA) in order to hypotonically lyse the 
cells. They were centrifuged at 18,500 x g for 10 min at 4˚C and the supernatant 
was removed from pelleted ‘ghosts’. To make triton shells, the ghost pellet was 
re-suspended in 50 μL chilled 1% triton X-100 in 50 mM Tris pH 8, 150 NaCl, 2 
mM EDTA (all SIGMA), and once again centrifuged at 18,500 x g for 10 min 
before separating the supernatant and insoluble pellet (Black et al., 2008). 
The pellets were resuspended to the same volume as the supernatant in buffer 
(i.e. 50 μL), and SDS-PAGE loading buffer  was added before heating to 95 ˚C 
for 10 min then applying the equivalent of 2 x 106 schizonts to each lane of an 
SDS-PAGE gel. The gel was transferred onto nitrocellusose at 100 mV, 400 A 
over 1 h transfer time in running buffer containing 10% methanol. Blots were 
probed with rabbit anti-GFP (Torrey Pines), rat anti- β spectrin or mouse anti-
band 3 to confirm successful extraction of fractions. 
 
2.2.7 Preparation of Gametocytes 
Asexual parasites in RPMI were adjusted to 0.1 % parasitemia and 6% 
haematocrit in 12.5 mL of RPMI media (Day 1).  The RPMI was exchanged for 
12.5 mL of fresh media on day 3, and exchanged for 25 mL of fresh media on 
days 4-11. Parasites were not passaged into new blood and were allowed to 
reach very high parasitema (~50%). Once a sufficient number of gametocytes 
had developed (Day 9), 2.8 ml of 0.5 M N-acetyl glucosamine (NAG -SIGMA) 
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was added to the culture to remove asexual parasites. This was replenished 
along with fresh RPMI each day for 3 days. On day 12, gametocytes were 
enriched by applying to a 65% percoll/sorbitol density gradient with 
centrifugation at 2300 x g for 10 minutes (Tanaka et al., 2013). The number of 
purified gametocytes was counted using a hemocytometer and normalised with 
sample buffer to the concentration of asexual parasites in a control culture, 
before applying 2 x 10 6 parasites to each well for SDS-PAGE gel 
electrophoreisis and western blotting. 
 
2.2.8 Lipid Kinase Inhibitors 
Wortmannin and phenyl-arsine oxide (SIGMA) were dissolved in DMSO and 
added to parasites expressing the full-length GARP-GFP construct at final 
concentrations of 10 µM and 2 µM, respectively. Bright field and fluorescence 
images of parasites were taken 5, 30 and 80 minutes following the addition of 
each compound. 
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2.3 Bioinformatics 
2.3.1 Protein and DNA sequence analysis 
Sequence disorder predictions were preformed using DISOPRED, and 
secondary structure predictions with PSIPRED (Buchan et al., 2013). 
PROTPARAM was used for calculating the predicted isoelectric point as well as 
amino acid percentages in individual proteins. Proteins were aligned in Jalview 
using standard TCOFFEE alignment (Waterhouse et al., 2009) .  
Plasmids were designed in APE and plasmid maps were built with SNAPGENE. 
Artemis software was used for genomic analysis.  
 
2.3.2 Comparison of GARP genes from Closely-Related Parasite Species 
A GARP homologue from P. gaboni was assembled from two incomplete 
protein sequences deposited in the NCBI, which were found using the inbuilt 
BLAST server (GenBank accession numbers: KYN95113.1 and KYN95116.1); 
the connecting region was assembled from sequence reads, which were also 
found using BLAST (GenBank Biosamples SAMN04053641 and 
SAMN04053639) (Sundararaman et al., 2016). The P. reichenowi GARP gene 
(PRCDC_0111200) was acquired from PlasmoDB (Version 26). 
 
2.3.3 Identification of putative, exported, lysine-rich, repeating protein 
sequences  
Protein coding sequences from P. falciparum, P. vivax, P. knowlesi, P. 
cynomolgi, P. reichenowi, P. berghei, P. chabaudi and P. yoelii (17X) were 
downloaded from PlasmoDB (Version 26). Putative exported proteins where 
identified by the presence of either a signal sequence (defined by SignalP 
(Petersen et al., 2011)), or a transmembrane domain within the first 100 
residues (defined using MPEX translocon TM analysis (Snider et al., 2009)) , 
and an RxL motif (where x is any amino acid) in the 50 residues following the 
signal sequence/transmembrane segment. Proteins containing more than 4 
transmembrane segments within the coding sequence are unlikely to be 
exported and were excluded from further analysis (see Appendix Text 1 for 
perl script).  
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A custom perl script utilising a sliding-window algorithm was used to identify 
proteins containing stretches of amino acids of at least 30 residues in length 
and with a lysine content of at least 20%.  Within the set of lysine-rich sequence 
fragments, repeating protein sequences were identified using the tandem repeat 
predictor T-REKS (standalone version, using a PSIM cut-off of 0.65) (Jorda and 
Kajava, 2009) (See Appendix Text 2 for perl script). Another custom perl script 
was used to select proteins in which the sequence region comprised of repeats 
was over 30 residues in length with an individual repeat unit length below 30 
residues. Multiple lysine-rich repeat sequences were found in some proteins 
(See Appendix Text 3 for perl script). The program XSTREAM (Newman and 
Cooper, 2007) was used to define the consensus sequence of each repeated 
array, the consensus error value for each repeat array, and the position of the 
repeated array within each protein. Parameters for XSTREAM were as follows; 
min word match = 0.6, min consensus match = 0.65, miss penalty = -3, and gap 
penalty = -5. Max period value was set to 40 residues unless shorter repeats 
were apparent within the predicted consensus sequence; other parameters 
were set to default values. Theoretical isoelectric point values were predicted by 
PROTPARAM (Gasteiger et al., 2005). 
 
2.3.4 Quantification of amino acid usage and repetitive sequences across 
species 
For the quantification of amino acid usage across Plasmodium species, protein 
sequences for P. falciparum, P. reichenowi, P. vivax, P. knowlesi, P. cynomolgi, 
P, berghei, P. chabaudi, and P. yoelii were downloaded from PlasmoDB 
(version 26). A perl script was written to scan all protein sequences for each of 
the 20 common amino acids, using global regular expression to search for 
single letter codes. The number of each amino acid was counted and the total 
printed out for each species.  
The same fasta protein sequences were used to calculate the number of 
proteins containing repetitive sequences across all Plasmodium species. The 
protein sequences were input into the repeat prediction program T-REKS. The 
output of T-REKS was analysed by a variation of the perl script ‘pickrepeats.pl’ 
as described earlier. This counted proteins containing repetitive sequences over 
30 residues in length, and printed out the results for each species. 
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2.3.5 Sequence analysis of proteins from different parasite isolates  
The protein sequences of lysine-rich proteins from different P. falciparum 
parasite strains were extracted from unassembled long-read PACBIO genome 
sequencing data obtained from the Pf3K consortium. Five lab isolates were 
included (3D7, DD2, IT, 7G8, and HB3) and eleven field isolates from Gabon, 
Guinea, UK, Kenya, Mali, Sudan, Senegal, Democratic Republic of the Congo, 
Togo, and Cambodia. No KAHRP genes were found in the DD2 or Kenyan 
isolates. LYMP was not found in one of the two Cambodian isolates. All 
alignments were created with T-COFFEE (Notredame et al., 2000), and 
represented with 'Multiple Align Show' (Stothard, 2000). 10 out of 141 gene 
sequences, indicated in Appendix Table 2, contain frameshift point mutations. 
It is unclear if these represent genuine mutations or sequencing errors in 
database sequences; for the purpose of sequence alignment the reading 
frames were restored. 
 
2.3.6 Sequence analysis of the KAHRP conserved domain  
Proteins with homology to the conserved domain of KAHRP and PfEMP3 were 
identified  by HMMer (Finn et al., 2011). Additionally, homologous sequences 
within the P. ovale genome were identified from unassembled sequence reads 
acquired from the Sanger Institute through the use of the in-built Blast server. 
Sequence reads from P. ovale proteins containing EKAL domains were 
assembled using the SEQman Ngen software (DNASTAR). Introns were 
manually annotated within genes from P. ovale, P. fragile, P. inui and P. 
cynomolgi where necessary. Potential sequencing errors resulting in frameshift 
mutations were corrected, and introns were annotated based on known 
Plasmodium splice sites. These modifications were made in five proteins from 
P. inui and P. cynomolgi (see Appendix Table 3). Sequences were aligned with 
T-COFFEE (Notredame et al., 2000) in Jalview (Waterhouse et al., 2009). 
Maximum likelihood estimation with TREE-PUZZLE (Schmidt et al., 2002) was 
used to create phylogenic trees based on an extended conserved domain, and 
assembled with FigTree v1.2.4 (Rambaut, 2014). Secondary structure 
predictions and disorder predictions were made by PSIPRED (Buchan et al., 
2013) and DISOPRED (Ward et al., 2004), respectively. 
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Chapter 3: The Glutamic-Acid Rich Protein (GARP): A Highly 
Charged Repetitive Protein Targeted to the Erythrocyte 
Periphery 
3.1 Abstract 
In a screen of GFP-tagged P. falciparum proteins predicted to be exported into 
the host cell, the glutamic acid-rich protein (GARP – gene identifier 
PF3D7_0113000) was found to localise to the periphery of the host erythrocyte. 
By expressing short fragments of GARP, we reveal that this targeting is 
conferred by the lysine-rich repetitive sequences of the protein, with three 
sequences composed of different repeated motifs each independently sufficient 
for localising to the periphery. Preliminary experiments indicate these 
sequences likely interact with components of the erythrocyte cytoskeleton. 
Truncation of one lysine-rich repeat indicated that targeting efficiency was 
dependent on the number of repeats present, indicating an avidity-based 
interaction. While P. falciparum GARP has expanded three functional repetitive 
sequences, the closely related species P. reichenowi and P. gaboni have 
expanded different non-targeting motifs or lack some repeats completely. We 
present a model for the de novo formation of functional targeting sequences in 
P. falciparum by expansion of lysine-rich motifs. 
 
3.2 Introduction 
The identification of proteins involved in erythrocyte modification is complicated 
by the difficulty in modifying the parasite genome. Gene deletions were 
traditionally conducted using single or double-crossover homologous 
recombination to substitute or modify the gene of interest (de Koning-Ward et 
al., 2015). Following transfection and drug selection, live parasites are usually 
observed after a period of between one and three months using this method, 
due to the rarity of integration events (Maier et al., 2006). One large screen of 
this kind has been conducted to date; the genes of several proteins containing a 
HT/PEXEL motif as well as proteins which were not predicted to be exported 
were deleted, and the effect on erythrocyte properties such as rigidity and 
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cytoadhesion were measured (Maier et al., 2008). This indicated that several 
genes are essential for asexual parasite growth; however it is also possible that 
a failure to recombine the plasmid was responsible for this phenotype (Maier et 
al., 2008). For successfully deleted genes it is often difficult to establish what 
constitutes a significant change in phenotype; several aspects such as the life 
stage of the parasites, parasitemia, and the levels of PfEMP1 surface antigen 
presented on the cell surface may affect deformability and cytoadhesive 
properties of the host cell (Kriek et al., 2003, Nash et al., 1989). Tightly 
synchronised parasites selected for a particular PfEMP1 antigen are therefore 
required, which is complicated by the long timescales required for parasite 
levels to recover following transfection. 
New technologies have greatly facilitated genome editing of P. falciparum 
parasites. The CRISPR/Cas9 system allows rapid and efficient site-directed 
modification of the genome (Ghorbal et al., 2014), while several conditional 
gene knock-down or deletion systems have enabled essential proteins to be 
probed. Proteins may be fused to a ligand-dependent FKBP protein 
destabilization domain (ddFKBP) (Armstrong and Goldberg, 2007) or genes 
may be flanked with LoxP sites and rapidly deleted by the addition of Cre 
recombinase (Jones et al., 2016). However, the cloning process is often 
laborious for these techniques, with multiple steps and recodonization of DNA 
often required (Jones et al., 2016). A simpler method for analysing protein 
localisation involves transfecting parasites with recombinant GFP-tagged 
proteins in plasmids which may be maintained episomally or integrated into the 
genome at a specific site. The p-INT integrase, for example, integrates plasmids 
containing an attP sequence into attB sites previously inserted into the parasite 
genome (Adjalley et al., 2010, Nkrumah et al., 2006). These proteins may be 
cloned with their endogenous promoters or with well-established strong 
promoters such as the PfCAM promoter for a clear fluorescent signal (Polson 
and Blackman, 2005).  
Prior to my arrival in the lab, a number of proteins predicted to be exported into 
the host cell were GFP-tagged and expressed from the PfCAM promoter. This 
screen identified a number of proteins which were localised to the periphery of 
the host cell, indicating an interaction with the erythrocyte membrane or the 
underlying cytoskeleton where important virulence-related changes are known 
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to occur. It is therefore likely given their localisation that these proteins may be 
involved in these modifications. One protein identified was the glutamic acid-rich 
protein (GARP), which was strongly targeted to the periphery of infected 
erythrocytes (Fig 3.1A). As no function has previously been assigned to GARP, 
we aimed to characterise its role in the host cell. 
GARP is an 80 KDa protein expressed by the parasite during the early 
trophozoite stage of the life cycle (Triglia et al., 1988). Like many Plasmodium 
falciparum proteins, it is highly repetitive and it is also enriched in charged 
residues; lysine, glutamate and aspartate constitute over half the amino acids in 
the protein. GARP is expected to be exported into the host erythrocyte; it 
contains an N-terminal signal sequence followed by a HT/PEXEL motif which is 
predicted to be cleaved in the endoplasmic reticulum, targeting the protein into 
the host cell. GARP contains five tandemly repeating sequences; the first four 
repetitive sequences contain mostly basic lysine residues while an acidic 100-
residue sequence at the C-terminus is predominantly composed of glutamic 
acid residues, giving the protein its name (Fig 3.1B). The lack of hydrophobic 
stretches within the protein suggests that it does not form a folded globular 
domain. Indeed, the protein disorder prediction program DISOPRED indicates 
the entire mature GARP sequence is intrinsically disordered (Fig 3.1C) (Ward et 
al., 2004). 
As with many repetitive sequences encoded by the parasite, GARP appears to 
be highly antigenic. Due to its reactivity to sera from adults in malaria endemic 
regions in Papua New Guinea, the protein sequence was deciphered in 1988 
(Triglia et al., 1988), however it has not been studied in detail since. A number 
of genome-wide experiments have indicated GARP may play an important role 
in the host cell; analysis of parasites infecting children with severe malaria 
indicated that GARP RNA transcripts were upregulated fivefold relative to 
parasites extracted from adults (Vignali et al., 2011), and different expression 
levels were also found in parasites with different PfEMP1 genes expressed 
(Ralph et al., 2005). GARP may therefore be involved in modulating 
cytoadhesion of infected erythrocytes.  The large gene deletion study previously 
mentioned did not observe a change in cytoadhesion upon deletion of GARP 
however, although some decrease in cytoskeleton rigidity was observed (Maier 
et al., 2008).  
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Figure 3.1 – The Glutamic Acid-rich protein (GARP) localises to the periphery of 
the host erythrocyte. (A) GFP-tagged GARP is localised to the periphery of the 
infected erythrocyte. Schematic of the infected cell, fluorescent image and phase 
contrast images are shown from left to right. Scale bar – 2µm. (B) The protein 
sequence of GARP. Basic residues are shaded blue and acidic residues in red. The 
five repetitive sequences are boxed and the signal sequence and HT/PEXEL motif are 
indicated. (C) Disorder prediction for GARP (using DISOPRED) (Ward et al., 2004). 
Amino acids are considered disordered if they have a confidence score over 0.5, 
represented by a dotted line.  
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To gain a greater understanding of the role of GARP and the domains 
responsible for its localisation at the erythrocyte periphery, multiple truncations 
of the protein were GFP-tagged and expressed in P. falciparum. These 
indicated several novel targeting sequences in the protein, and comparison with 
closely related species presents new insights into the evolution of functional 
disordered and low complexity sequences in the parasite.  
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3.3 Results 
3.3.1 Truncations of GARP indicate multiple targeting sequences are 
present in the protein 
To narrow down the protein sequence responsible for targeting GARP to the 
erythrocyte periphery, the sequence was split into three segments and cloned 
in-frame with a C-terminal GFP tag. As fragments lacking the N-terminal 
HT/PEXEL motif would not be exported into the host cell, these sequences 
were fused to the N-terminal 61 residues of the REX3 protein which has been 
used previously to mediate export and does not interact with any erythrocyte 
components on its own (Tarr et al., 2014, Sargeant et al., 2006). The N-terminal 
174 residues of the protein, GARP1-174, comprised the signal sequence, the 
endogenous HT/PEXEL motif and the first lysine-rich repeating sequence. The 
consensus sequence for this repeated motif, as defined by the repeat prediction 
program XSTREAM, is EKK (Newman and Cooper, 2007). This indicates the 
most common residues in each position; however the first position alternates 
between E, D, H and K (see sequence logo, Fig 3.2A). When expressed in P. 
falciparum parasites, this fragment was robustly exported into the host cell 
where it localised at the periphery of the erythrocyte, as with the full-length 
protein (Fig 3.2B). Fluorescence was also observed within the parasite; this is 
common for exported proteins which must be trafficked via the endoplasmic 
reticulum and are often internalised into the food vacuole of the parasite as it 
feeds on haemoglobin from the erythrocyte cytosol (Wickham et al., 2001). 
A construct containing the middle fragment, GARP175-523, encompassed another 
three tandemly repeated regions. The first contains seven repeats of the 
imperfectly repeated motif E-KE--K-KKQ-; dashes indicate the length of the 
repeated motif varies and that gaps are the most common feature within a 
position. The third and fourth repeats are adjacent to each other and represent 
nine EEHKE motifs followed by five repetitions of KGKKD. This construct 
encompassing all three repeats also localised GFP to the erythrocyte periphery, 
indicating there are multiple targeting sites within GARP (Fig 3.2C).  
The C-terminal truncation, GARP524-673, contained the acidic C-terminus of the 
protein, including 8 iterations of the sequence EEDEDDA. The GFP 
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fluorescence in this case was seen in the erythrocyte cytosol only, with no 
indication of peripheral targeting by this fragment (Fig 3.1D). 
 
 
Figure 3.2 – Multiple sequences within the Glutamic acid-rich protein (GARP) 
target the erythrocyte periphery. (A) Representation of GARP. The four lysine-rich 
repeating regions are highlighted in blue, and labelled R1-R4. The number of iterations 
of each tandem repeat is also shown. The export sequence represents both the ER-
targeting signal sequence and the HT motif for export. Sequence logos for the four 
lysine-rich repeats are shown below with conservation of each residue position 
represented on y-axis (bits). (B-D) GFP-tagged GARP truncations expressed in P. 
falciparum parasites. Construct representation shown to the left, GFP fluorescence and 
bright field images are shown on the left and the right panels, respectively.  
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3.3.2 Lysine-rich repeating sequences within GARP localise to the 
infected erythrocyte periphery 
To establish whether the first fragment, GARP1-174, was directed to the 
erythrocyte periphery via its lysine-rich repeats, two new constructs were 
created by splitting the sequence into two halves: one, GARP50-118, extended 
from the HT/PEXEL motif of the protein to the start of the repeats, while the 
other, GARP119-163, contained the first lysine-rich repeat sequence (see Fig 
3.2A). Both these constructs and all N-terminally truncated proteins hereafter 
were fused C-terminal to the GFP tag as the positioning of basic residues 
immediately adjacent to the REX3 HT-motif was shown to hinder export, 
possibly by impeding insertion into the ER. The construct configuration was 
therefore REX31-61: GFP: GARP fragment: Strep tag. Additional constructs were 
made encompassing the second lysine-rich repeat region in insolation as well 
as the sequence comprising the third and fourth repeat regions (constructs 
GARP372-446 and GARP253-340, respectively). When expressed by P. falciparum 
parasites, all three of the sequences containing lysine-rich repeats exhibited 
strong peripheral fluorescence (Fig 3.3B-D). Conversely, the non-repetitive and 
uncharged N-terminus of the protein, GARP50-118, was localised in the 
erythrocyte cytosol (Fig 3.3A). To confirm that the position of the GFP tag did 
not influence its targeting, the acidic C-terminus of GARP (GARP535-673) was 
also cloned after the GFP tag, and remained cytosolic as observed previously 
(Fig 3.3E). 
The targeting of GARP to the erythrocyte periphery can therefore be attributed 
to three lysine-rich repeating sequences. Each sequence is composed of 
different repeating motifs, suggesting that this may be a general phenomenon 
which may apply to other similar sequences. The repetitive but acidic C-
terminus did not localise to the erythrocyte periphery, confirming that this is not 
a characteristic of all repeating sequences, although this sequence may play 
another role at the periphery of the host cell. 
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Figure 3.3 – The Lysine-rich repetitive sequences of GARP target the erythrocyte 
periphery. (A-E) GFP-tagged truncations of GARP expressed in P. falciparum 
parasites. A schematic of each construct, GFP fluorescence and bright field images are 
shown from left to right. The export sequence represents the signal sequence and 
HT/PEXEL motif. Lysine-rich repeats are shaded blue and labelled according to 
position. Scale bar – 2µm.  
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3.3.3 The targeting efficiency of lysine-rich repeat sequences is length-
dependent 
The repetitive nature of all peripherally-localised sequences within GARP 
suggests that this may be an avidity-based interaction where each motif 
contributes to the overall affinity for a binding partner at the cell periphery. In 
this case, the length of the sequence may directly affect the targeting efficiency. 
To approximately define the minimum length required for peripheral localisation, 
the first lysine-rich repeat sequence of GARP was truncated from 45 residues to 
30 and 15 residue segments; containing fifteen, ten and five repeats of the 
(EDKH)KK motif, respectively (Fig 3.4). These three constructs contained a 
REX3 export sequence followed by GFP, with the GARP fragment at the C-
terminus. An extended linker sequence was inserted between GFP and the 
GARP fragment, to ensure no protein interactions were disrupted by the 
proximity of their binding site to GFP. GARP119-163(+linker) exhibited a clear 
localisation at the erythrocyte periphery, as seen for the same sequence without 
the linker, indicating the linker did not affect targeting (Fig 3.4A). A ring of GFP 
fluorescence at the membrane was also apparent for the truncated fragment 
GARP134-163, although the peripheral targeting was less efficient than that of the 
longer fragment; a greater amount of GFP fluorescence was seen in the 
erythrocyte cytosol in this case (Fig 3.4B). The shortest fragment of 15 
residues, GARP149-163, was not efficiently recruited to the periphery relative to 
the larger fragments (Fig 3.4C). 
To confirm these observations, twenty images of parasites expressing each 
GFP-tagged fragment were analysed using ImageJ. Plots of fluorescence 
intensity across the membrane are shown in Fig 3.5. A peak in fluorescence is 
apparent at the periphery for the fifteen and ten-repeat fragments (Fig 3.5A-B), 
whereas the shorter fragment shows a more uniform distribution throughout the 
erythrocyte (Fig 3.5C). The intensity of the fluorescent signal at the periphery 
relative to the erythrocyte cytosol was quantified for each image, and 
normalised to the background signal. The fold difference at the periphery 
relative to the cytosol was calculated for each image and the average is shown 
for all three constructs. This indicates a clear and significant reduction in 
targeting efficiency as the number of repeats decreases (Fig 3.5D). While some 
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fluorescence was observed at the periphery for the 5-repeat fragment, this was 
not significant and likely results from very low affinity for peripheral components. 
These data suggest that in the context of the first GARP repeat, a sequence of 
approximately 30 amino acids in length is necessary for robust peripheral 
targeting. This suggests that each repeated unit has some affinity for the 
binding partner, collectively contributing to an increased avidity of the 
interaction.  
 
Figure 3.4 – Truncating the first charged repeat of GARP decreases targeting 
efficiency. (A-C) Truncated fragments of the first lysine-rich repeat sequence (blue) of 
GARP, GFP-tagged and expressed in P. falciparum parasites. Expressed proteins are 
shown on the left, with dotted lines indicating the region cloned from the full-length 
protein. The export sequence (purple) of REX3 was used to drive export of each 
fragment. An additional linker was placed between the GFP and GARP fragments. 
GFP fluorescence and phase contrast images are shown in the left and right panels, 
respectively. Scale bar – 2µm.  
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Figure 3.5 - Quantification of GFP fluorescence at the periphery of infected 
erythrocytes. A 40-pixel plot profile was taken across the erythrocyte periphery. The 
background and cytoplasmic signals were taken as the average intensity of pixels 1-5 
and 30-35, respectively. Peripheral fluorescence was determined as the maximal signal 
intensity between pixels 15-25. The ratio of the normalised peripheral to cytosolic 
signal was calculated. (D) Statistical analysis by one-way ANOVA with multiple 
comparisons was performed, with significance indicated by asterisks with a P-value < 
0.0002 (*** - extremely significant), P-value < 0.0021 (** - very significant) and ns – not 
significant. Error bars: SEM. 
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3.3.4 Expansion of repeating lysine-rich sequences can generate 
sequences with a targeting function in exported parasite proteins 
Expansion and contraction of repeating sequences commonly occurs through 
DNA slippage during replication or unequal crossover during meiosis (DePristo 
et al., 2006). All targeting sequences within GARP are composed of repetitive 
sequences, with targeting efficiency shown to be dependent on the number of 
repeats. It is therefore likely that repeat expansion may have contributed to the 
evolution of these sequences.  
To investigate this, the protein sequences of Plasmodium species closely 
related to P. falciparum were compared. The chimpanzee-infecting species P. 
reichenowi and P. gaboni have recently undergone full genome sequencing, 
and are some of the closest relatives to P. falciparum found to date 
(Sundararaman et al., 2016, Otto et al., 2014). Both contain a homolog of 
GARP, which is not found in any other sequenced Plasmodium genomes. In P. 
reichenowi, the syntenic GARP sequence is mostly conserved with P. 
falciparum GARP; it contains an acidic C-terminus and the second, third and 
fourth lysine-rich repeat regions are similar. However, within the region of the 
first lysine-rich repeats the sequence diverges: the homologous region of P. 
reichenowi GARP contains only five repeats of the (EDHK)KK motif whereas P. 
falciparum GARP has fifteen (Fig 3.6 and 3.7A). Instead, a more acidic DE(TK) 
repeat has expanded in P. reichenowi GARP. 
In P. gaboni, more differences are apparent. While the acidic C-terminus and 
second lysine-rich repeat region of the protein are mostly intact, the other 
repetitive regions have undergone major changes: the third and fourth repeats 
have not expanded in this parasite species and instead an alternative lysine rich 
repeat with the consensus motif D(KQ)KKEQTEEHKHD has repeated five times 
near the C-terminus of the protein. Another insertion consists of five repetitions 
of the eight-residue sequence KP(AT)D(EVA)A(QL)H. Additionally, the first 
lysine rich repeat region has expanded differently again in P. gaboni compared 
to P. falciparum and P. reichenowi; a (HDN)KN repeat has expanded in this 
region in addition to four repeats which conform to the P. falciparum (EKDH)KK 
motif (Fig 3.6 and 3.7A). Analysis of the DNA sequence encoding the first 
lysine-rich repeat region indicates that the variation in repeated motifs is the 
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result of divergent expansion of different sequences rather than a frame-shift 
leading to an alternative open reading frame.  
P. falciparum GARP - M N V L F L S Y N I C I L F F V V C T L N F S T K C F S N G L L K N Q N I L N K S F D S I T G R L L - 50 
P. reichenowi GARP - M N V L F L S Y N I C I L F F V V C T L N F S T K C F S N D L L K N Q N I L N K S F A F I T G R L L - 50 
P. gaboni GARP - M N V L F L S Y N I C I L F L F V C T L K F S T K C F S N D L L K N Q N I V N K T F N F K S R R L L - 50 
I 
                                                     
P. falciparum GARP - N E T E L E K N K D D N S K S E T L L K E E K D E K D D V P T T S N D N L K N A H N N N E I S S S T - 100 
P. reichenowi GARP - N E A E L E K N K N D S T N S E T L L K D E K D E T - - - - - - - - - - - - - - - - - - - - - - - - - 76 
P. gaboni GARP - D E T E L E K N K N D N S T S E S I L K S E K D K K D N T H G T S N D N S K D F Y E N N K F F L S T - 100 
I 
                                          
 
          
P. falciparum GARP - D P T N I I N V N D K D N E N S V D - - - - - - - - - - - - - K K K D K K E K K H K K D K K E K K E - 137 
P. reichenowi GARP - - - - - - - - - - - - - - - - - - - - - - - D E T D E K D E T D E K D E T D E T D E K D E K H K K H - 104 
P. gaboni GARP - D Q I D I T D V N D K D N E N S A S G T N N N V N K K K K K N H K N D K N S K N S K N N K N S K N N - 150 
I 
 
 
                                                   
P. falciparum GARP - K K D K K E K K D K K E K K H K K E K K H K K D K K K E E N S E V M S L Y K T G Q H K P K N A T E H - 187 
P. reichenowi GARP - K K D K K E T N E K E E N V K E S S G K K K K E K K T K Q N N E M M S L Y K T G Q H K P K N A T E H - 154 
P. gaboni GARP - K N N K N N K K N N Y D K N N K N D K K K K K G K K K K Q N N E V M S L Y K T G Q H K P K N A R D N - 200 
I 
                                                     
P. falciparum GARP - G E E N L Y E E M V S E I N N N A Q G G L L L S S P Y Q Y R E Q G G C G I I S S V H E T S N D T K D - 237 
P. reichenowi GARP - A E Q N L H N E M V S E I N N N E Q S E S L L S S P C G Y S E Q G G C G T L S S V H E T S N N I N D - 204 
P. gaboni GARP - D E Q N I Y E K F I N E L T N N L E S T L L L S S L Y P Y S E Q G G C G I I S T V H D V F Y D I K E - 250 
I 
                              
 
                      
P. falciparum GARP - N D K E N I S E - - - - - D K K E D H Q Q E E M L K T L D K K E R K Q K E K E M K E Q E K I E K K K - 282 
P. reichenowi GARP - N D K E N K S E - - - - - D K K D D P K Q E E M L K T L D K K E R K Q K E K E M K K Q E K I E K K K - 249 
P. gaboni GARP - N D Y E N K D E E N K D V D K K Y E Q K Q E E T L K T L D K K E R R Q K E K E M K E H Q K - - - K Q - 297 
I 
 
 
                                                   
P. falciparum GARP - K K Q E E K E K K K Q E K E R K K Q E K K E R K Q K E K E M K K Q K K I E K E R K K K E E K E K K K - 332 
P. reichenowi GARP - K K K E E K E K K K Q E K E R K K Q E K K E R K Q K E K E M K K Q E K I E K K K K K K E E K E N - - - 297 
P. gaboni GARP - K E K E M K E H Q K K Q K E R K K K E D K E K K K L E K E K K M K E V T E K K K Q K K Q T - - - - - - 342 
I 
                                        
 
            
P. falciparum GARP - K K H D K E N E E T M Q Q P D Q T S E E T N N E I M V P L P S P L T D V T T P E E H K E G E H K E E - 382 
P. reichenowi GARP - K K H D K E N E E T M Q Q Q E Q T S E E N N N E N M V P L P S P V T D V S T P E E D K T E Q D K T E - 347 
P. gaboni GARP - - K Q I E Q N K E K I Q Q Q Q Q T S E E T N N E I M A P L P S P V T D V S T T Q E H K T E E K K E - - 390 
I 
                                   
 
                 
P. falciparum GARP - E H K E G E H K E G E H K E E E H K E E E H K K E E H K S K E H K S K G K K D K G K K D K G K H K - - 431 
P. reichenowi GARP - E D K T E Q - - - - - D K T E Q D K T E Q D K T E Q D K S K E K K Q K E K R K K G K K - - - - G K - - 387 
P. gaboni GARP - E G K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - H K I - 396 
I 
  
 
                                                  
P. falciparum GARP - - K A K K E K V K K H V V K N V I E D E D K D G V E I I N L E D K E A C E E Q H I T V E S R P L S Q - 480 
P. reichenowi GARP - - K G K K E K G K K H V V K N V M G D E D K D D V E I I N L E D K K A C E E Q H I T V E S R P L Y Q - 436 
P. gaboni GARP - D T K E K E K E E T H I L K N F I G T E H E D N I Q I I T L E D K K T C E Q Q H I T V K N K P L Y Q - 446 
I 
                                                     
P. falciparum GARP - P Q C K L I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - D E P E Q L T - 493 
P. reichenowi GARP - Q Q Y K L M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - D E P E Q L S - 449 
P. gaboni GARP - S Q Q K I I Q P K P A D E A Q H K P A D E A Q H K P T D V A L H K P T D V A L H K P T D A A Q Q L T - 496 
I 
                                                     
P. falciparum GARP - L M D K S K V E E K N L S I Q E Q L I G T I G R V N V V P R R D N H K K K M A K I E E A E L Q K Q K - 543 
P. reichenowi GARP - S K D K S K V E E K H L S I Q E Q L I G T I G R V N V V P R R D N K K N K M T N K D E T E V Q E Q K - 499 
P. gaboni GARP - L T D K T D V K E K H L S I Q E Q L I G N I G K V N V G P K K D D K I K N I T K K H E K K V Q K H T - 546 
I 
                                                     
P. falciparum GARP - H V D K E E - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 549 
P. reichenowi GARP - D G D K E E - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 505 
P. gaboni GARP - H V D K K K E Q T E E H K H D D Q K K E Q T E E H K H D D K K K E Q T E E H K H D D K K K E Q T E E - 596 
I 
                                                     
P. falciparum GARP - - - - - - - - - - - - - - - - - - - - - - D K K E E S K E V E E E S K E V - - - - Q E D E E E V E E - 574 
P. reichenowi GARP - - - - - - - - - - - - - - - - - - - - - - D K K E E S K E E D E E E E E E - - - - E N D E E E E E E - 530 
P. gaboni GARP - H K H D D K K K E Q T E E H K H D D K K E D K K E E S E E D S D E E S E E E S E E G S D E E S E E E - 646 
I 
                                                     
P. falciparum GARP - D E E E E E - - - E E E E E E E E E E E E E E - - - - - - - - - - E E E D E V E E D E D D A E E D E - 611 
P. reichenowi GARP - E E E N E E - - - E E E N E E E E E N E E E E - - - - - - - - - - E N E E E S E E E - - - - - - - - - 559 
P. gaboni GARP - S E E G S E E E S E E E S E E G S E E E S E G E D D D E D E E D E E D D D E D E E D D D E D E E D D - 696 
I 
                                                     
P. falciparum GARP - D D A E E D E - D D A E E D D D D A E E D D D D A E E D D D E D E D E D E E E E E D E E E E E E S E - 660 
P. reichenowi GARP - - - - - - - - - - - - - - - - - - - - - - - E E S E E S E - E E N D D E E S E E E E S E E E E E S E - 586 
P. gaboni GARP - E D E D D E E D D D D E N D D D E N D D D E D D D E E D D E D E E D E D D D E E E E D E D N E E S E - 746 
I 
                                                     
P. falciparum GARP - K K I K R N L R K N A K I 
                                     
- 673 
P. reichenowi GARP - K K I K R N L R K N A E I 
                                     
- 599 
P. gaboni GARP - K N K K T N L R K N - - A 
                                     
- 757 
I 
                                                     
Figure 3.6 – Alignment of the GARP protein sequence from P. falciparum, P. 
reichenowi and P. gaboni. Residues with 50% conservation or greater are shaded 
and the lysine-rich repeats (R1-R4) of P. falciparum GARP are boxed. 
R1 
R2 
R3 
R4 
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Once established, repetitive sequences often expand and contract dynamically, 
however it is uncommon for repeats to disappear completely; mutations in the 
sequence often fix sequence elements in place and expansion is generally 
more common than contraction in short tandem repeat sequences (Wheeler et 
al., 2007). As the only repetitive sequences common to all three closely-related 
Plasmodium species are the second lysine-rich sequence and acidic C-
terminus, it is likely these were the only repetitive sequences present within the 
common ancestor of these species. 
As our previous truncations of the first lysine-rich repeat sequence in P. 
falciparum suggests that five repetitions of the consensus motif is not sufficient 
for robust peripheral localisation, the homologous sequences within P. 
reichenowi and P. gaboni may not be sufficient to target the erythrocyte 
periphery. To test this, the N-terminus of the P. reichenowi GARP protein was 
GFP-tagged for expression in P. falciparum parasites; this construct contained 
the region of the first repetitive sequence only (Fig 3.7C). As predicted, the 
GFP-tagged P. reichenowi fragment GARP71-130 did not localise to the periphery 
of the erythrocyte, but remained cytoplasmic with some fluorescence retained 
within the parasite food vacuole (Fig 3.7C). This was compared to the 
previously mentioned homologous fragment of P. falciparum GARP119-163 which 
exhibits strong localisation at the periphery (Fig 3.7B). To confirm that P. 
gaboni GARP has not expanded a functional targeting domain at the 
homologous region to the third and fourth repeats in P. falciparum GARP, a 
sequence encompassing this region of both proteins was also GFP-tagged. As 
expected, the P. gaboni sequence remained in the erythrocyte cytosol (Fig 
3.7E) while the P. falciparum sequence was robustly targeted to the periphery 
(Fig 3.7D). 
While the acidic C-terminus and second lysine-rich repeat region of both P. 
reichenowi and P. gaboni GARP are largely intact, the loss of additional 
targeting sequences may affect protein function. In this case it is apparent that 
repeat expansion has led to the de novo formation of a targeting module in P. 
falciparum; such expansive changes to protein sequences on a relatively short 
timescale may provide a means of rapid evolution for the parasite. 
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Figure 3.7 – Repeat expansion may generatate functional targeting sequences. 
(A) Representation of GARP from P. falciparum (upper), P. reichenowi (middle), and P. 
gaboni (lower) with the export motif in purple and the acidic C-terminus in red. Lysine-
rich repeats matching those of P. falciparum are in blue. Alternative repeated motifs 
from P. reichenowi and P. gaboni are shown in pink and turquoise, respectively. 
Alignment of two lysine-rich repeat regions of PfGARP and its homologous regions in 
PrGARP and PgGARP are shown below.  Flanking conserved sequences are in grey. 
(B and D) GFP-tagged PfGARP, (C) PrGARP, and (D) PgGARP fragments 
(schematics of cloned region below and fluorescence and phase contrast images to left 
and right). Scale bar – 2µm. (F) Comparison of peripheral fluorescence with statistical 
analysis (**** - extremely significant). Error bars represent SEM. 
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3.3.5 Western Blotting confirms the expression of the correctly-sized 
protein fragments 
To confirm the expression of the correct GFP-tagged GARP fragments, 
erythrocytes infected with schizont-stage parasites were purified and analysed 
by western blotting (Fig 3.8). Anti-GFP was used to probe protein fragments, 
with anti-histoaspartic protease used as a loading control as this protein is 
highly expressed throughout the parasite life cycle. Bands at approximately the 
correct sizes were observed for most parasite lines, with degradation bands 
visible for several GARP constructs, possibly corresponding to protease 
cleavage sites within the protein. GFP-only bands at around 25 KDa are also 
commonly seen for GFP-tagged constructs. Many proteins also ran higher than 
expected, and the full-length protein often appeared as a blurred band much 
higher than the expected size of 100 KDa. This size discrepancy is common in 
repetitive or highly charged proteins, while blurry bands often correspond to 
post-translational modifications. While modifications to the protein cannot be 
dismissed, the unusual sequence composition of GARP likely affects its 
behaviour during SDS-PAGE electrophoresis. 
 
Figure 3.8 – Western blots of GFP-tagged GARP constructs. Anti-GFP western blot 
(top panel) of transfected parasites expressing GFP-tagged GARP constructs. 
Approximately 2 x 106 percoll-purified schizonts were loaded per lane, with anti-HAP 
used to confirm equal loading (lower panel). 
 
70 
 
 
3.3.6 Solubility Extraction Suggests GARP is bound to the Cytoskeleton 
Various components of the erythrocyte periphery may provide a binding surface 
for the lysine-rich sequences of GARP. The protein may interact with lipids in 
the erythrocyte membrane or it may bind to components of the unique 
erythrocyte cytoskeleton or other Plasmodium proteins localised to this region. 
The cytoskeleton is composed of a network of spectrin filaments linked to the 
membrane by both the Ankyrin and junctional complexes (Mankelow et al., 
2012). The cytoskeletal framework is known to be detergent insoluble, along 
with any proteins which are bound to its core components (Black et al., 2008). 
This was utilised to establish whether GARP interacts with the cytoskeleton, 
which is known to be extensively modified by the parasite. 
Solubility extraction experiments were performed with erythrocytes infected with 
GARP1-174 as this fragment was easily visualised by western blot compared to 
the full-length protein.  Components of red cells were sequentially extracted 
according to their solubility in different buffers (Fig 3.9A). Hypotonic hemolysis 
of the infected cells with a low-salt buffer was first performed in order to release 
the soluble components of the erythrocyte cytoplasm to create red blood cell 
‘ghosts’, where membrane and cytoskeleton components remain within the cell 
pellet. Following this, a 1% Triton detergent solution was used to solubilise the 
lipids and proteins within the erythrocyte membrane. Cytoskeletal 
transmembrane proteins such as Band 3 are also partially removed by this 
process but most cytoskeleton-associated proteins remain in the pellet fraction. 
Anti-spectrin and anti-band 3 antibodies were used to probe a western blot of 
the treated cells to confirm the correct extraction of proteins. 
Bands corresponding to GFP-tagged GARP1-174 were observed by western blot 
in both the pellet and supernatant of hypotonically lysed cells (Fig 3.9B); this is 
not surprising as some cytosolic fluorescence was also observed in 
erythrocytes infected with parasites expressing this fragment. Subsequent 
treatment with triton solution consistently yielded a similar distribution of protein 
in both insoluble and soluble fractions in three independent experiments, 
however an additional wash with triton solution was not able to extract any more 
of the GARP protein and a high proportion remained in the insoluble pellet (Fig 
3.9B). This suggests that at least a fraction of the GFP-tagged GARP1-174 
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protein is interacting with the erythrocyte cytoskeleton. The extraction of roughly 
half the protein during both hypotonic lysis and triton extraction may indicate 
that a proportion of the protein is only weakly associated with the cytoskeletal 
framework. However, while spectrin remained in the triton insoluble pellet as 
expected, Band 3 was only partially extracted; this may indicate incomplete 
solubilisation of proteins under the conditions used. 
 
Figure 3.9 –Triton solubility extraction of red blood cells expressing the first 
GARP repeat sequence.  (A) Depiction of erythrocyte components extracted at each 
step. Cells were first hypotonically lysed followed by extraction in 1% triton detergent. 
(B) Western blot with anti-spectrin, anti-Band 3 and anti-GFP used to probe the 
localisation of proteins at each step. 
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Smaller bands were also observed in extracted fractions for GFP-tagged 
GARP1-174; these are likely to be degradation products of the protein which were 
observed to a lesser extent previously. Interestingly, while the full-length protein 
fragment is evenly distributed between triton soluble and insoluble fractions, a 
fragment of around 40 KDa is predominantly insoluble. As the lysine-rich C-
terminal end of the protein fragment is GFP-tagged and the blot is probed with 
anti-GFP antibodies, this fragment likely contains the lysine-rich repeats of the 
protein. This may indicate an association between this sequence and the 
cytoskeleton, although it may also be a result of higher rates of proteolysis 
within the triton pellet. 
As the behaviour of GARP1-174 was similar to that of Band 3 when extracted with 
triton, a sodium carbonate extraction was also performed to extract all proteins 
which are not integral to membrane bilayers (Fujiki et al., 1982). Spectrin is 
therefore solubilised by sodium carbonate whereas Band 3 is not (Fig 3.10A). 
The lack of hydrophobic regions within GARP makes its incorporation into 
membranes highly unlikely, however when cells expressing the GARP119-163 
fragment were extracted with sodium carbonate, a large proportion of the 
protein remained in the insoluble fragment (Fig 3.10B). This may be explained 
by incomplete solubilisation of proteins contained within the parasite; 
incomplete extraction of GARP present in the secretory pathway or food 
vacuole of the parasite may account for this band. To support this, the 
extraction of the parasite-localised soluble protein histo-aspartic protease (HAP) 
was simultaneously probed using anti-HAP (Liu et al., 2005); this protein was 
also distributed between both soluble and insoluble fractions during both 
hypotonic lysis and carbonate extraction. Unlike GARP, HAP was also fully 
extracted by triton solution. It is therefore likely that GARP is not incorporated 
into the membrane and likely associates with the cytoskeleton, however the 
results are difficult to interpret due to the unusual sequence composition of 
GARP, which may affect its solubility in different solutions. 
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Fig 3.10 – Na2CO3 extraction of proteins from parasites expressing the first 
GARP repeat sequence.  (A) Integral membrane proteins are insoluble in Na2CO3. (B) 
Anti-spectrin, Anti-Band 3, Anti-HAP and Anti-GFP were used to probe the localisation 
of proteins at each step. 
 
3.3.7 Lipid Kinase Inhibitors do not affect the Localisation of GARP 
While the previous experiments suggested that GARP likely interacts with the 
erythrocyte cytoskeleton, the basic nature of the protein suggests it may have a 
natural affinity for negatively charged head groups on phospholipids, for 
example. Interestingly, lipid rafts enriched in PIP2 have been shown to form in 
the erythrocyte membrane upon P. falciparum infection (Murphy et al., 2007). 
To test whether GARP associates with these rafts, we added two known lipid 
kinase inhibitors to the cells to disrupt the balance of phosphatidylinositol 
phosphorylation. Wortmannin inhibits phosphoinositide 3-kinases (PI3Ks) which 
convert PIP2 into PIP3, while phenylarsine-oxide (PAO) inhibits 
phosphatidylinositol 4-kinases (PI4Ks) which are required for the formation of 
PIP2.  
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Both compounds were dissolved in DMSO and added to parasite cultures at 
final concentrations of 10 µM and 2 µM for wortmannin and PAO, respectively.  
DMSO alone was added to control cells. Images of parasites expressing the 
full-length GARP GFP-tagged construct were taken 5, 30 and 80 minutes 
following the addition of each compound. No effect on protein targeting was 
seen in this time for either inhibitor, suggesting that GARP does not associate 
with phosphatidylinositol lipids (Fig 3.11). After 24 hours the PAO-treated 
parasites were almost completely dead, suggesting that PIP2 formation may be 
essential. Inhibition of PI4Ks with other compounds has previously been shown 
to result in the death of the parasite (McNamara et al., 2013); however PAO is 
also a known tyrosine phosphatase inhibitor and this and other off-target effects 
may be responsible for its anti-malarial activity. Parasites treated with 
wortmannin were unaffected after 24 hours, although this is likely due to the 
rapid degeneration of the drug in aqueous conditions. Further experiments are 
necessary to validate the effect of these inhibitors. 
 
Figure 3.11 – Lipid kinase inhibitors do not affect peripheral targeting. Parasites 
expressing GFP-GARP were treated with a DMSO control, wortmannin, or PAO. They 
were imaged after 5, 30 and 80 minutes to observe any effect on localisation. 
 
75 
 
3.4 Discussion 
As modifications to the erythrocyte cytoskeleton and membrane are essential 
for parasite survival within the host, the identification of a novel protein 
localising to this region provides a new avenue of investigation for explaining 
such changes. GARP is a particularly unusual protein; such highly charged and 
repetitive proteins have previously been dismissed as nonsense protein 
sequences with no function (Muralidharan et al., 2011). The independent 
localisation of three lysine-rich repeating sequences to the erythrocyte periphery 
indicates this is not the case, and that expansion of repeats in Plasmodium may 
provide a means for creating novel targeting modules. 
The idea that repeat expansion may contribute to protein evolution has been 
suggested previously (Muralidharan and Goldberg, 2013, Moxon et al., 1994, 
Andrade et al., 2001, Levinson and Gutman, 1987, Verstrepen et al., 2005, 
DePristo et al., 2006, Gemayel et al., 2010, Gemayel et al., 2012, Toll-Riera et 
al., 2012). Single amino acid repeats are highly mutable and their expansion 
may create space for a novel domain to emerge (Muralidharan and Goldberg, 
2013). We provide direct evidence that expansion of a disordered and highly 
conserved repetitive sequence can lead to a gain of function by comparing 
closely related parasite species. While the P. reichenowi GARP sequence has 
expanded a non-functional acidic repetitive region at its N-terminus, P. 
falciparum has expanded a lysine-rich functional targeting sequence. In P. 
gaboni, a peripheral-targeting lysine-rich repeat is missing entirely. These 
divergent expansions may be in response to selective pressure within the 
chimpanzee or human hosts. Alternatively, repeats may expand randomly with 
non-functional repeats retained as neutral spacer sequences.  
The peripheral-targeting function of the lysine-rich repetitive sequences in 
GARP suggests they may contribute to rigidification of the cytoskeleton or the 
anchoring of cytoadhesive components to the cell membrane. Both these 
modifications are essential for the parasite to avoid the host immune system by 
sequestering infected erythrocytes in the microvasculature (Craig et al., 2012b). 
As the majority of GARP is composed of charged repetitive regions, its function 
is likely to be directly conferred by these sequences and their adhesion to 
peripheral components. Solubility extraction of the first lysine-rich repeat of 
GARP did not conclusively confirm an interaction with the erythrocyte 
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cytoskeleton; the highly charged nature of the protein likely affects its solubility 
in detergents and makes interpretation of these results difficult. However, as a 
large proportion of the protein remained in the insoluble fraction after multiple 
washes with triton buffer, some association with the triton-insoluble cytoskeleton 
is probable. This is supported by the fact that lipid kinase inhibitors do not affect 
localisation, making an interaction with lipid rafts unlikely, although it cannot be 
ruled out completely based on these preliminary experiments. 
Multiple sequences with a targeting function were found within GARP, 
suggesting the protein may crosslink various components of the erythrocyte 
cytoskeleton. This may be involved in stabilising protein complexes or 
preventing spectrin filaments from deforming, for example. This may explain the 
slight decrease in erythrocyte rigidity observed on deletion of the GARP gene 
(Maier et al., 2008). Interestingly, several degradation bands are present in 
Western blots of GARP, suggesting the protein may be cleaved by proteases. 
This cleavage may be a necessary step towards allowing merozoites to egress 
from the cell, by dismantling the rigid cytoskeleton. Alternatively, the protein 
may be degraded in the food vacuole or during cell lysis. The blurred band 
observed for the protein may also indicate heterogeneous post-translational 
modification to the protein resulting in a broader size range. 
The three lysine-rich sequences within GARP are composed of different 
repeated motifs. Repetitive sequences are present in more than 30% of the 
proteins encoded by the parasite (Mendes et al., 2013), and many are enriched 
in lysine residues due to the AT-rich nature of the parasite genome (DePristo et 
al., 2006). Similar sequences to those within GARP are therefore common 
within the parasite, and may confer the same targeting function. As proteins 
localised to the periphery of the erythrocyte play important roles in host-cell 
modification, the discovery of a novel targeting domain provides a significant 
step towards identifying other proteins localising to this region. 
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Chapter 4: Multiple Lysine-rich repeating Proteins with a 
Targeting Function 
4.1 Abstract 
In addition to the glutamic acid rich protein (GARP), several other proteins 
encoded by P. falciparum contain lysine-rich repetitive sequences. To establish 
whether these also form functional targeting sequences, an algorithm was 
written to identify proteins with a repetitive sequence containing over 20% lysine 
residues. Eleven proteins were selected to be GFP-tagged, including two which 
fell below the assigned criteria of the algorithm. Of these, eight repetitive 
sequences were localised at the erythrocyte periphery. Additionally, the Hyp12 
protein contained a lysine-rich sequence capable of targeting the periphery in 
isolation but targeting was inhibited by the presence of an acidic sequence in 
the full-length protein. Four proteins containing functional lysine-rich sequences 
were previously uncharacterised, while others were taken from proteins 
containing other domains capable of targeting the erythrocyte periphery or 
binding to cytoskeletal components (including KAHRP, MESA and LYMP) One 
novel protein was only weakly expressed in asexual stages under its 
endogenous promoter but was upregulated in gametocytes, indicating a role in 
modifying erythrocytes during the sexual stage of the life cycle. Analysis of long-
read sequence data of parasite field-isolates and lab strains indicates the length 
of some functional lysine-rich repeat sequences are highly variable, suggesting 
that the parasite may modulate the targeting efficiency of proteins by expanding 
and contracting repetitive sequences. 
 
4.2 Introduction 
The protein export predictor EXPORTPRED estimates that 458 proteins 
encoded by the malaria parasites are exported into the host cell, based on the 
presence of a signal sequence and a host targeting (HT/PEXEL) motif 
RxLxE/D/Q (Sargeant et al., 2006). It has since become apparent that an N-
terminal transmembrane domain may be utilised instead of a signal sequence to 
direct proteins to the ER, and that some mutations to the fifth position of the 
HT/PEXEL motif still allow cleavage by plasmepsin V and export into the host 
cell (Tarr et al., 2013, Boddey et al., 2013, Schulze et al., 2015). Lysine may 
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also replace arginine at the first position of the motif, although this has not been 
investigated in detail and it is not clear whether other residues at the fifth 
position are tolerated in this case (Schulze et al., 2015). Additionally, a 
significant number of PEXEL-negative exported proteins (PNEPs) have been 
identified (Heiber et al., 2013). It is therefore likely that the number of proteins 
involved in modifying the host cell is greater than first imagined. Within the 
current ‘exportome’ of the parasite, many proteins are characterised as 
‘conserved proteins of unknown function’, whose protein sequence bears little 
homology to proteins from other species and which do not contain any known 
functional domains. It is likely given the presence of an export element that 
many of these proteins play an important role within the host cell. The 
identification of several peripheral targeting sequences within the previously 
uncharacterised protein GARP suggests that many other peripherally-localised 
proteins may remain undiscovered, and that other protein domains may also be 
capable of targeting this important area of the cell. 
The screen of uncharacterised exported proteins which identified GARP also 
uncovered another peripheral targeting domain in the PHISTb family of proteins 
(Tarr et al., 2014). Protein fragments encompassing the Plasmodium RESA N-
terminal (PRESAN) domain of several of these proteins were found to 
independently localise to the erythrocyte periphery when exported by P. 
falciparum parasites (Tarr et al., 2014). The PRESAN domain of one PHISTb 
protein, named the lysine-rich membrane-associated PHISTb protein (LYMP), 
has been shown to associate with the ATS domain of PfEMP1 (Oberli et al., 
2016, Oberli et al., 2014), however it is not known whether the other proteins 
within this family also adhere to variant surface antigens. The C-terminus of 
LYMP is capable of binding to the cytoskeletal component Band 3 (Oberli et al., 
2016), possibly anchoring the surface antigen to the erythrocyte cytoskeleton. 
Deletion of LYMP reduces cytoadhesion of infected cells. The Band 3-binding 
C-terminus of the protein contains a 100 residue stretch followed by a lysine-
rich repeat sequence; however it is not clear whether the lysine-rich repeats 
themselves are responsible for this interaction. 
A peripheral-targeting module is also found in the mature-erythrocyte infecting 
surface antigen (MESA) (Bennett et al., 1997, Black et al., 2008). Contrary to its 
name it is not presented on the erythrocyte surface but instead binds to protein 
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4.1, a component of the junctional complex connecting the membrane to the 
cytoskeleton (Lustigman et al., 1990). While no function has yet been found for 
MESA, it has been characterised in detail and the protein 4.1 binding site was 
found to be a 20-residue sequence near the N-terminus of the protein, named 
the MESA erythrocyte cytoskeleton-binding (MEC) motif (Bennett et al., 1997). 
A search for other proteins containing this binding motif indicated that as many 
as 13 proteins contain similar sequences, with several shown to be capable of 
binding 4.1 in vitro, as well as adhering to inside out erythrocyte vesicles (Kilili 
and LaCount, 2011). While binding was weak in many cases, it is possible that 
many of these proteins also localise to the erythrocyte periphery in vivo. A yeast 
two hybrid screen also identified a PHISTa protein (PF3D7_0402000) capable 
of binding protein 4.1 via its PRESAN domain (Parish et al., 2013). 
 
Figure 4.1 – The erythrocyte cytoskeleton and membrane is modified by parasite 
proteins. Depiction of knob structures within the erythrocyte membrane, with the 
Plasmodium protein KAHRP in blue, PfEMP1 in purple, and cytoskeleton binding 
proteins LYMP, MESA, PfEMP3, Pf332, RESA and PHISTa protein PF3D7_0402000 in 
yellow. 
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Like LYMP, both MESA and PF3D7_0402000 contain repetitive and highly 
charged sequences; MESA is almost entirely composed of repeats of varying 
charge, while the PHISTa protein PF3D7_0402000 contains a repetitive lysine-
rich C-terminus. Other proteins previously found to localise to the periphery also 
contain highly charged repetitive sequences. For example, the ring-stage 
surface antigen (RESA) and Pf332 both contain acidic repeats rich in di-
glutamate motifs (Cowman et al., 1984); while the majority of the PfEMP3 
protein is composed of glutamate and lysine-rich repeats. As with MESA and 
PF3D7_0402000, the cytoskeleton targeting motif for each of these was found 
in non-repetitive and uncharged segments (Knuepfer et al., 2005, Pei et al., 
2007b, Waller et al., 2007b, Waller et al., 2010, Bennett et al., 1997, Parish et 
al., 2013, Foley et al., 1991); PfEMP3, RESA, and Pf332 bind to α-spectrin and 
actin, β-spectrin,  and actin, respectively (Foley et al., 1991, Pei et al., 2007b, 
Pei et al., 2007a, Waller et al., 2007a, Waller et al., 2010) and all three proteins 
are involved in modulating the rigidity of the cytoskeleton (Glenister et al., 2009, 
Hodder et al., 2009, Glenister et al., 2002, Pei et al., 2007a, Pei et al., 2007b, 
Mills et al., 2007). A representation of the erythrocyte cytoskeleton including the 
P. falciparum proteins binding to its components is shown in Fig 4.1.  
Due to the enrichment of lysine residues in the parasite genome, many lysine-
rich repetitive sequences are found in exported proteins which have no known 
function. The discovery that three different lysine-rich repeats within GARP are 
capable of targeting the periphery suggests that this may be a conserved 
phenomenon. We sought to investigate similar sequences in previously 
uncharacterised proteins as well as those with known roles at the erythrocyte 
periphery (Fig 4.1). 
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4.3 Results 
4.3.1 Prediction of Exported Proteins by a new Algorithm 
To investigate whether sequences similar to those in GARP are capable of 
targeting to the erythrocyte periphery, we searched for putative exported 
proteins containing lysine-rich repetitive sequences. Exported proteins contain a 
HT/PEXEL motif with the consensus sequence RxLxE/D/Q; however it has 
been shown that other residues may occur at the fifth position of the motif. As 
the available programs for predicting protein export do not account for this 
variation in the fifth position, a new algorithm was written for this purpose. All 
5777 P. falciparum proteins were downloaded from the parasite database, 
PlasmoDB (version 26) in fasta format. As entry into the ER may be mediated 
by a signal sequence or an N-terminal transmembrane domain, all proteins 
were first analysed by the signal peptide predictor SignalP (Petersen et al., 
2011) and the transmembrane domain identification software MPEX translocon 
TM analysis (Snider et al., 2009). Of all programs tested, MPEX proved to be 
the most successful in predicting N-terminal transmembrane domains in 
proteins known to be exported into the host cell.  
A perl script (Exportfind.pl – see Fig 4.2 for data flow chart) was written to 
analyse the output of these programs, and proteins which contained either a 
signal sequence or a transmembrane domain within the first 50 residues were 
selected. The sequences of these proteins were then searched using regular 
expression for RxL motifs (where x is any residue) within 100 residues of the 
signal peptide cleavage site or the end of the transmembrane domain. Proteins 
conforming to the above criteria were considered to be likely candidates for 
export, and were output in fasta format. Proteins with more than 4 
transmembrane domains were later removed from this exported protein subset, 
as they are unlikely to be targeted to the periphery as soluble proteins, and are 
therefore not of interest. 
Using our ‘Exportfind’ algorithm, 573 proteins are predicted to be exported. The 
‘Exportpred’ prediction software built into the PlasmoDB website predicts that 
458 proteins are exported (When Exportpred score threshold = 1) (Sargeant et 
al., 2006). Of these, 376 were also predicted by our algorithm (Fig 4.3). 
Proteins which were not predicted to be exported by our algorithm were mainly 
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from the VAR gene family (56 proteins) which are PEXEL-negative exported 
proteins (PNEPs) (Kriek et al., 2003). Other proteins predicted by ‘exportpred’ 
but not ‘exportfind’ include those containing a KxLxE/D/Q host-targeting motif, 
which has also been shown to be a functional export signal in some instances 
(Schulze et al., 2015). Considering KxLxEDQ motifs in our algorithm resulted in 
728 proteins predicted to be exported, including several proteins which are 
likely to function within the parasite, such as Acyl-CoA synthase (ACS6); the 
smaller RxL dataset was therefore used for detecting functional lysine-rich 
repeats to reduce false positives. Some additional proteins predicted by our 
algorithm are known to be exported, suggesting that it is less likely to miss 
potential candidates, although verification of export in some selected proteins 
will be required. 
 
Figure 4.2 - PERL script for the prediction of proteins exported from the parasite 
into the host cell. Programs are shaded grey and INPUT/OUTPUT text files in blue. 
Within the algorithm, green diamonds represent a YES/NO decision and yellow boxes 
represent processes. 
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Figure 4.3 – Venn diagram comparing proteins predicted to be exported by the 
parasite into the erythrocyte by two algorithms. Exported proteins predicted by 
‘exportfind’ are represented by the orange circle and those predicted by established 
program ‘exportpred’ are in purple. Of 82 proteins predicted by exportpred and not 
exportfind, 56 are VAR genes, which are not exported by the canonical export pathway. 
 
4.3.2 Many Exported Proteins Contain Lysine-rich Repetitive Sequences 
Lysine-rich sequences were identified in exported protein sequences using a 
sliding window algorithm written for this purpose (Chargesearch.pl – see Fig 
4.4). The proteins were scanned for sequences where 4 or more lysine residues 
were present in a 20 residue window.  If 30 or more consecutive windows 
reached this threshold, the corresponding protein sequence was considered 
lysine-rich and output in fasta format. Multiple lysine-rich sequences may 
therefore be found in each protein. A range of window lengths and lysine 
thresholds were tested; 20% lysine in a 20 residue window gave the largest 
number of protein sequences which were considered likely candidates by 
comparison to the GARP sequences. Altogether, 242 lysine-rich sequences 
were identified by ‘Chargesearch’. 
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Figure 4.4 - PERL script for the identification of lysine-rich sequences. The 
programs MPEX and SignalP were used to predict transmembrane domains (TM) and 
signal sequences (SS), respectively. Programs are shaded grey, and INPUT/OUTPUT 
text files in blue. Within the CHARGESEARCH.pl algorithm, green diamonds represent 
a YES/NO decision and yellow boxes represent processes. 
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As the peripheral targeting sequences of GARP were all repetitive, the program 
T-REKS was used to find tandem repeats within lysine-rich protein sequences 
(Jorda and Kajava, 2009). The program assigns a PSIM score to each repetitive 
sequence by considering the variation from the consensus motif, which 
represents the most common residue found at each position within the repeated 
sequence. A PSIM cut-off of 0.65 was used, with some lysine-rich sequences 
containing more than one different repeated motif. A perl script (pickrepeats.pl – 
see Fig 4.5 for data flow) was written to analyse the output of T-REKS and to 
select the longest repetitive sequence for each lysine rich repeat; repetitive 
sequences longer than 30 residues were selected as possible peripheral-
targeting protein sequences. The program retrieved the sequence of the lysine-
rich input fragment and the full length protein for each repetitive sequence. An 
alternative repeat prediction program, X-STREAM, was used to assign the 
consensus sequence, the motif length, the position of the repeat within the 
protein, and the error from consensus (analogous to psim) for each protein 
(Newman and Cooper, 2007).  
Thirty sequences, including those within GARP, were found to conform to the 
above criteria, with some proteins containing multiple repeating lysine-rich 
sequences resulting in 21 proteins altogether (Table 4.1). Additionally, exported 
proteins which were predicted by ‘Exportpred’ but not by our algorithm were 
analyzed, resulting in the addition of PHISTc protein PF3D7_0936800 to the list, 
which contains a KxLxE/D/Q HT/PEXEL motif (Schulze et al., 2015). A search 
of all known PNEPs did not find any proteins with repetitive sequences 
containing over 20% lysine. When all P. falciparum proteins were used as input 
for the ‘chargesearch.pl’ and ‘pickrepeats.pl’ programs, 410 lysine-rich 
sequences were found in 343 proteins, indicating that these sequences are not 
reserved for exported proteins. Some of these, for example the merozoite 
adhesive erythrocytic binding protein (MAEBL) (Blair et al., 2002) or the rhoptry-
associated membrane antigen (RAMA) may be released into the host cell upon 
invasion to interact with host-cell components. Altogether, 5.9% of all parasite 
proteins contain lysine-rich repeats which fulfil our criteria, whereas they were 
found in only 3.9% of proteins predicted by our algorithm to be exported. This 
suggests there is no particular enrichment for these repeats in proteins exported 
into the host cell. It is possible expansion of lysine-rich repeats is selected 
86 
 
against in exported proteins which are not required to be targeted to the 
periphery, whereas within the parasite they are retained as neutral spacer 
sequences. 
 
Figure 4.5 - PERL script for the identification of tandemly repeated motifs within 
lysine-rich protein sequences. The program T-REKS was used to predict short 
tandemly repeated protein sequences. Programs are shaded grey, and 
INPUT/OUTPUT text files in blue. Within the PICKREPEATS.PL algorithm, green 
diamonds represent a YES/NO decision and yellow boxes represent processes. 
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Table 4.1 – P. falciparum proteins with charged repeat sequences predicted to 
target to the erythrocyte periphery. Proteins selected to be GFP-tagged and 
expressed in P. falciparum are highlighted in green. An asterisk indicates proteins 
which did not localise to the erythrocyte periphery. The consensus sequence, position 
within the protein, repeat unit length, number of repeat units, and the error from 
consensus were defined by XSTREAM (Newman and Cooper, 2007). Theoretical pI 
calculated by PROTPARAM is shown for each fragment (Gasteiger et al., 2005). 
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4.3.3 Lysine-rich Repeats from Multiple Known Cytoskeleton-binding 
Proteins are capable of Targeting the Erythrocyte Periphery 
Sequences encoding lysine-rich repeat sequences from nine predicted exported 
proteins (Table 4.1 – highlighted in green) were selected for testing in P. 
falciparum infected erythrocytes. GFP-tagged genes fragments were assembled 
and co-transfection of the plasmids with the pINT plasmid allowed integration of 
the DNA into an attB site within the parasite genome (Nkrumah et al., 2006). 
Gene expression was driven by the PfCAM promoter, and protein localisation 
was assessed by fluorescence microscopy of live cells. As several proteins 
identified were previously known to target the erythrocyte periphery by other 
cytoskeleton-binding domains, the lysine-rich repeating sequences of these 
proteins were independently cloned in-frame with a REX3 export sequence.  
The lysine-rich C-terminus of LYMP has previously been implicated in 
interactions with the erythrocyte. The entire C-terminus of the protein was 
shown to bind inside-out erythrocyte vesicles (Proellocks et al., 2014); however 
the lysine-rich repeats alone were not sufficient for this interaction in vitro 
(Proellocks et al., 2014). The C-terminus was later shown to interact with 
cytoskeleton component band 3 by co-immunoprecipitation and in vitro binding 
assays, but the role of the repeats in this interaction was not tested (Oberli et 
al., 2016). To establish whether the lysine-rich repeat sequence of LYMP is 
capable of targeting the erythrocyte periphery independently in vivo, the 
sequence encoding the repeats, LYMP419-528, was cloned at the C-terminus of 
GFP and the Rex3 export sequence. When expressed by P. falciparum, this 
construct resulted in a clear ring of fluorescence at the periphery of the infected 
erythrocyte (Fig 4.6A). While it is not clear whether this localisation is due to an 
interaction with band 3, it indicates an interaction between the lysine-rich 
repeats of LYMP and peripheral components. This occurs independently of the 
interaction between the PHISTb PRESAN domain of LYMP with the ATS 
domain of PfEMP1 (Oberli et al., 2014, Oberli et al., 2016). 
Another PHISTb protein containing a lysine-rich repeating C-terminus, 
PF3D7_1476200, has previously been shown by the Osborne group to localise 
to the erythrocyte periphery (Tarr et al., 2014). It is unclear whether this is also 
due to an interaction with PfEMP1. When the lysine-rich repeats alone, 
PF3D7_1476200443-512, were expressed with a GFP tag, the fluorescent signal 
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was concentrated at the periphery (Fig 4.6B). The similarity between the two 
peripheral-targeting domains in LYMP and PF3D7_1476200 suggests they may 
play a similar role at the periphery.  
 
 
Figure 4.6 - Lysine-rich repeating sequences are present in proteins known to 
target the erythrocyte periphery. (A-D)  Identities of proteins are shown above each 
image. The left- and right-hand images show GFP localisation and a phase contrast 
image, respectively. A representation of the full-length protein is shown below each 
image, with the lysine-rich repeat regions in blue, export sequences (signal sequence 
and PEXEL-HT motif) in purple, PRESAN/PHIST domains in orange, acidic sequences 
in red, and the MESA erythrocyte cytoskeleton-binding (MEC) motif in brown. Dotted 
lines indicate the protein sequence cloned into each GFP-tagged construct, shown 
below the full-length protein. Protein schematics are approximately to scale, with MESA 
downscaled by ½. Scale bar - 2 μm.  
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The PRESAN domain of the PHISTa protein PF3D7_0402000, unlike other 
PRESAN domains characterised to date, has been shown to interact with the 
junctional complex component band 4.1 (Parish et al., 2013). 
Immunofluorescence localisation of the protein indicated its co-localisation with 
protein 4.1 at the parasitophorous vacuole (Parish et al., 2013); however, this 
protein contains a canonical HT/PEXEL motif and would therefore be expected 
to be exported and to bind protein 4.1 at the erythrocyte cytoskeleton. Once 
again, the lysine-rich repeat sequence at the C-terminus of the protein, 
PF3D7_0402000305-428, was robustly localised to the periphery of the host cell 
(Fig 4.6C). 
MESA has also been shown to interact with protein 4.1, this time via a MESA 
erythrocyte cytoskeleton-binding (MEC) motif near the N-terminus of the protein 
(Bennett et al., 1997). In these experiments, no other fragments of MESA 
appeared to interact with inside out erythrocyte vesicles (IOVs) in vitro (Bennett 
et al., 1997). The majority of the protein is composed of highly charged repeat 
sequences, three of which contain over 20% lysine residues. The second 
lysine-rich repeat sequence and flanking sequence has duplicated to form the 
third repeat.   A GFP fusion protein that contains both of these sequences 
(MESA850-1147) was expressed by P. falciparum parasites. This fragment also 
localised to the periphery of the infected cell (Fig 4.6D), despite not binding 
IOVs in vitro. 
A lysine-rich repeat of KAHRP has been previously shown to bind spectrin (Pei 
et al., 2005); a detailed look at the lysine-rich repeats of KAHRP will be given in 
Chapter 6. 
4.3.4 Novel Lysine-rich Repeating Proteins Localise to the Erythrocyte 
Periphery 
While the above-mentioned proteins have previously been shown to interact 
with cytoskeletal components or to localise to the erythrocyte periphery, other 
candidates containing lysine-rich repeat sequences are uncharacterised. Some 
contain PRESAN domains which have not been previously shown to behave as 
functional targeting domains. The protein PF3D7_1201000 contains two 
PRESAN domains belonging to the PHISTb and PHISTc subgroups, and 
previous unpublished work by our group indicated the PHISTb domain may 
weakly interact with the cytoskeleton. The protein PF3D7_1148700 contains a 
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PHISTc domain and is annotated as a gametocyte exported protein (GEXP12) 
as protein fragments have been detected by mass spectrometry in gametocyte 
stages of the parasite as well as in asexual stages. The lysine-rich repeats of 
both proteins were fused to GFP, and both exhibited fluorescence at the 
erythrocyte periphery. In the case of PF3D7_1201000292-397, the peripheral 
signal was relatively weak and only clearly visible in 50-80% of infected cells 
(Fig 4.7A). GFP-tagged GEXP12231-370, however, demonstrated more robust 
targeting of the C-terminal repeats (Fig 4.7B). 
 
Figure 4.7 – Multiple novel proteins from P. falciparum target the erythrocyte 
periphery. (A-D)  Identities of proteins are shown above each image. The left- and 
right-hand images show GFP localisation and a phase contrast image, respectively. A 
representation of the full-length protein is shown below each image, with the lysine-rich 
repeat regions in blue, export sequences (signal sequence and PEXEL-HT motif) in 
purple, PRESAN/PHIST domains in orange, acidic sequences in red, and 
transmembrane domains in yellow. Dotted lines indicate the protein sequence cloned 
into each GFP-tagged construct, shown below the full-length protein. Protein 
schematics are approximately to scale. Scale bar - 2 μm. 
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Unlike most lysine-rich repeat proteins discussed previously in the chapter 
which contain a folded domain, the PF3D7_1102300 protein, like GARP, is 
predicted to be entirely intrinsically disordered; the majority of the sequence is 
lysine-rich and repeating and no other potential cytoskeleton-binding domains 
are present. A fusion protein comprising the N-terminus of Rex3, GFP, and the 
lysine-rich sequence of PF3D7_1102300, (PF3D7_1102300121-415), was 
expressed in P. falciparum. GFP fluorescence was again localised at the 
periphery of the infected cell (Fig 4.7C); some brighter foci of fluorescence are 
also seen in some cells.  
Protein PF3D7_0114200 (Hyp2) is predicted to contain a C-terminal 
transmembrane domain as well as a lysine-rich repeat sequence. To test 
whether this lysine-rich repeating region can independently target the periphery, 
the transmembrane domain was removed and the repetitive sequence, Hyp297-
302, was GFP-tagged. In this case the fluorescence remained localised within 
the cytosol of the erythrocyte, with no peripheral targeting (Fig 4.7D).  The 
repeat sequence of the protein consists of eight repeats of the consensus motif 
KDHMKDDTKDDT, giving it an overall acidic character. The aspartate residues 
may therefore interfere with the targeting of lysine-residues to the periphery.  
Of the nine repetitive sequences with a lysine content of greater than 20%, eight 
were localised to the erythrocyte periphery (see chapter 6 for analysis of the 
KAHRP lysine-rich repeats), indicating  a low rate of false positives  for 
predicting functional lysine-rich repeat sequences using the criteria of 20% 
lysine in a moderately conserved repetitive sequence. To test the 
appropriateness of the thresholds for lysine-richness and repeat conservation 
selected for the algorithm, two proteins which fell short of these criteria were 
selected for testing. PF3D7_1149100.1 contains six repetitions of a 40-residue 
motif, but is composed of only 17% lysine residues. PF3D7_1301400 (Hyp12) 
contains a lysine-rich C-terminus which is not predicted to be repetitive by T-
REKS, however lowering the consensus match threshold in XSTREAM predicts 
a degenerate motif with the consensus sequence K-KKEK-QE repeated 8 times 
with a consensus error of 0.36. Interestingly, a GFP fusion of the lysine-rich C-
terminus, Hyp12297-381 was robustly localised to the periphery of the erythrocyte, 
suggesting that highly conserved repeats may not be necessary for targeting 
(Fig 4.8A). However, GFP-tagged PF3D7_1149100.1121-450 was observed only 
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in the erythrocyte cytosol, indicating that a certain level of lysine-richness may 
be required for peripheral localisation within the erythrocyte (Fig 4.8B).  
 
Figure 4.8 - Testing the algorithm criteria for peripheral targeting. (A) Protein 
Hyp12 contains a lysine-rich sequence with highly degenerate repeats below the 
consensus error threshold of 0.7, while (B) Protein Pf3D7_1149100.1 contains 17% 
lysine residues – below the 20% assigned threshold. The left- and right-hand images 
show GFP localisation and a phase contrast image, respectively. A representation of 
the full-length protein is to the right, with the lysine-rich repeat regions in blue, acidic 
sequence in red and export sequences (signal sequence and PEXEL-HT motif) in 
purple. Dotted lines indicate the protein sequence cloned into each GFP-tagged 
construct. Protein schematics are approximately to scale. Scale bar - 2 μm. 
 
4.3.5 Characterising Full-length Peripherally-Localised Proteins 
Many proteins which localise to the erythrocyte periphery are trafficked via 
Maurer’s clefts, and some proteins containing lysine-rich repeats predicted to 
target the periphery have been shown to be retained in this compartment 
(Nunes et al., 2010). To confirm that the endogenous versions of all proteins 
tested are robustly exported and localised to the periphery in the same manner 
as the lysine-rich fragments, the full-length proteins were tagged with a C-
terminal GFP-tag and expressed under the PfCAM promoter. MESA, KAHRP, 
LYMP, and the PHISTb protein PF3D7_1476200 have all been localised 
previously using antibodies or full-length proteins, and were not tested (Tarr et 
al., 2014, Horrocks et al., 2005, Coppel et al., 1988).  
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Figure 4.9 - Expression of full-length lysine-rich proteins. (A-F)  Identities of 
proteins are shown above each image. The left- and right-hand images show GFP 
localisation and a phase contrast image, respectively. A representation of each protein 
is shown below each image, with the lysine-rich repeat regions in blue, export 
sequences (signal sequence and PEXEL-HT motif) in purple, PRESAN/PHIST domains 
in orange, acidic sequences in red, and transmembrane domains in pink. Dotted lines 
indicate the protein sequence cloned into each GFP-tagged construct, shown below 
the full-length protein. Protein schematics are approximately to scale.  
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Proteins PF3D7_1102300 and GEXP12 were robustly exported and localised to 
the erythrocyte periphery (Fig 4.9A-B). In some cases, particularly in high-
parasitemia cultures, the GFP signal was also observed in numerous puncta at 
the periphery (not shown). The PHISTa protein PF3D7_0402000 was also 
robustly localised to the periphery (Fig 4.9C). The HYP2 protein was again 
expressed without the transmembrane C-terminus and was efficiently exported 
using its endogenous HT/PEXEL motif, as was the full-length protein 
PF3D7_1149100.1. Both remained in the erythrocyte cytosol, concurring with 
the behaviour of the individual repeating fragments (Fig 4.9D-E). The two-
PRESAN protein PF3D7_1021000 contains a non-canonical HT/PEXEL motif 
‘RILSS’ and the full-length protein was poorly exported into the erythrocyte, with 
a high proportion of the GFP signal seen in the parasitophorous vacuole. Some 
localisation at the periphery was observed in a number of cells (Fig 4.9F), 
however this localisation was not significantly increased relative to the REX3 
sequence alone. The isolated lysine-rich fragment of this protein was also 
weakly targeted to the periphery. 
4.3.6 Acidic and Basic Sequences in Hyp12 Interact and Inhibit Targeting 
In our previous experiments we demonstrated that the lysine-rich C-terminus of 
Hyp12 was strongly recruited to the periphery of the host cell. Surprisingly, the 
full-length protein expressed with a C-terminal GFP-tag remained in the 
erythrocyte cytosol (Fig 4.10A). We hypothesised that the GFP tag may 
interfere with localisation by shielding interactions with the lysine-rich 
sequences, so the Hyp12 sequence following the predicted cleavage site of the 
HT-PEXEL motif was cloned at the C-terminus of GFP. The GFP signal 
remained mainly cytosolic in this case, although some weak peripheral signal 
was seen in some cells (Fig 4.10B). Hyp12 contains a long acidic sequence at 
its N-terminus mainly composed of glutamate and aspartate residues; to 
investigate whether this sequence may block the interaction between the basic 
C-terminus and the erythrocyte periphery, this sequence was removed. 
Remarkably, in this case the fluorescent signal was robustly localised at the 
erythrocyte periphery, at levels comparable to the lysine-rich sequence alone 
(Fig 4.10C-D). Given the highly-charged nature of the sequences, it is likely that 
the acidic sequence directly interacts with the basic C-terminus, preventing it 
from interacting with peripheral components. Whether some trigger may 
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separate these sequences and allow the protein to be targeted to the periphery 
remains to be seen (Fig 4.10E).  
 
Figure 4.10 – The Hyp12 protein contains an acidic sequence which inhibits 
targeting to the erythrocyte periphery. (A-C) The left- and right-hand images show 
GFP localisation and a phase contrast image, respectively. A representation of the full-
length protein is to the left, with acidic sequences in red, basic sequences in blue, and 
export sequences (signal sequence and PEXEL-HT motif) in purple. (D) Quantification 
of the relative fluorescent signal at the erythrocyte periphery. Error bars represent 
SEM. ns – Not significant (P-value > 0.5) **** - Extremely significant (P-value < 
0.0001). Error bars represent SEM. (E) A potential model for dissociation of the 
charged sequences with an unknown trigger, which may lead to peripheral localisation. 
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4.3.7 A Peripherally-Targeted Protein is Upregulated in Gametocytes 
A number of transcriptomic and proteomic studies have indicated that the 
majority of proteins tested are expressed in the asexual stage of the parasite life 
cycle (Oehring et al., 2012, Le Roch et al., 2004). However it has been shown 
that overexpression or mis-timed expression may lead to mis-localisation of 
proteins in the parasite; the PfCAM promoter is a strong promoter which is 
active from early trophozoite stages of the parasite. To confirm that proteins 
containing lysine-rich repeats were capable of targeting the periphery at 
endogenous expression levels, the PfCAM promoter in some plasmids was 
replaced with the endogenous promoter sequence. The promoter sequences of 
GARP and PF3D7_1476200 were cloned from 1084 bp, and 926 bp upstream 
of the genes, respectively. Strong GFP fluorescence was observed for both 
proteins from early trophozoite stages onward (Fig 4.11A-B), concurring with 
several microarray studies indicating a high level of transcription at this stage 
for both genes (Le Roch et al., 2004). The proteins were robustly exported and 
clearly located at the erythrocyte periphery, as seen for the full-length proteins 
under the PfCAM promoter. 
 
Figure 4.11 – Both GARP and PF3D7_1476200 are expressed in asexual parasites 
under their endogenous promoters. (A and B) GFP-fluorescence and phase contrast 
images are shown on the left and right panels, respectively. A schematic of the protein 
is shown with lysine-rich repeats in blue, the export sequence in purple, the PHISTb 
domain in orange, acidic stretches in red, and the promoter in yellow.  
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Fragments of all proteins apart from protein Pf3D7_1102300 have been 
detected in asexual stages by mass spectrometry analysis. This protein is 
almost entirely composed of lysine-rich repeats which are expected to be 
digested by trypsin, possibly explaining why the protein isn’t detected by mass 
spectrometry. However, as transcription levels for the protein are also low (Le 
Roch et al., 2004), we decided to express the GFP-tagged full length protein 
under the endogenous promoter to confirm whether it is present in asexual 
parasites. The PfCAM promoter was replaced with the 967 nucleotides 
upstream of the Pf3D7_1102300 gene in the vector used to express the full-
length protein. 
Very low levels of fluorescence were detected from the protein in asexual 
parasites. A faint signal was detected above the background signal in some 
cells, indicating that the protein is expressed to some extent; in these cases a 
clear ring was observed at the erythrocyte periphery even in very weakly 
fluorescent cells (Fig 4.12A). A slightly stronger signal was observed in very 
late parasites. A very small proportion of young parasites displayed strong 
fluorescence which was robustly exported and localised at the periphery of the 
host cell. Interestingly, gametocytes which were present in the culture displayed 
a much stronger signal, indicating the protein may be expressed in sexual stage 
parasites (Fig 4.11B-C). The transcription data for the protein supports this, 
with an increase in transcription in sexual stage parasites relative to asexual 
stages (Pelle et al., 2015). It is possible that the young fluorescent parasites in 
the culture are early-stage gametocytes which have yet to become elongated. 
In later-stage gametocytes where some elongation of the parasite is evident, 
the fluorescent signal is clearly localised at the erythrocyte periphery (Fig 
4.11B). The protein is still expressed in the highly elongated late stage 
gametocytes, although the distribution is more disperse and foci of fluorescence 
can be seen at the tips of the cell in some cases (Fig 4.11C).  
A previous study has indicated that Pf3D7_1102300 is upregulated during heat 
shock in asexual stages (Oakley, 2006). We tested this theory by incubating the 
parasites at 41°C for 12-24 hours before imaging. Many more young fluorescent 
parasites were observed, although the signal was still low relative to the PfCAM 
promoter. Quantification of the protein signal by western blot confirms an 
increase in expression after heat shock and in gametocytes (Fig 4.11D). It is 
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therefore possible that Pf3D7_1102300 plays a role in gametocytes and is 
upregulated during malarial fever.  
 
 
Figure 4.12 – The lysine-rich repeating protein Pf3D7_1102300 is upregulated in 
gametocytes and during heat shock. (A-D) Parasites expressing Pf3D7_1102300 in 
various life stages and under heat shock. GFP-fluorescence and phase contrast 
images are shown on the left and right panels, respectively. A schematic of the protein 
is shown with lysine-rich repeats in blue, the export sequence in purple and the 
promoter in yellow. (E) Anti-GFP western blot of the parasites. 
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These data indicate that many diverse repetitive lysine-rich sequences, in which 
the size of the repeated unit can vary from 3-30 residues in length, have a 
propensity to localise to the periphery of the infected erythrocyte in asexual and 
sexual stage parasites. In Hyp12, a separate highly acidic sequence completely 
blocks the interaction of the lysine-rich sequence with the cell periphery, likely 
due to an interaction between the sequences. Although many of the repeating 
sequences contain both acidic and basic residues, most sequences capable of 
targeting the erythrocyte periphery had a theoretical isoelectric point value of 
over 9 (Table 4.1). The two exceptions, MESA (pI: 4.90) and the PHISTb/c 
protein PF3D7_1476200 (pI: 4.71), both display the least prominent peripheral 
targeting, and the aspartate-rich repeats of PF3D7_0114200 (pI: 5.12) 
remained entirely cytosolic. It is likely given the basic nature of lysine residues 
that the interaction with peripheral components is conferred by electrostatic 
interactions, and acidic residues within the repeats may therefore interfere with 
binding. Further work is required to elucidate the specific requirements for 
peripheral localisation. 
 
4.3.8 Variation in length between lysine-rich repeat regions in different P. 
falciparum strains 
The length of repeat sequences often varies between different parasite strains 
(Tan et al., 2010) and the preceding experiments with GARP suggest that 
variation in length of lysine-rich repeats may influence the efficiency with which 
these sequences can target proteins to the erythrocyte periphery. Using ‘long-
read’ sequence data generated by the PF3K consortium, we determined the 
extent of length variation in lysine-rich repeating sequences in the proteins 
shown to target the erythrocyte periphery. We compared the gene sequences of 
five laboratory strains of P. falciparum parasites (3D7, DD2, HB3, IT, and 7G8) 
as well as 11 parasites isolated from infected people from diverse geographic 
locations (Gabon, Guinea, UK, Kenya, Mali, Sudan, Senegal, Democratic 
Republic of the Congo, Togo, and Cambodia). 
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Figure 4.13 – The number of repeating units in peripheral-targeting proteins 
varies between different field isolates and lab strains. (A-H) Alignment of proteins 
containing lysine-rich repeating regions indicates considerable variation in length 
between strains. Histograms represent the frequency (y-axis) with which a given 
number of repeats (x-axis) is observed across all isolates. Schematics show the repeat 
architecture of the proteins from the PF3D7 strain. The export sequences (Signal 
sequence and PEXEL-HT motif) are in purple, lysine-rich repeats are in blue (>20% 
lysine), and other repeats in green. Schematics are approximately to scale. 
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Significant variation in repeat number is seen in many lysine-rich targeting 
sequences. The repeating sequences of LYMP, PHISTa protein 
PF3D7_0402000, and the first repeat of GARP, contain 5 to 7, 9 to 15, and 12 
to 17 copies of repeating motifs, respectively (Fig 4.13A-C). Although unlikely to 
lead to a complete loss or gain of function, these changes may modulate the 
targeting efficiency of these protein sequences.  The C-terminal repeat region of 
PF3D7_1102300  contains either 13 or 14 copies of the repeat motif 
EREKREKKEKE but the repeat sequences of the PHISTB protein 
PF3D7_1476200, GEXP12 and Hyp12 are invariant (Fig 4.13D-G). The 5’ 
repeats of KAHRP do not vary but variations in repeat number are observed for 
the 3’ repeats, as has been reported previously (Fig 4.13H) (Hirawake et al., 
1997, Triglia et al., 1987). In 3D7 parasites, the protein PF3D7_1201000, 
contains two PRESAN domains, which are separated by 18 units of the 
sequence DEKEK. In all isolates the repeat unit number has expanded; in some 
cases by as much as twofold (Fig 4.13I). 
In 3D7 parasites, MESA contains five repeat sequences; the first, third, fourth 
and fifth repeats vary significantly (Fig 4.14A). In the 3D7 genome, the 
sequence encoding the third repeat region, which is itself variable in length (Fig 
4.14B), is duplicated to form the fourth repeat. In other genomes the sequence 
is further duplicated resulting in 3 or 4 copies of this repeat sequence and its 
flanking regions (Fig 4.14C). GFP-tagged lysine-rich sequences from both 
MESA and PF3D7_1201000 displayed a weak fluorescence signal at the 
erythrocyte periphery; duplication and extension of the repeat regions may 
increase targeting efficiency of these sequences. 
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Fig 4.14 – Variation between field isolates in the repetitive sequences of MESA. 
(A) Schematic of the MESA protein sequence from the Pf3D7 strain. Histograms above 
each repeat sequence represent the frequency (y-axis) with which a given number of 
repeats (x-axis) is observed across all isolates. The export sequences (Signal 
sequence and PEXEL-HT motif) are in purple, lysine-rich repeats are in blue (>20% 
lysine), and other repeats in green. (B) Variation in the first KEKEEV repeats of MESA 
between isolates (origin indicated by country code in gene name – see methods). (C) A 
large protein domain (yellow) is duplicated twice in Pf3D7 and 3 or 4 times in field 
isolates. 
 
 
 
 
 
 
104 
 
4.4 Discussion 
Repetitive protein sequences are present in more than a third of P. falciparum 
proteins, yet very few examples of functional repeats have been identified to 
date. In addition to GARP, we have now identified three previously 
uncharacterised proteins which contain lysine-rich repetitive sequences capable 
of targeting the erythrocyte periphery: the entirely-charged protein 
PF3D7_1102300, PHISTc protein GEXP12, and protein PF3D7_1201000 which 
contains both PHISTb and PHISTc domains. These proteins may play important 
roles in modifying the erythrocyte membrane or cytoskeleton, and add to an 
increasingly complex network of proteins which localise to this important area. 
Elucidating how these proteins interact with the erythrocyte and with each other 
will greatly contribute to our understanding of the wholesale takeover of host 
cells by the parasite. 
Interestingly, both PF3D7_1102300 and GEXP12 are expressed in 
gametocytes (Le Roch et al., 2004). Dramatic modifications to the host cell 
occur as parasites differentiate into the sexual stage; knob structures are lost in 
the early stages yet the parasites somehow sequester in the bone marrow and 
spleen, before being released back into circulation in later stages (Pelle et al., 
2015). The gametocyte-infected erythrocytes initially become even more rigid 
than during asexual stages, but towards late gametocyte stages they become 
highly deformable in order to re-enter the circulatory system to be ingested by a 
mosquito (Tiburcio et al., 2012). These processes are largely unexplained and 
whether the lysine-rich proteins are involved in modulating these changes  
remains to be seen. 
Several proteins previously shown to interact with peripheral components of the 
erythrocyte are present in our cohort of lysine-rich repeating proteins. Of those 
tested, only LYMP and KAHRP have been previously attributed with functional 
roles in the erythrocyte; gene deletion of both proteins resulted in a loss of 
cytoadhesion (Proellocks et al., 2014, Crabb et al., 1997, Glenister et al., 2002), 
and KAHRP is also known to modulate the rigidity of the host cell and form 
cytoadherent knob structures (Crabb et al., 1997, Glenister et al., 2002, Rug et 
al., 2006). It is hypothesised that LYMP contributes to adhesion by anchoring 
the PfEMP1 surface antigen to the host cell surface, mediated by its PRESAN 
domain and a C-terminus which contains lysine-rich repeats (Proellocks et al., 
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2014, Oberli et al., 2014, Oberli et al., 2016). While it remains unclear whether 
the lysine-rich repeats are directly involved, their localisation at the periphery 
suggests they may contribute to PfEMP1 stabilisation.  
Three additional proteins which contain functional lysine-rich repeats also 
contain a PRESAN domain, and may therefore play a similar role to LYMP at 
the cell surface. About 60 variants of the PfEMP1 surface antigen have been 
found in P. falciparum, and it is possible that different PRESAN domains may 
bind the ATS domains of different versions of the protein. Interestingly, the 
PHISTc PRESAN domain of another lysine-rich protein on our list of candidates, 
PF3D7_0936800, has also been shown to interact with PfEMP1 but with a lower 
affinity than LYMP (Mayer et al., 2012); whether the lysine-rich repeats are 
functional in this case remains to be tested. Several PHISTb proteins contain 
PRESAN domains capable of localising to the periphery (Tarr et al., 2014); the 
lysine-rich repeat protein PF3D7_1476200 contains a PHISTb domain which 
may also interact with PfEMP1. However the PRESAN domain of PHISTa 
protein PF3D7_0402000 binds to protein 4.1 in vitro, suggesting the PRESAN 
domain may instead represent a general protein-interaction domain (Parish et 
al., 2013). As the lysine-rich repeats of this protein are also capable of targeting 
the erythrocyte periphery, it may play a role in crosslinking protein 4.1 to other 
cytoskeletal components.  
Four of the proteins tested have been included in a large-scale gene deletion 
screen (Maier et al., 2008). Individually deleting the genes encoding GARP, 
PF3D7_1102300, PHISTa protein PF3D7_0402000 and PHISTb/c protein 
PF3D7_1201000 does not result in a striking phenotype; however some 
decrease in infected cell rigidity is observed (Maier et al., 2008). Given the 
similarity between many of the lysine-rich proteins that we have characterized, it 
is likely that individual genes may be functionally redundant and that deletion of 
single genes may not be sufficient to reveal a phenotype. A more pronounced 
phenotype may be observed in vivo where fever and components of human 
serum have both been shown to affect the ability of the parasite to modulate the 
host cell; RESA strongly rigidifies the cytoskeleton under febrile temperatures 
(Mills et al., 2007), and previously knob-negative parasites can gain knob 
structures after injection into a human host (Stanisic et al., 2016). Similar 
simulation may be required to reveal a phenotype for these proteins. 
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Interestingly, the protein PF3D7_1102300, which is almost entirely composed of 
repeats, is upregulated fivefold during heat-shock (Oakley, 2006), and also in 
parasites selected for adhesion to a brain receptor (Claessens et al., 2012). As 
GARP is upregulated in children suffering from severe malaria and in parasites 
expressing different variant surface antigens (Vignali et al., 2011, Ralph et al., 
2005), an important role for these proteins may only become apparent in the 
context of a malarial infection. 
The full-length Hyp12 protein is localised in the erythrocyte cytosol, as shown 
by us and others previously (Petersen et al., 2015). However the presence of a 
C-terminal lysine-rich sequence in the protein which is capable of robustly 
targeting the erythrocyte periphery suggests that a particular trigger may ‘switch 
on’ this function. It may be possible to disrupt the interaction of the basic 
sequence with the inhibitory acidic sequence which is required to block 
localisation. This may potentially represent an additional level of adaptability for 
the parasite, allowing it to retain proteins in the erythrocyte cytosol until they are 
required at the periphery. Two other proteins belong to the Hyp12 family of 
‘hypothetical’ exported proteins, yet neither of the other two proteins contains 
either the lysine-rich C-terminus or the acidic N-terminus, suggesting these 
oppositely charged sequences expanded at the same time. The conserved 
sequence between the three proteins lies between the two charged sequences, 
and is predicted to form a folded domain. Further investigation is required to 
elucidate the role of this protein and its homologues in the host cell.  
Many of the lysine-rich repeating sequences in P. falciparum appear to be 
undergoing constant expansion and contraction. A high level of conservation 
between units in a repetitive sequence suggests a recent expansion has 
occurred, while mutations which build up over time can fix a repeat sequence in 
place. More degenerate repeats are therefore usually less prone to expand and 
contract (Jorda et al., 2010, Hughes, 2004). This is also observed in the 
PACBIO sequencing data, where the more degenerate repeats of the PHISTb 
protein PF3D7_1476200, the second repeat of GARP and the first lysine-rich 
repeat of KAHRP do not vary between isolates whereas the almost-perfect 
repeats of PF3D7_1201000 and PHISTa protein PF3D7_0402000 are highly 
dynamic. However, the highly conserved repeats of GEXP12 and 
PF3D7_1102300 are invariant, suggesting a more complex mechanism for 
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driving repeat mutability. While flexibility in the length of a repeat sequence may 
suggest its role is not essential for the parasite, retaining repeat adaptability 
may confer an advantage in different host environments. 
As highly degenerate repeats such as those within Hyp12 are capable of 
targeting the periphery, the pattern of lysine residues within a sequence may 
not be important for targeting; indeed, the lengths of repeating units vary 
between 3 and 30 residues in the proteins tested. Repeat expansion may 
therefore be utilised for gaining longer lysine-rich sequences but conservation of 
repeats does not appear to be necessary for function. The disordered nature of 
the sequences likely allows sufficient flexibility for lysine residues to be 
positioned in relation to a binding partner. Alternatively, lysine-rich sequences 
may interact with different components at the periphery depending on the 
repetitive motif present. 
There is also no apparent consensus in sequence composition between 
functional lysine-rich sequences; despite the high predicted isoelectric points of 
most of the sequences, many peripherally-localised repeats also contain acidic 
residues, and glutamine residues are also common. This variability between 
lysine-rich repeat sequences makes accurate prediction of sequences with a 
targeting function difficult. Despite this, the algorithm was successful in 
predicting a targeting function in eight out of nine proteins selected. Some 
untested proteins such as PfEMP3, the FIKK kinases FIKK4.1 and FIKK7.1, and 
the megadalton repeat protein Pf11-1 are also implicated in modulating 
cytoskeletal properties (Scherf et al., 1992, Brandt and Bailey, 2013, Nunes et 
al., 2010, Knuepfer et al., 2005, Pei et al., 2007a, Waller et al., 2007b). 
However, FIKK4.1 and the PfEMP1 trafficking protein (PTP3) have been shown 
to localise to Maurer’s clefts or the erythrocyte cytoplasm, respectively (Nunes 
et al., 2007, Maier et al., 2008). The lysine-rich repeats of MESA and LYMP 
were not able to independently associate with inside out erythrocyte vesicles in 
vitro (Bennett et al., 1997, Proellocks et al., 2014), suggesting that post-
translational modifications may be involved.  Testing of other lysine-rich 
repeating sequences may elucidate more details on the criteria required for 
targeting.  
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Chapter 5: Potential Domains for Modulating Cytoadhesion are 
Conserved between Plasmodium Species  
5.1 Abstract 
While erythrocyte modifications are known to be important for parasite survival 
for P. falciparum, their role in other Plasmodium species is not well established. 
We show that lysine-rich repetitive sequences are present in all Plasmodium 
species whose genomes have been sequenced, and that one such sequence 
from a P. knowlesi protein is capable of targeting the erythrocyte periphery 
when expressed by P. falciparum parasites. This protein is particularly 
interesting as it also contains a domain homologous to the N-terminus of P. 
falciparum KAHRP, which is known to play important roles in the formation of 
knob structures. We confirm that the first lysine-rich repeat of KAHRP is 
capable of targeting the cytoskeleton as previously indicated in vitro, and that 
the conserved domain also forms GFP puncta at the host cell periphery, 
indicating it may play a clustering role. This conserved domain was shown to be 
present in more than twenty proteins across primate-infecting Plasmodium 
species, including the well-studied PfEMP3 protein which was previously shown 
to modulate erythrocyte rigidity. The identification of several conserved targeting 
sequences across different species of Plasmodium suggests the mechanisms 
for modifying the erythrocyte are more conserved than previously thought. 
 
5.2 Introduction 
Five Plasmodium species are known to infect humans, with P. falciparum 
causing the most severe form of malaria. P. vivax is the most prevalent outside 
sub-Saharan Africa; it is not as virulent as P. falciparum but can prove fatal in 
some cases (Anstey et al., 2012). P. vivax parasites can remain dormant in the 
liver as hypnozoites which can lead to relapse of the disease, making 
eradication difficult. The species P. ovale and P. malariae also infect humans 
but are not widespread and have comparatively mild symptoms (Collins and 
Jeffery, 2007, Collins and Jeffery, 2005). The fifth malaria species known to 
infect humans, Plasmodium knowlesi, is a zoonotic malaria species which 
primarily infects macaques but may also be transferred to humans, where it can 
be fatal (Cox-Singh et al., 2008). Relative to P. falciparum, little is known about 
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these other malaria species. However, the genomes of all human-infecting 
Plasmodium species apart from P. malariae have now been fully sequenced, 
allowing new insights into these important species (Ansari et al., 2016, Gardner 
et al., 2002, Carlton et al., 2008, Pain et al., 2008). 
It was originally believed that Plasmodium falciparum originated from the closely 
related chimpanzee-infecting species P. reichenowi, possibly at the point our 
human ancestors diverged from chimpanzees more than 5 million years ago 
(Escalante and Ayala, 1994). Recently however, mitochondrial and nuclear 
DNA from parasites found in the faeces of African gorillas and chimpanzees has 
been sequenced, indicating that a gorilla-infecting parasite species, named P. 
praefalciparum , is the true ancestor of P. falciparum (Liu et al., 2010). Within 
this clade, named Lavernia, other closely-related parasite species were found to 
infect chimpanzees and gorillas in a host-dependent manner; P. reichenowi, P. 
gaboni and P. billcollinsi infect chimpanzees while P. adleri, P. blacklocki and P. 
praefalciparum infect gorillas (Liu et al., 2010). Phylogenetic analysis of 
mitochondrial gene sequences such as cytochrome oxidase subunit 1 (COX1) 
indicates these species are highly divergent from other human-infecting 
Plasmodium species such as P. vivax and P. knowlesi (Fig 5.1). 
The other human-infecting Plasmodium species cluster with species infecting 
macaques and other Asian old-world monkeys; P. vivax, P. knowlesi, P. inui, P. 
fragile, P. hylobati and P. cynomolgi are all closely related, while P. malariae 
and P. ovale are more divergent. This concurs with phylogenic analysis 
performed on other protein sequences (Escalante and Ayala, 1994, Perkins and 
Schall, 2002). Malaria is also found in many other animal species; P. berghei, P. 
chabaudi, and P. yoelii infect mice and rats and have been instrumental in 
developing in vivo models of malaria disease in laboratory mice (Craig et al., 
2012a). Over 250 other Plasmodium species have been identified, for example 
P. gallinaceum which infects birds and P. mexicanum which infects lizards.  
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Figure 5.1 – Phylogenic tree of selected Plasmodium species infecting primates, 
birds, reptiles and rodents. A sequence fragment from the mitochondrial protein 
COX1 of each species was aligned by TCOFFEE and phylogeny was calculated by 
TREEPUZZLE maximum likelihood analysis and assembled using FigTree (Schmidt et 
al., 2002). Branch lengths are not to scale. The main vertebrate species invaded by 
each parasite species is represented on the right.  
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In P. falciparum-infected patients, sequestration of parasites in the brain 
microvasculature is believed to be responsible for symptoms such as seizures, 
coma and respiratory distress associated with cerebral malaria (Macpherson et 
al., 1985).  Patients infected with other Plasmodium species rarely become 
comatose, however other symptoms of cerebral malaria have now been 
documented in both P. vivax and P. knowlesi infected patients (Anstey et al., 
2012, Cox-Singh et al., 2010).  In an autopsy of a patient who died following a 
case of severe P. knowlesi malaria, infected erythrocytes were found to be 
congested in the blood vessels of the brain, suggesting that parasite 
sequestration may be occurring (Cox-Singh et al., 2010). In P. vivax-infected 
patients, late-stage parasites have been observed in peripheral circulation in 
some patients but not in others (Lopes et al., 2014). It is not known whether 
cytoadhesion in these parasites is important for virulence, or whether the 
molecular mechanisms involved in antigen presentation and variation are 
conserved with P. falciparum. 
The role of the knob-associated histidine-rich protein KAHRP in cytoadhesion is 
well-established; immuno-gold labelling of KAHRP in electron micrographs 
demonstrates a clear localisation within the electron dense knob protrusions 
(Culvenor et al., 1987, Taylor et al., 1987), and deletion of the KAHRP gene 
results in a loss of knobs and reduced cytoadhesion, as well as a 50% decrease 
in erythrocyte rigidity (Crabb et al., 1997, Glenister et al., 2002).  Proteins with 
domains homologous to KAHRP were previously found in P. knowlesi and P. 
vivax (Sargeant et al., 2006); however they were assumed not to be exported 
and their role has not been investigated. Other domains which are conserved in 
exported proteins from different species have been found to behave similarly; 
PHISTb domains in both P. knowlesi and P. vivax proteins were capable of 
targeting the erythrocyte periphery, for example (Tarr et al., 2014). To establish 
whether other erythrocyte-modulating mechanisms may be conserved between 
Plasmodium species, we investigated the role of lysine-rich repeats and other 
domains in a KAHRP homolog from P. knowlesi. Our findings indicate much 
greater conservation between species than previously thought. 
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5.3 Results 
5.3.1 Peripheral Targeting of Lysine-rich Repeating Sequences is 
conserved between Plasmodium Species 
To investigate whether the targeting of lysine-rich repeat regions to the 
erythrocyte periphery is conserved within Plasmodium species, we searched 
other parasite genomes for putative exported proteins that contain lysine-rich 
repeating sequences. The protein sequences for the primate-infecting species 
P. reichenowi, P. vivax, P. knowlesi, and P. cynomolgi, as well as mouse-
infecting species P. berghei, P. chabaudi and P. yoelii were downloaded from 
the malaria database PlasmoDB. The ‘exportfind.pl’, ‘chargesearch.pl’ and 
‘pickrepeats.pl’ programs were used with the same parameters as applied to P. 
falciparum. The proteins predicted to contain sequences with a targeting 
function are shown in Table 5.1.  
The largest numbers of potential periphery-targeting sequences were found in 
the P. reichenowi genome, with 21 proteins containing lysine-rich repeats, most 
of which are syntenic to those identified in P. falciparum. The genomes of three 
closely-related species that infect primates; P. knowlesi, P. vivax and P. 
cynomolgi contained 18, 15 and 6 lysine-rich repetitive proteins, respectively. 
These species do not have a strong A/T-rich bias relative to P. falciparum, and 
codon usage is more balanced meaning lysine residues are not as enriched 
(Fig 5.2A). Most P. cynomolgi proteins were also conserved in P. knowlesi and 
P. vivax, however other protein families have expanded in these two human-
infecting species. Notably, lysine-rich repeats are present in four P. vivax 
proteins from the PRESAN-domain family Pv-fam-E (RAD), which form an AT-
rich gene cluster on chromosome 5 (highlighted in blue, Table 5.1). These may 
play a similar role to P. falciparum proteins such as LYMP. Likewise, in P. 
knowlesi a group of 8 homologous proteins contains 6 exported lysine-rich 
repeating proteins with the consensus motif ‘KKEE’ (highlighted in green, Table 
5.1). These divergent gene families may play a human-specific role in the 
erythrocyte. Generally, fewer peripheral-targeting lysine-rich repeats were 
predicted in Plasmodium species infecting rodents; P. yoelli, P. chabaudi and P. 
berghei contain 10, 5 and 3, respectively. While lysine is similarly enriched in 
these parasites relative to P. falciparum, tandem repeats are less common (See 
Fig 5.2B). 
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Gene ID Alias Consensus Sequence Position 
Within 
Protein 
Repeat 
Unit 
Length 
Number 
of Repeat 
Units 
Error from 
Consensus PBANKA_0524700 
 
 EIYMENKKEEQQQSKKKEKVI 466-577 21 5.33 0 
PBANKA_0711200 
 
 EIKKTPTT- 233-355 8 15.25 0.09 
PBANKA_1145400 
 
 
EEKSEKKSKKKSEKKSEKKSEEKS 
217-295 24 3.29 0.14 
PCHAS_0404100 CSP  PGDK 79-175 4 24.25 0.11 
PCHAS_0521700 
 
 KENGEEKVT 677-714 9 4.22 0.03 
PCHAS_0524900 
 
 KKKETVIEIYMEDKKGEQQHP 437-493 21 2.71 0.12 
PCHAS_1201300 
 
 KEKQEK-ERKE 957-1043 10 8.7 0.23 
 QKPTD 814-960 5 29.4 0.12 
PCHAS_1370100 
 
 DGKKIFEEKKES 169-201 12 2.75 0.15 
 EKKSSNEKKTPG 199-231 12 2.75 0.06 
PCYB_051130 
 
 EKKAEKET 237-278 8 5.25 0.1 
PCYB_052240 RAD  KESKPNV 375-425 7 7.29 0.2 
PCYB_063210 EBP  EGDKG 285-313 5 5.8 0.17 
PCYB_081160 TRA  KKSPIIES 228-279 8 6.5 0.15 
PCYB_084720 
 
 PKKGAE 299-361 6 10.5 0.19 
PCYB_115490 
 
 NEKPKE 234-287 6 9 0.02 
 KGKD 216-227 4 3 0.15 
PKNH_0100400 
 
 KEEK 51-75 4 6.25 0 
PKNH_0200400 
 
 KEEV 442-486 4 11.25 0.16 
PKNH_0400300 
 
 KEEV 191-288 4 24.5 0.07 
PKNH_0623000 
 
 GKKECPFKAQNSESDKCA 462-703 18 13.44 0.04 
PKNH_0807900 
 
 KKEE 69-110 4 10.5 0.1 
PKNH_0841300 
 
 EKGAQKPGQKKVQEKKDSN 276-320 19 2.37 0 
 KKEE 69-170 4 25.5 0.06 
PKNH_0900500 
 
 KYENG 162-361 5 40 0.17 
PKNH_1100500 
 
 KYE-NG 162-263 5 20.2 0.17 
PKNH_1149200 
 
 KEK-E-QEKK- 209-270 8 7.25 0.21 
PKNH_1149700 
 
 KKEE 69-142 4 18.5 0.11 
PKNH_1246800 
 
 GNKYENKHEEKL 355-379 12 2.08 0.16 
 YNDK 322-350 4 7.25 0.03 
PKNH_1247400 
 
 GAQKPAQQKVQEKKDSNEK 344-491 19 7.79 0.03 
 EEKK 77-232 4 39 0.1 
PKNH_1304600 
 
 PPKGTKKKTPTEETEQQA 153-188 18 2 0.03 
PKNH_1313400 
 
 PTPKKE 266-299 6 5.67 0.09 
PKNH_1325700 KAHRP  PTVSQPPK 304-363 8 7.5 0.08 
 EQAKK 364-432 5 13.8 0 
PKNH_1325800 
 
 ETEKQDKPKYTYGSYKYPTVK 313-404 21 4.38 0.12 
 KKEKEKKDKKE 917-959 11 3.91 0.2 
PKNH_1441900 
 
 KKKEKEKEKE 242-271 10 3 0.1 
PKNH_1473200 
 
 KEEK 51-111 4 15.25 0 
PRCDC_0053100 RIFIN  KRQKHKEQRDKNIQKIIEKDKR 82-125 22 2 0 
PRCDC_0060600 PHISTB  KENNDNE 256-269 7 2 0.14 
PRCDC_0111200 GARP  KKERKQKEKEMKKQEKIEKK-- 229-296 20 3.4 0.19 
PRCDC_0112400 EPF3  DHMK 105-212 4 27 0.14 
PRCDC_0201000 EMP3  GLKENAELKNKELRNKGSD 694-793 19 5.26 0.03 
 KNKDI 796-818 5 4.6 0.26 
PRCDC_0201100 KAHRP GE-KKKSKKNKD-
NDDAESFKSKKSVKEK 
362-452 27 3.3 0.08 
 KGATKEASTS 545-613 10 6.9 0.09 
PRCDC_0500100 MESA  EKND-EKKDKVLG-EGDKEDVK 402-473 20 3.5 0.17 
PRCDC_0500500 PIESP2  KHKEDH 184-232 6 8.17 0.06 
PRCDC_0506400 SUB3  KNNDS 246-294 5 9.8 0.14 
PRCDC_0531400 LYMP  ENKKAGS 437-494 7 8.29 0.09 
PRCDC_0723000 FIKK 
7.1 
 KKEDKSCMKKTHGNKAEDE 226-305 19 4.21 0.08 
 DLIKNKEG 84-176 8 11.62 0.14 
PRCDC_0727700 PTP4  FVDNKEKTLGKHE-HHEEHVKGK 1210-
1444 
22 10.68 0.2 
PRCDC_1001500 PTP5  NETEKKTDQ 22 -262 9 4.33 0.05 
PRCDC_1037500 GSP 
 EKEEKIKKKKVIEKKK 1513-
1547 
16 2.19 0.28 
 E-PK-KEK--AP 623-
1776 
8 18.75 0.21 
 KDVKAKHK 550-
1566 
8 2.12 0.12 
 EEKFLK 370-381 6 2 0.17 
 D-EK 331-366 3 11.67 0.11 
PRCDC_1100800 
 
 ERKEREEREKQ 134-392 11 23.55 0.26 
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Table 5.1 – Proteins from multiple parasite species contain lysine-rich repeat 
sequences predicted to target to the erythrocyte periphery. Gene identifiers as 
follows: P. berghei – PBANKA, P. chabaudi – PCHAS, P. cynomolgi – PCYB, P. 
knowlesi – PKNH, P. reichenowi – PRCDC, P. vivax – PVX and P. yoelli – PY17X. The 
consensus sequence, position within the protein, repeat unit length, number of repeat 
units, and the error from consensus were defined by XSTREAM (51). The RAD family 
of P. vivax proteins is coloured blue and a conserved group of P. knowlesi proteins are 
coloured green. The P. knowlesi KAHRP-like protein is in red. 
PRCDC_1146600 PHISTc  KECIPKECIK 263-332 10 7 0.2 
PRCDC_1249000 LRR  DKKEDVDNEKYG 529-593 12 5.42 0.18 
PRCDC_1400500 
 
 QKKKKPSKYDDIRRFGEPT 73-139 19 3.53 0.13 
PRCDC_1431700 LRR5  KNNE 604-656 4 13.25 0.15 
PRCDC_1475300 PHISTB  KKEEDV 372-404 6 5.5 0.09 
PRCDC_1475600 
 
 NKEENKDN 471-505 8 4.38 0.06 
PVX_002507 Pv-fam-
b 
 GAMKNDTKKTPAKR 85-282 14 14.14 0.08 
PVX_002535 PHIST  LEEKLNVKKLQELVKLKD 87-143 18 3.17 0.19 
PVX_003535 
 
 NEMGK 192-247 5 11.2 0.11 
PVX_081440 
 
 KKRLKEEE 121-142 8 2.75 0.18 
 RKERK 92-103 5 2.4 0.17 
PVX_081835 KAHRP 
 KKETK 526-564 5 7.8 0.08 
 EINTE 563-642 5 16 0.14 
 EKKK- 686-713 4 6.75 0.07 
PVX_086900 
 
 RSHKKD 713-784 6 12 0.18 
PVX_089435 RAD 
 KKPTA-QV 436-483 7 6.86 0.12 
 EKKPDGK 484-504 7 3 0.19 
 GKPVE 503-515 5 2.6 0.08 
PVX_089790 RAD  KGKTPD 238-370 6 22.17 0.09 
PVX_089795 RAD  KGEAK 264-318 5 11 0.07 
PVX_089810 RAD  TKPKAG 238-265 6 4.67 0.04 
PVX_097575 TRA  PQSKAKQQ 962-1054 8 11.62 0.14 
PVX_110825 Pv-fam-
D 
 KNDDKDSFISGKS 1010-
1061 
13 4 0.13 
PVX_110835 
 
 EGDQ--D-GK-EDKGEEDEDGK 258-297 18 2 0.22 
 CPYKDQSVDKKE 772-823 12 4.33 0.1 
 KKTANVKKGAEP 1200-
1226 
12 2.25 0.04 
 DK-D-KDDK 293-337 7 6 0.32 
 EEEAKKL 1146-
1195 
7 7.14 0.16 
PVX_118682 EMP3  EAKKPEVKKT 001-
1030 
10 3 0.17 
PVX_119225 
 
 KKAAAP 3 7-362 6 9.33 0.14 
PY17X_0114200 fam-b  KKADVND 284-377 7 13.43 0.11 
PY17X_0114400 fam-b  DNKLDDK 175-198 7 3.43 0 
PY17X_0216300 
 
 KTEKIKNEVSN 603-688 11 7.82 0.13 
PY17X_0405400 CSP  KDDLPKEEK 89-122 9 3.78 0.12 
PY17X_0526100 
 
 EKVIEIYMEDKKGKEQESKKK 462-766 21 14.52 0.25 
PY17X_0711400 
 
 EIKKAPTSTEIKKASTST 233-307 18 4.17 0.13 
PY17X_0932500 Tyr-
tRNA 
ligase 
 EELKN 391-445 5 11 0.07 
PY17X_1112100 
 
 EIDKSIKKEEEHIKK- 120-173 15 3.6 0.26 
PY17X_1203700 
 
 QVTDK 1242-
1313 
5 14.4 0.15 
 QVSDK 677-768 5 18.4 0.14 
 QVTDK 787-1070 5 56.8 0.12 
PY17X_1440700 GyrA  KDE 125-164 3 13.33 0.15 
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Figure 5.2 – Amino acid bias and repetitive sequences across Plasmodium 
species. A) Percentages of each amino acid represented within the open reading 
frames of all species. B) Percentage of proteins containing at least one repetitive 
sequence over 30 residues in length, as predicted by T-REKS. 
 
5.3.2 A P. knowlesi Protein contains lysine-rich repeats with a targeting 
function 
To test whether lysine-rich sequences from parasites other than P. falciparum 
have targeting functions, we selected a protein from P. knowlesi to be tested. 
PKNH_1325700 (highlighted in red, Table 5.1) contains a non-canonical HT-
PEXEL sequence, ‘RSLSV’, and two repetitive lysine-rich stretches at its C-
terminus (Fig 5.3A). Notably, it also contains an N-terminal 70-residue 
sequence which is predicted to form a folded domain and is homologous to the 
N-terminus of Plasmodium falciparum KAHRP (Sargeant et al., 2006). The 
KAHRP-like domain has been identified in PKNH_1325700 previously, as well 
as in three P. vivax proteins; however it was assumed that these proteins would 
not be exported as they did not contain the canonical HT/PEXEL sequence 
RxLxE/D/Q (Sargeant et al., 2006).  
When expressed in P. falciparum -infected erythrocytes with a GFP tag, full-
length PKNH_1325700 was efficiently exported into the host cell, indicating that 
its PEXEL sequence is functional and confirming that the classical protein 
export prediction methods may lead to false negatives. Interestingly, the GFP 
signal appears as a partially punctuate distribution around the periphery of the 
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red blood cell (Fig 5.3B). In younger parasites, fewer of these puncta were 
present and a continuous line of fluorescence was apparent around the 
periphery of the cell (Fig 5.3C).  It is not clear whether these puncta represent 
knob structures; knobs have not been previously identified in P. knowlesi-
infected cells, however the punctuate pattern is similar to that seen with anti-
KAHRP antibodies in P. falciparum (Dixon et al., 2011, Waller et al., 2008). 
 
Fig 5.3 – The P. knowlesi protein PKNH_1325700 contains a C-terminal 
peripheral-targeting repetitive sequence and an N-terminal domain also found in 
PfKAHRP. (A) Representation of P. falciparum KAHRP (upper) and P. knowlesi protein 
PKNH_1325700 (lower), with lysine-rich repeat regions shown in blue and their 
consensus motifs shown above. The first repeat of PKNH_1325700 contains 12.5% 
lysine residues and is coloured light blue. The conserved region found in both proteins 
is in orange, the histidine-rich region in yellow and the export sequence in purple. (B-C) 
P. falciparum expressing the GFP-tagged full-length PKNH_1325700 in late parasites 
and early parasites, respectively. (D) The GFP-tagged C-terminal repeat region of 
PKNH_1325700. A schematic of the protein, a GFP fluorescence image, and a phase 
contrast image are shown from left to right. Scale bar – 2µm.  
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To test whether the lysine-rich sequence alone is able to target to the 
erythrocyte periphery, Rex3 and GFP were fused to residues 303-445 of 
PKNH_1325700; this includes the first and second lysine-rich repeat region 
which have lysine contents of 12.5% and 40%, respectively. This GFP tagged 
protein formed a continuous ring at the erythrocyte periphery (Fig 5.3D). The 
lack of GFP puncta for the lysine-rich repeats indicates they are not responsible 
for the apparent self-association of the P. knowlesi KAHRP protein. These data 
confirm that lysine-rich sequences from multiple parasite species may form 
modules with a targeting function. 
5.3.3 The role of P. falciparum and P. knowlesi KAHRP domains in the 
host cell 
Given that KAHRP is a key cytoskeleton-associated protein involved in 
sequestration of P. falciparum -infected erythrocytes, we sought to investigate 
the roles of the different protein domains within the P. falciparum and P. 
knowlesi proteins. P. falciparum KAHRP is composed of a signal sequence and 
a HT/PEXEL motif, followed by a histidine-rich region. The conserved folded 
domain separates this sequence from the two repetitive lysine-rich sequences 
in the protein, commonly named the 5’ and 3’ repeats. The 5’ repeats are made 
up of four degenerate copies of the consensus sequence SKKH--KD-HDGE-
KKK, while the 3’ repeats are highly conserved and compose of 6 iterations of 
the ATKEASTSKE motif. C-terminal truncations of the protein have indicated 
that both repeats are required for the formation of normal knob structures and 
have some influence on erythrocyte rigidification (Rug et al., 2006). The 
histidine-rich repeats of the protein are however sufficient for localisation to the 
periphery of the host cell (Wickham et al., 2001). The 5’ repeats of KAHRP have 
been shown to interact with PfEMP1 by nuclear magnetic resonance 
spectroscopy (Waller et al., 1999, Ganguly et al., 2015), although this could not 
be replicated by another group (Mayer et al., 2012). Others have indicated the 
5’ repeats interact with spectrin, although an extended sequence following the 
repeating sequence was also required in vitro (Pei et al., 2005). 
To establish whether the repeats are capable of targeting the periphery of the 
host cell in vivo, we expressed a GFP-tagged KAHRP fragment encompassing 
both repeats, as well as each repetitive lysine-rich repeat individually. 
KAHRP351-598, which includes both repeating sequences, was exported by the 
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REX3 export signal and localised robustly to the periphery of the host cell (Fig 
5.4A). Truncation of this fragment to include the 5’ repeats only, KAHRP363-428, 
resulted in a similar distribution at the erythrocyte periphery; however there was 
a reduction in the targeting efficiency for the shorter fragment with an increase 
in cytosolic GFP fluorescence relative to the peripheral signal (Fig 5.4B and D). 
The 3’ repeats did not demonstrate any localisation at the erythrocyte periphery 
(Fig 5.4C and D). These data indicate that the 5’ lysine-rich repeats are 
sufficient for peripheral targeting but that the intervening sequence may also 
contribute to this interaction. A series of bands were seen for the 3’ repeats of 
KAHRP in western blots, indicating it may be truncated or modified (Fig 5.4E). 
 
Figure 5.4 – The 5’ but not the 3’ repeats of KAHRP target the periphery. 
Representation of P. falciparum KAHRP (upper) and GFP-tagged truncated fragments 
(lower) with lysine-rich repeat regions shown in blue. The conserved region is in yellow, 
the histidine-rich region in orange, and the export sequence in purple. (A-C) P. 
falciparum expressing the GFP-tagged KAHRP fragments. A schematic of the protein, 
a GFP fluorescence image, and a phase contrast image are shown from left to right. 
Scale bar – 2µm. (D) Quantification of fluorescence at the periphery relative to the 
cytosol for each parasite line (***- extremely significant. Ns – not significantly localised 
to the periphery relative to the REX3 N-terminus alone). Error bars - SEM. (E) Anti-
GFP western blot confirms expression of correct fragment, with anti-HAP loading 
control (below). 
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To establish whether the domain which is conserved between P. falciparum 
KAHRP and the P. knowlesi homolog PKNH_1325700 is involved in interactions 
with components of the host cell, we expressed GFP and REX3 fusions of the 
conserved domain. For both PfKAHRP136-263 and PKNH_132570075-232, puncta 
of GFP fluorescence were seen at the periphery of the host cell (Fig 5.5A-D). 
These were generally not as numerous as those seen for the full length P. 
knowlesi PKNH_1325700 protein. The number of GFP puncta varied between 
cells; in some parasites fewer puncta were present and fluorescence was 
mainly cytosolic (Fig 5.5A), whereas others exhibited a similar distribution to the 
full length protein with spots of GFP forming a rim around the erythrocyte (Fig 
5.5B and D). Additionally, some weak non-punctuate peripheral localisation 
was also observed in some cases (Fig 5.5C). The localisation of the conserved 
domain was indistinguishable between the P. falciparum and P. knowlesi 
proteins, suggesting a similar function for the domain in both proteins. 
 
Figure 5.5 – The conserved domain of PfKAHRP and PKNH_1325700 form GFP 
puncta at the erythrocyte periphery. (A-B) Two representative cells are shown for 
each construct. The left- and right-hand images show GFP localisation and a phase 
contrast image, respectively. A representation of the full-length protein and cloned 
construct is shown below each image, with lysine-rich repeat regions shown in blue, 
conserved region in yellow, the histidine-rich region in orange, and the export 
sequence in purple. Scale bar – 2µm. 
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5.3.4 A conserved KAHRP-like domain in other Plasmodium species 
The domain conserved between P. falciparum KAHRP and the P. knowlesi 
protein PKNH_1325700 was also previously observed in three P. vivax proteins. 
Using the hidden Markov model program HMMer, we identified a homologous 
domain in several additional proteins from the primate-infecting species P. 
reichenowi, P. knowlesi, P. vivax, P. cynomolgi, P. fragile, P. ovale, and P. inui 
(Fig 5.6). Notably, in P. falciparum , the conserved domain is also found at the 
N-terminus of the erythrocyte cytoskeleton-associated PfEMP3 protein; like 
KAHRP, PfEMP3 has been implicated in modulating the rigidity and 
cytoadhesion of the host erythrocyte (Waterkeyn et al., 2000, Glenister et al., 
2002).  
As the conserved domain is present in both EMP3 and KAHRP we refer to it as 
the EMP3-KAHRP-like domain or EKAL domain. It is predicted to form a folded 
domain and contains several conserved acidic residues as well as a fully-
conserved tyrosine residue (Fig 5.7A and B). Twenty-four proteins containing 
an EKAL domain were found altogether within parasite species for which 
genome sequencing data was available. These proteins can be grouped into 
seven branches; five branches are closely related to PfKAHRP while two 
represent homologs of the EMP3 protein (Fig 5.7C). Remarkably, each parasite 
genome encodes at least one protein with a KAHRP-like EKAL domain and a 
lysine-rich repeating sequence that may target the protein to the periphery of 
the infected host cell (Fig 5.7C). Other repetitive sequences which are not 
lysine-rich are also present in many of the proteins, however only P. falciparum 
KAHRP and its P. reichenowi homolog contain a histidine-rich repetitive 
sequence at the N-terminus. PfEMP3 is also mainly composed of repetitive 
sequences, some of which are predicted to target the erythrocyte periphery by 
our algorithm (See Table 4.1). Although sequence homology in PfEMP3- and 
KAHRP-like proteins is largely restricted to the EKAL domain, it is likely that the 
lysine-rich sequences confer a similar peripheral-targeting function in many of 
the EKAL-domain proteins. 
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Figure 5.6 – Alignment of conserved domain across primate-infecting 
Plasmodium species. Proteins were aligned using T-COFFEE (54). Residues with 
over 70% identity or similarity are shaded in dark grey and light grey, respectively, 
using Multiple Align Show (55). A black line above the alignment represents the highly 
conserved EMP3-KAHRP-like (EKAL) domain and a dotted line represents an 
extended conserved domain used for assembling a phylogenic tree (Fig 5.7). 
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Figure 5.7 – The EMP3-KAHRP-like (EKAL) domain is present within multiple 
repeat-containing Plasmodium proteins. (A) Secondary structure prediction for the 
EKAL domain of PfKAHRP (PSIPRED (72)). (B) Sequence logo of the EKAL domain 
derived from all 24 proteins. Residue position is shown on the x-axis and conservation 
is represented on the y-axis (bits). (C) Left: phylogenic tree of KAHRP and EMP3 
homologs in P. falciparum (Pf3D7), P. reichenowi (PRCDC), P. vivax (PVX), P. 
knowlesi (PKNH), P. cynomolgi (PCYB), P. fragile (PFR), P. inui (PI), and P. ovale 
(PO). Proteins with potential frameshift mutations are indicated with an asterisk. P. 
ovale proteins were assembled de novo and have been named EKAL1-4. Numbers at 
each node represent Quartet Puzzling (QP) support values predicted by 
TREEPUZZLE, where values represent the reliability of groupings (70). Right: 
diagrams representing each protein sequence.  PCYB_001100 and PFR A0A0D9QJA3 
may be truncated due to gaps in the assembled sequences.  
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The phylogenic relationship between EKAL domain proteins is broadly similar to 
that of other conserved proteins such as mitochondrial protein COX1 (Fig 5.1); 
Plasmodium falciparum and P. reichenowi form a divergent clade while proteins 
from P. vivax, P. knowlesi, P. cynomolgi, P inui and P. fragile cluster together 
(Fig 5.7C). These proteins are syntenic to each other but not to any P. 
falciparum EKAL domain proteins. In the P. falciparum and P. reichenowi 
genomes KAHRP and PfEMP3 are adjacent to each other in the subtelomeric 
region of chromosome 2; interestingly, two conserved EKAL domain proteins 
present in P. knowlesi, P. vivax, P. fragile and P. cynomolgi also neighbour 
each other on chromosome 4. Neither of these proteins belongs to the PfEMP3 
clade, however, and the open reading frames lie on different strands. Only one 
of the syntenic pair was found in P. inui; this may be due to incomplete 
sequencing or gene loss. A group of three EKAL domain proteins are only 
present in P. ovale linages, supporting its divergence from other primate-
infecting parasites. The EKAL domain was not found in any proteins encoded 
by mouse-infecting malaria species, indicating it may only confer a selective 
advantage in primates. 
Our identification of KAHRP and PfEMP3 homologs in seven different primate-
infecting species of Plasmodium suggests that the erythrocyte modifications 
mediated by these proteins in P. falciparum may also apply to the other species. 
KAHRP is associated with cytoadhesion and severe malaria; identifying the 
roles of different EKAL domain proteins may elucidate the causes of severe 
disease in other Plasmodium species. 
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5.4 Discussion 
Cytoadhesion of P. falciparum -infected erythrocytes to receptors on endothelial 
cells is believed to be essential for parasite virulence (Smith et al., 1995, Viebig 
et al., 2005, Craig et al., 2012b, Fatih et al., 2012). Erythrocytes infected by 
malaria parasites are substantially less deformable than uninfected 
erythrocytes, and may therefore be detected and cleared by the spleen (Buffet 
et al., 2006, Safeukui et al., 2008, Buffet et al., 2009, Huang et al., 2014). The 
sequestration of these parasites in the brain and other organs prevents parasite 
clearance, and is believed to be a major cause of cerebral malaria and death 
(Macpherson et al., 1985). It was previously believed that only P. falciparum 
caused adhesion of infected erythrocytes, however evidence is growing that 
other human-infecting parasite species may behave similarly (Carvalho et al., 
2010, Fatih et al., 2012). Our observation that several protein domains which 
are likely to play a role in erythrocyte cytoadhesion and rigidity are conserved 
between Plasmodium species supports this theory. We have identified proteins 
with similar domain architecture to LYMP, KAHRP and PfEMP3 in multiple 
primate-infecting parasite species, indicating that erythrocyte modifications may 
occur in a conserved manner. 
Cytoadhesion is mediated by the interaction of variant members of the PfEMP1 
family of surface proteins with endothelial cell receptors such as CD36, VCAM 
and ICAM-1 (Pasloske and Howard, 1994). Recently it has been shown that P. 
knowlesi-infected erythrocytes extracted from patients are able to bind to 
recombinantly expressed VCAM and ICAM-1, but not to CD36 (Fatih et al., 
2012). Likewise, P. vivax-infected erythrocytes were also capable of binding to 
placental cryosections and endothelial cells, as well as isolated ICAM-1 but not 
CD36 (Carvalho et al., 2010). Interestingly, both VCAM and ICAM-1 require 
induction by cytokines for expression while CD36 is constitutively expressed, 
suggesting that P. knowlesi and P. vivax may only cytoadhere during an 
inflammatory response. While the PfEMP1 protein family is not present in the 
other parasite species, both P. knowlesi and P. vivax contain gene families 
which have been linked to cytoadhesion. In P. vivax, antibodies against the VIR 
family of proteins were able to block adhesion to endothelial cells (Carvalho et 
al., 2010). In P. knowlesi, the schizont Infected Cell Agglutination variant 
antigen (SICAvar) family is presented on the surface of infected erythrocytes 
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and has been shown to be antigenically variant (Corredor et al., 2004, Barnwell 
et al., 1983, Howard et al., 1983). While there is no sequence homology 
between these gene families and PfEMP1, it remains to be seen whether they 
perform similar functions. 
The clustering of the PfEMP1 surface antigen in ‘knob’ protrusions on the 
erythrocyte surface is essential for cytoadhesion under flow conditions as 
experienced within the host (Crabb et al., 1997, Baruch et al., 1996). To date 
however, no mechanism for surface antigen clustering has been observed in 
other human-infecting parasite species, and no knob structures have been 
documented on the cell surface of infected erythrocytes. KAHRP is a major 
component of these knob structures; deletion of the gene results in an absence 
of knobs and reduced cytoadhesion under flow conditions (Crabb et al., 1997). 
Our identification of a protein domain homologous to KAHRP in all known 
primate-infecting Plasmodium species indicates that antigen clustering may also 
be conserved. While this conserved domain was previously identified in P. 
knowlesi, P. vivax and P. fragile, the significance for antigen presentation was 
not discussed as it was assumed the proteins would not be exported (Sargeant 
et al., 2006). We show that the full length P. knowlesi homolog is robustly 
exported into the host cell using a non-canonical HT/PEXEL motif. Similar 
motifs are present in other EKAL-domain proteins indicating they are also likely 
to be exported into the host cell. The P. fragile homolog identified in the 
previous study was not found in a more recently sequenced genome of the 
parasite; the previous identification of this protein is therefore assumed to be a 
contaminant from P. falciparum infection as the sequences are almost identical. 
When expressed independently, the EKAL domains from P. knowlesi and P. 
falciparum KAHRP formed puncta of GFP at the erythrocyte periphery. It is not 
clear whether this is due to self-association between the EKAL domains 
themselves or whether the domain clustered by association with other proteins 
localised to the erythrocyte periphery, such as complete knob structures. It may 
be of interest to express the fragment in P. falciparum DD2 parasites which lack 
knob structures due to a deletion of the KAHRP gene. Full-length KAHRP has 
been previously shown to self-associate in vitro, and it is believed this is 
responsible for the assembly of the protrusions (Oh et al., 2000). As the lysine-
rich repeats of both P. falciparum and P. knowlesi KAHRP proteins form a 
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uniform distribution at the periphery, it is possible the EKAL domain is 
responsible for the punctuate distribution of the full-length P. knowlesi protein. 
The lysine-rich repeats may anchor the protein to the cytoskeleton while the 
EKAL domain self-associates into clusters.  The lack of electron-dense 
protrusions in electron micrographs of erythrocytes infected by other 
Plasmodium species may be explained by the absence of a histidine-rich region 
in these KAHRP homologs; histidine-rich motifs may bind metal ions to give an 
electron dense appearance. A closer inspection of these cells may therefore 
elucidate some form of protein clustering. The remainder of each of the EKAL 
domain proteins is highly divergent and contains many different repeat 
sequences; these may have adapted to interact with different surface antigens. 
The binding partners of P. falciparum KAHRP at the periphery are controversial; 
the 5’ repeats have been shown to interact with PfEMP1 by some groups (Oh et 
al., 2000, Ganguly et al., 2015) but not others (Mayer et al., 2012), and they 
have also been shown to bind to spectrin (Pei et al., 2005). A sequence prior to 
these repeats has been shown to bind Ankyrin in vitro (Magowan et al., 2000, 
Weng et al., 2014), although a larger fragment of the protein was shown to bind 
to a complex of actin, spectrin and protein 4.1 (Oh et al., 2000), which is located 
at the opposite end of the spectrin filaments to Ankyrin. An in vivo analysis of 
KAHRP domains was previously done by C-terminally truncating GFP-tagged 
KAHRP (Rug et al., 2006). While this indicated that the 5’ and 3’ repeats are 
both involved in the formation of complete knob structures, they did not 
elucidate a targeting function for these sequences as the N-terminal histidine-
rich sequence was present in all fragments tested and is itself sufficient for 
localisation to Maurer’s clefts and the erythrocyte periphery (Waller et al., 1999).  
We show that the 5’ repeats but not the 3’ repeats are capable of localising to 
the erythrocyte periphery. A fragment encompassing both repeats 
demonstrated stronger peripheral targeting; this concurs with in vitro protein-
binding experiments between KAHRP fragments and spectrin which required an 
extra sequence following the repeats (Pei et al., 2005). The sequence 
immediately adjacent to the 5’ repeats is also lysine rich and likely originated 
from the same repeated sequence as some motifs are still present, however the 
sequence has degenerated over time. A series of bands were seen for the 3’ 
repeats of KAHRP in western blots, these may represent degradation of the 
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protein upon cell lysis. Alternatively, differential phosphorylation of the protein 
may affect the electrophoretic mobility of the fragment; each KEATKEAST 
repeat has previously been shown to contain at least two phosphorylation sites 
(Lasonder et al., 2012). These may modulate protein targeting; however we 
observed no peripheral localisation of these repeats under any conditions.  
We identify for the first time a homologous domain between KAHRP and 
PfEMP3. As the genes are adjacent to each other at the subtelomeric region of 
chromosome 2, it is likely a gene duplication event occurred and the 
homologous domain was retained whereas the rest of the gene diverged. The 
proteins are expressed at similar times in young parasites and are transported 
to the erythrocyte cytoskeleton via the Maurer’s clefts (Knuepfer et al., 2005). 
PfEMP3 is made up of several repeating sequences, some of which are 
predicted by our algorithm to target the erythrocyte periphery. C-terminal 
truncations of the protein have been GFP-tagged previously and indicated a 
region between residues 120-500 is responsible for targeting to Maurer’s clefts 
and the erythrocyte periphery within infected erythrocytes (Knuepfer et al., 
2005). This region includes the EKAL domain but is also rich in lysine residues 
therefore it is not clear which sequence is responsible for targeting. Others have 
shown that a 14-residue N-terminal fragment of the protein binds to spectrin and 
actin in vitro (Waller et al., 2007a); however this sequence includes the 
HT/PEXEL motif of the protein and is therefore cleaved in the mature form. In 
this study no other regions of PfEMP3 were found to bind to inside-out 
erythrocyte vesicles (Waller et al., 2007a), indicating other malaria proteins or 
post-translational modifications may be required for the localisation of the 
protein at the periphery. Like KAHRP, PfEMP3 has been implicated in 
modulating rigidity (Glenister et al., 2002). It has been suggested that blocking 
PfEMP3 in Maurer’s clefts blocks PfEMP1 transport to the cell surface 
(Waterkeyn et al., 2000), but unlike KAHRP, deletion of the gene had no 
significant impact on the formation of knob structures. The expansion of 
different repetitive sequences in the two proteins may therefore have generated 
different functions. 
We confirm that lysine-rich repeats capable of targeting the erythrocyte 
periphery are conserved across Plasmodium species. The repetitive C-terminus 
of P. knowlesi KAHRP robustly localises to the periphery when expressed in P. 
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falciparum -infected erythrocytes. Localisation of the protein in P. knowlesi –
infected erythrocytes will be necessary to confirm that no other P. falciparum 
proteins mediate the targeting function, however. Many other lysine-rich repeats 
were predicted to be functional across all Plasmodium species. While the 
sequences of these repeats differ, it is possible they all behave as variable-
length targeting modules as seen in P. falciparum, and may diversify the 
behaviour of other functional domains such as the EKAL or PRESAN domains, 
which are also conserved between Plasmodium species. Indeed, PHISTb 
proteins in both P. knowlesi and P. vivax have also been shown to target the 
erythrocyte periphery (Tarr et al., 2014). Several proteins with domain 
arrangements similar to those within LYMP were observed in other species. For 
example, many of the RAD family proteins of P. vivax also contain a PRESAN 
domain and lysine-rich C-terminal repeats. Like KAHRP, the lysine-rich repeats 
of LYMP are likely to be functionally important due to the protein’s role in 
cytoadhesion, and these RAD proteins may play a similar role in anchoring 
surface antigens to the erythrocyte surface. 
While we have demonstrated that many similarities exist between Plasmodium 
species, there are also many differences. The varying levels of repeat 
expansion and A/T bias in the genomes of the different Plasmodium clades may 
confer a selective advantage in particular hosts. For example, much fewer 
lysine-rich repeats are present in the genomes of mouse-infecting malaria 
species, possibly indicating a primate-specific role for these proteins. 
Conversely to P. falciparum, P. vivax parasites do not rigidify the host 
reticulocytes they invade (Suwanarusk et al., 2004, Handayani et al., 2009). 
This may allow P. vivax-infected cells to evade the spleen in an alternative way. 
Vesicular caveolae known as Schüffner's dots (Aikawa et al., 1975)are also 
visible at the periphery of P. vivax and P. ovale-infected cells (Udagama et al., 
1988); no function has been assigned to these structures. Comparing 
peripherally-localised proteins between species may explain the differences 
observed and lead to a greater understanding the mechanisms underlying 
severe malaria in some Plasmodium species. 
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Chapter 6: General Discussion 
Repetitive protein sequences have recently been shown to be crucial for protein 
function in many organisms from yeast to dogs (Verstrepen et al., 2005, Fondon 
and Garner, 2004)(reviewed in (Gemayel et al., 2012)). For example, the 
selectivity filter of the nuclear pore complex is formed by polypeptide segments 
comprised of phenylalanine and Glycine rich repeats (Schmidt and Gorlich, 
2016), repetitive sequences in many RNA-binding proteins are important for 
protein localization in RNA granules (Kato et al., 2012), glutamine-rich repeats 
modulate transcription factors activity (Gemayel et al., 2015), serine/arginine 
rich repeats form splicing activation domains (Philipps et al., 2003), and 
histidine repeats serve as a nuclear speckle localization sequences (Salichs et 
al., 2009). Yet despite containing more repetitive proteins than any other 
species whose genomes have been sequenced to date, there are currently few 
functions assigned to repeats in Plasmodium (McHugh et al., 2015, Ferguson et 
al., 2014). We show that several proteins from P. falciparum contain lysine-rich 
tandemly repeating sequences that confer a peripheral localisation in the 
infected erythrocyte. Four of the nine proteins identified were previously 
uncharacterised, including the glutamic acid-rich protein (GARP) which contains 
three distinct lysine-rich repeat sequences with a targeting function. 
The underlying mechanism behind the prolific expansion of repetitive 
sequences in P. falciparum relative to other species is not known. We show that 
novel repeats have expanded in GARP proteins from closely related species on 
a relatively short timescale. In general, repeats are thought to expand and 
contract due to the dissociation of DNA strands during replication, with DNA 
secondary structures leading to re-annealing of the new strand at the incorrect 
position (see section 1.3.2) (DePristo et al., 2006). This process may occur 
more frequently in the highly AT-rich genome of the parasite, with weaker base-
pairing interactions facilitating the dissociation of DNA strands. Our analysis of 
the genome of the similarly AT-rich organism Dictyostelium discoideum 
(Szafranski et al., 2005) reveals that it also contains a high number of repetitive 
sequences relative to other species (13% of all protein sequences – not shown), 
suggesting that AT-richness may be sufficient to drive repeat protein expansion. 
However this is much lower than the 27% of proteins which contain repeats in 
P. falciparum, and not all repetitive sequences are located in AT-rich regions of 
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the P. falciparum genome. Additionally, P. vivax and P. cynomolgi contain a 
much lower bias towards AT-rich codons yet are also enriched in repetitive 
sequences, while the AT-rich genomes of P. berghei and P. chabaudi contain 
relatively few repetitive proteins. This may be due to selective pressure within 
these species.  
Expansion of repeats has been studied in detail in the case of Huntington’s 
disease where the expansion of CAG repeats forming poly-glutamine tracts is 
related to disease onset. A number of DNA repair pathways are implicated in 
this process (Jonson et al., 2013b, Lin and Wilson, 2007, Zhang et al., 2012); it 
is therefore interesting to note that P. falciparum does not utilise the canonical 
non-homologous end joining machinery to repair double strand breaks, instead 
recruiting its own repair machinery (Kirkman et al., 2014). This pathway has not 
been characterised however it may contribute to trinucleotide repeat formation 
and expansion by allowing greater dissociation of DNA strands. Oxidative stress 
also contributes to the extension of CAG repeats, an effect attributed to an 
increase in DNA breakages (Jonson et al., 2013a). Reactive oxygen species 
are produced by the parasite upon infection (Atamna and Ginsburg, 1993), 
which may also result in an increase in repeat formation. 
Repeat expansion is often considered detrimental for protein function; the 
aggregation of asparagine and glutamine rich repeats is associated with 
neurological disorders and prion disease (Halfmann et al., 2011, Perutz et al., 
2002). In P. falciparum, a quarter of proteins contain asparagine-rich tracts 
which require additional chaperones to inhibit aggregation during malarial fever 
(Muralidharan et al., 2012). The mystery of why the malaria parasite has 
evolved a unique propensity to expand repeats in this manner has perplexed 
scientists for decades, particularly as so few repetitive sequences appear to be 
essential for protein function. Our observation that several of these sequences 
represent localisation sequences may in part explain why they appear to be 
selected for. The utilisation of repeat expansion for the formation of variable 
high-avidity binding sequences may represent enough of an advantage for the 
parasite to overcome any adverse effects.  
By comparing the GARP sequences of the closely related parasites P. 
falciparum, P. reichenowi and P. gaboni, we demonstrate that repeat expansion 
can generate functional sequences de novo. Peripheral-targeting sequences 
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have expanded in P. falciparum whereas they are absent or non-functional in 
the other two species. It has been hypothesised previously that repetitive 
sequences may play important roles in protein evolution (Kashi and King, 2006, 
Andrade et al., 2001, DePristo et al., 2006, Gemayel et al., 2010, Gemayel et 
al., 2012, Jansen et al., 2012, Toll-Riera et al., 2012). Many repetitive 
sequences are present in eukaryotic proteins however these are usually highly 
conserved between protein homologues. Most form modular arrays of folded 
domains such as Ankyrin repeats, kelch repeats or leucine-rich repeats, which 
are collectively referred to as solenoid domains (Andrade et al., 2001). While it 
is likely that solenoid domains originated from repeat expansion, the sequence 
conservation between each repeat has been lost in most cases (Kajava, 2012, 
Jorda et al., 2010). These sequences are therefore unable to expand and 
contract and evidence of their de novo formation in the distant past has not 
been found. We present evidence of P. falciparum actively generating new 
functional domains, and the high level conservation between most repeats 
indicates that very few have yet to be fixed in place and likely retain the 
capability to expand and contract (Jorda et al., 2010). 
As well as allowing the parasite to generate new targeting sequences, the 
dynamic nature of repetitive sequences may provide the parasite a means of 
rapid adaption to selective pressure. We show that many of the sequences 
capable of targeting the erythrocyte periphery contain a variable number of 
repeated motifs between the fifteen isolates tested. The truncations of the 
GARP lysine-rich repeat demonstrated that targeting efficiency is directly 
proportional to the number of repeats present; therefore the propensity to target 
the periphery of the host cell may naturally vary for the repetitive proteins 
investigated here. While no repetitive sequences appeared to be contracted to 
the point where they would no longer be functional, long-read sequencing data 
for additional isolates may uncover greater variation. Within proteins which 
modulate key properties of the host cell such as rigidity, cytoadhesion and 
nutrient import, changes to repeat length and therefore targeting efficiency may 
directly modulate such effects. We present a model in which repeat expansion 
and contraction can generate novel targeting modules or modulate the targeting 
efficiency of exported parasite proteins (Fig 6.1).  
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Figure 6.1 – Evolution of novel targeting domains and modulation of targeting 
efficiency by repeat expansion. 
Several studies indicate that alteration of repeat sequence length can modulate 
protein function (Gemayel et al., 2010). For example, the length of the repeated 
sequences in the cell surface adhesion protein Flo1 modulates adhesion of 
yeast cells (Verstrepen et al., 2005). Changes in the lengths of repeating 
sequences can also modulate the activity of transcription factors (Gemayel et 
al., 2015, Katti et al., 2000) and changes in dog skull morphology can be 
correlated with altered lengths of repetitive sequences in transcription factors 
(Fondon and Garner, 2004). Repeats in the carboxy-terminal domain (CDT) 
of RNA polymerase II have been shown to directly influence the protein’s 
function by recruiting transcription factors (Meinhart et al., 2005). The length of 
the CTD in all mammals is tightly regulated with exactly 52 repeats present in all 
species; truncation of repeats has been shown to impair function (Chapman et 
al., 2004, Rosonina and Blencowe, 2004). In the RNA polymerase II of 
Plasmodium species, however, the number of repeats is highly variable, with 
more repeats in primate-infecting species and even substantial variation in CTD 
lengths between P. falciparum isolates (Kishore et al., 2009). This may 
modulate transcription of variable surface antigens (Ukaegbu and Deitsch, 
2015). The variability in this important protein suggests that sequences prone to 
repeat expansion and contraction may still play important roles despite being 
highly changeable. 
The functions of these sequences remain to be elucidated. While KAHRP and 
LYMP play important roles in mediating cytoadhesion (Crabb et al., 1997, 
Proellocks et al., 2014), the fact that no significant change in this property was 
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observed upon deletion of four of the other proteins tested suggests they may 
play diverse roles in the cell (Maier et al., 2009). As the lysine-rich repeats of 
KAHRP and LYMP have been implicated in binding to spectrin (Pei et al., 2005) 
and band 3 (Oberli et al., 2016), respectively, the different motifs within each 
protein may all mediate binding to different cytoskeletal components (Fig 6.2A).  
The function of proteins such as GARP and PF3D7_1102300, which do not 
contain any folded domains, is likely to be conferred by the repeats themselves. 
For example, the proteins may prevent the extension of spectrin filaments by 
linking spectrin repeats (Fig 6.2B). This could explain the slight decrease in 
rigidity observed upon deletion of the proteins (Maier et al., 2009). The 
expression of PF3D7_1102300 in gametocytes suggests it may be involved in 
the additional rigidification observed for early sexual-stage parasites as they are 
sequestered in the bone marrow (Tiburcio et al., 2012), while the slight 
upregulation seen during heat shock may serve a similar purpose to RESA in 
stabilising the cell during febrile episodes (Diez-Silva et al., 2012).  
The identification of multiple peripheral targeting sequences in several proteins 
suggests they may be crosslinking different cytoskeletal components. For 
example, MESA may stabilise the interaction between protein 4.1 and other 
cytoskeletal components.  Other lysine-rich repeats may simply serve as 
targeting sequences for localising other important domains to the erythrocyte 
periphery, or for recruiting other proteins to this region (Fig 6.2C). The various 
PRESAN domain proteins may be involved in the trafficking or stabilisation of 
PfEMP1 on the erythrocyte surface, for example.  
Electrostatic interactions between the basic lysine residues and a negatively-
charged partner are likely responsible for the peripheral localisation of the 
repeating sequences. There are many potential candidates; the sequences may 
non-specifically bind to the negatively charged head groups of membrane lipids 
or to phosphorylation sites or acidic residues on the surface of cytoskeletal 
components. Triton extraction of GARP indicated that an interaction with the 
insoluble cytoskeleton is likely. However, many peripherally-located parasite 
proteins are highly acidic; RESA, Pf332 and PfEMP3 all contain glutamate-rich 
repeats, and interactions between the basic and acidic sequences of these 
proteins may form a network of proteins at the cell periphery (Fig 6.2D).  
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Figure 6.2 - Potential roles for lysine-rich repeats at the cell periphery. (A) Lysine-
rich repeats may all bind different components of the erythrocyte cytoskeleton. (B) 
Some repeating sequences may bind spectrin repeats and modulate their flexibility or 
(C) others may also serve to target functional domains such as PHIST domains to the 
periphery. (D) Alternatively, a protein interaction network may be formed through the 
interaction of acidic and basic sequences. 
 
The interaction between the acidic and basic sequences of Hyp12 indicates that 
such an association between oppositely charged proteins is possible. To our 
knowledge, such an interaction between two highly charged sequences 
predicted to be entirely disordered has not been seen previously. A signal from 
the parasite such as the release of calcium ions may trigger the dissociation of 
the sequences and ‘switch on’ peripheral localisation. Alternatively, the parasite 
may have expanded acidic sequences to ‘switch off’ the targeting function of 
lysine-rich repeats which do not confer an advantage. GARP, MESA, PHISTb 
protein PF3D7_1476200, and the PHISTb/c protein PF3D7_1201000 all contain 
highly acidic sequences which may also interact with their lysine-rich repeats. 
While the full-length GARP, MESA and PF3D7_1476200 protein were robustly 
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localised to the periphery, the additional targeting domains in these proteins 
may overcome the effects of blocking targeting by the lysine-rich sequence. The 
targeting efficiency of full-length PF3D7_1201000 was reduced relative to the 
lysine-rich fragment alone, however the poor export of the protein made further 
characterisation of this effect difficult. The cytosolic localisation of the acidic C-
terminus of GARP suggests that this sequence does not interact with the 
peripherally-localised lysine-rich repeats, however. 
The variation in peripheral targeting observed between different lysine-rich 
sequences likely indicates that peripheral targeting is mediated by a relatively 
weak interaction in most cases and that either decreasing the number of 
repeats or decreasing the affinity of each individual repeat unit may reduce 
targeting efficiency. To narrow down the constraints which are important for 
targeting, some of the characteristics of the sequences tested have been 
plotted against the fluorescence intensity at the periphery (Fig 6.3). There is no 
significant correlation between the length of the sequence fragment and the 
targeting efficiency, suggesting the composition of the repeat unit itself plays the 
most important role (Fig 6.3A). Indeed, there is a significant correlation between 
the targeting efficiency and the isoelectric point of the sequence (Fig 6.3B) as 
well as the number of lysine residues (Fig 6.3C). The most significant 
correlation to targeting efficiency is with the net amount of basic residues after 
subtracting the number of acidic residues (Fig 6.3D). This suggests that 
negative residues generally decrease the targeting efficiency of a lysine-rich 
sequence; sequences containing more basic than acidic sequences display a 
stronger signal at the erythrocyte periphery and this increases with the 
increasing number of basic residues over acidic residues. The one outlier in this 
comparison is the full length GARP sequence; this may be due to the fact that 
multiple lysine-rich sequences are present within the protein. 
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Figure 6.3 – Correlation between sequence characteristics and the efficiency of 
peripheral targeting. Error bars represent SEM. Significance of correlation (Spearman 
R) was calculated with Graphpad Prism and indicated by asterisks with a P-value < 
0.0001 (**** - extremely significant), P-value < 0.0002 (*** - extremely significant), P-
value < 0.0021 (** - very significant) and ns – not significant. The (A) Sequence length, 
(B) Number of lysine residues, (C) Net basic residues (basic – acidic), and (D) 
isoelectric point was plotted on the X-axis against the relative fluorescence intensity at 
the periphery on the Y-axis. 
 
Few proteins in other species contain sequences as charged and repetitive as 
those of P. falciparum; however there are some examples of similar sequences 
with known functions. These are mainly found in structural proteins; the arginine 
and glutamate-rich protein trichohyalin is involved in crosslinking keratin in hair 
and nail fibres (Steinert et al., 2003), while the lysine and glutamate-rich  
axoneme-associated protein mst101 was shown to be an essential component 
of sperm flagella in fruit flies (Neesen et al., 1999). Covalent linkages are 
involved in fortifying the structures of both these proteins, with disulphide bonds 
linking mst101 filaments together (Neesen et al., 1999) while lysine and 
glutamine residues in trichohyalin are cross-linked by transglutaminase (Tarcsa 
et al., 1997). That the erythrocyte cytoskeleton is rigidified in a similar way has 
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been suggested previously (Adini et al., 2001), and such post-translational 
modifications may explain the smeared band observed for many of the proteins 
by western blot.  
Notably, other charged repetitive proteins have been shown to bind cytoskeletal 
components. Both the human microtubule associated protein (MAP1B) and the 
C. elegans proteins CYLC-1 and CYLC-2 are rich in lysine residues and 
associated with microtubule assembly (Lacroix et al., 2016, Noble et al., 1989), 
while the sperm protein cylicin has been shown to bind to actin filaments in 
boars (Rousseaux-Preost et al., 2003). While the erythrocytes of non-
mammalian vertebrates contain a tubulin skeleton surrounding the cytoskeleton, 
tubulin fibres are lost upon maturation of erythrocytes in humans, although a 
pool of soluble tubulin is believed to remain (Amaiden et al., 2011). 
Redistribution of tubulin may affect erythrocyte deformability (Amaiden et al., 
2012). Actin is mainly present at the junctional complex of the erythrocyte 
cytoskeleton in short capped filaments. These are remodelled upon parasite 
invasion and can be seen in electron micrographs linking the cytoskeleton to 
Maurer’s cleft structures (Cyrklaff et al., 2011). It is possible that the charged 
repeat proteins are involved in this process, or they may bind to other 
filamentous components of the cytoskeleton such as spectrin.  
The localisation of so many charged proteins to the erythrocyte periphery is 
likely to drastically modify the electrophysical environment surrounding the 
cytoskeleton. Knob structures have been shown to be positively charged 
(Aikawa et al., 1996), which may contribute to their interaction with receptors. 
Other basic residues may confer a similar localisation to lysine-rich repeats; a 
poly-histidine sequence in KAHRP also targets the erythrocyte periphery 
(Waller et al., 1999), and the histidine rich protein II may also interact with 
cytoskeletal components, potentially in a pH-dependent manner (Akompong et 
al., 2002, Benedetti et al., 2003). Arginine residues are under-represented in the 
AT-rich P. falciparum genome, and no arginine-rich repeats were found in our 
search with the exception of the protein PF3D7_1102300 which was also 
enriched for lysine. Some arginine-rich sequences were however found in the P. 
vivax, P knowlesi and P. cynomolgi genomes, which do not contain such an 
extreme codon bias.  
138 
 
In addition to the lysine-rich repeat sequences, we also identify a conserved 
folded domain which may target the erythrocyte periphery in KAHRP and 
PfEMP3-like proteins. The localisation of the EKAL domain in puncta at the 
periphery suggests it may be a component of knob structures, although it is 
unclear whether it is capable of targeting the periphery in the absence of pre-
formed knobs. Both KAHRP and PfEMP3 contain other domains capable of 
localising to the periphery (Knuepfer et al., 2005, Waller et al., 2007a, Weng et 
al., 2014, Oh et al., 2000, Rug et al., 2006, Waller et al., 1999, Pei et al., 2005) 
and most other EKAL domain proteins contain lysine rich repeats predicted to 
have a targeting function. It is therefore possible that this domain serves 
another purpose, perhaps self-associating to cluster surface antigens on the 
surface. Further work will be required to elucidate the function of this domain, 
and establish its role in the other primate-infecting parasite species. 
 
 
6.1 Conclusions and Further Work 
The aim of this thesis was to identify new protein domains capable of targeting 
the erythrocyte periphery, where important virulence-related changes are known 
to occur. We have successfully identified two modules capable of localising to 
this region: the tandemly repeated lysine-rich sequences and the EKAL domain. 
The functional lysine-rich repeats described here are not homologous in the 
traditional sense as the repeated motifs vary in length and composition and 
likely originated from individual repeat expansion events. Nevertheless, the 
criteria used for our algorithm resulted in the identification of several 
peripherally-targeting sequences, suggesting that the common features of these 
sequences are sufficient to confer a targeting function. While the lysine-rich 
repeats are predicted to be intrinsically disordered, the EKAL domain is 
predicted to form a conserved folded structure; differences in phenotype 
between KAHRP and PfEMP3 deletions suggest the function of the domain may 
have diverged, however.  
In addition to the identification of novel targeting modules, we have also gained 
an insight into the evolution of the parasite. The adaptability of P. falciparum is 
considered to be one of the main hurdles to designing new antimalarial 
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treatments, with resistance is an ever-growing problem. The ability to from new 
functional targeting domains at much greater rates than through point mutations 
likely accelerated the evolution of Plasmodium species and contributed to the 
spread of malaria to most animal species on the planet. Rapid expansion and 
contraction of established peripheral-targeting repeating sequences may also 
allow additional flexibility in modulating the properties of the host erythrocyte in 
different hosts. While repetitive sequences are generally highly divergent 
between Plasmodium species, the identification of the conserved EKAL domain 
in primate-infecting species may indicate similar mechanisms are used for 
surface receptor presentation and cytoadhesion in these species. A closer look 
at the evolutionary differences between species may lead to a greater 
understanding of the causes of severe malaria. 
Many of the previously-uncharacterised lysine-rich repeat proteins may play 
important roles at the erythrocyte periphery, and our identification of additional 
targeting modules in proteins with known cytoskeleton-binding motifs may 
elucidate their precise roles at this important region. Some proteins present 
interesting avenues for further research; the entirely charged protein 
PF3D7_1102300 may play a role in gametocyte development while the Hyp12 
protein appears to contain a functional lysine-rich sequence which is ‘switched 
off’ and may require a trigger to become functional.  
Identifying the binding partners of the lysine-rich repeats will be essential for 
understanding their function. We have made some progress in designing a 
protein-binding assay to identify cytoskeletal components which may associate 
with our proteins of interest. This is based on the AVEXIS assay which was 
used for identifying surface receptors involved in erythrocyte binding upon 
invasion, and requires the in vitro recombinant expression of biotinylated 
cytoskeleton baits and reporter-tagged prey proteins. This system has been 
tested with known binding partners within the erythrocyte cytoskeleton, and has 
also been used to test for novel interactions between the PfEMP1 surface 
antigen and the PRESAN domain of different proteins. Once the system has 
been optimised this new assay will be used to test for binding interactions 
between lysine-rich repeat proteins and the cytoskeleton. 
As some interactions may involve additional parasite proteins or post-
translational modification, a technique for identifying binding partners in vivo is 
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also being explored. BioID allows for the biotinylation of proteins in close 
proximity to the protein of interest by attaching it to a promiscuous biotin ligase. 
Biotinylated proteins are then isolated and identified by mass spectrometry. 
Both GARP and KAHRP fragments have been tagged and preliminary work 
suggests the biotin ligase is capable of biotinylating erythrocyte components 
within the host cell. Both these techniques are currently in development and we 
hope they will soon be able to further elucidate the roles of the peripheral-
targeting proteins identified here.   
In addition to identifying the binding sites of the proteins identified, a phenotypic 
analysis will be necessary to elucidate their roles within the cell. Using new 
conditional genome engineering techniques uncharacterised genes may be 
deleted and their functions analysed by testing erythrocyte properties such as 
rigidity and cytoadhesion. While the deletion of multiple genes may be required 
for a clear phenotype to appear in some cases, the removal of the repetitive 
sequences from proteins with known functions such as KAHRP and LYMP may 
demonstrate the importance of these sequences for protein function. Simulating 
in vivo conditions may be necessary to observe a function for some proteins, as 
they may behave differently under heat shock or at different pH levels, or at 
different life stages such as during sexual stage development. 
The discovery of novel domains targeting the erythrocyte periphery 
demonstrates that we still do not possess the full picture where host cell 
modification is concerned. It is likely that many other proteins play a role in this 
region, and establishing how they interact together will require both a holistic 
analysis of the cytoskeletal network as well as a more detailed look at the 
structure and function of individual proteins. We hope that this work contributes 
to this goal, and that this understanding will eventually lead to new treatments 
for preventing the most severe manifestations of malaria. 
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Appendix 
Construct 
Fold-difference in 
Fluorescence at 
Membrane relative 
to Cytosol 
Standard 
Deviation 
P-value 
(Significance) 
Full-Length GARP 3.27 0.86 <0.0001 (****) 
GARP119-163 2.39 0.43 <0.0001 (****) 
GARP253-340 3.23 0.61 <0.0001 (****) 
GARP372-446 1.71 0.29 <0.0001 (****) 
GARP524-673 0.92 0.07 0.9988 (ns) 
 
GARP50-118 0.92 0.06 0.9548 (ns) 
 
GARP (+ promoter) 2.90 0.72 <0.0001 (****) 
GARP119-163 (+linker) 2.29 0.60 <0.0001 (****) 
GARP134-163 1.76 0.29 <0.0001 (****) 
GARP149-163 1.12 0.20 0.2323 (ns) 
 
GARP372-446 (+linker) 1.76 0.37 <0.0001 (****) 
P. reichenowi GARP71-130 0.90 0.06 0.9181 (ns) 
 
P. gaboni GARP381-412 0.94 0.07 0.9248 (ns) 
 
PF3D7_1102300121-415 3.90 0.65 <0.0001 (****) 
GEXP12231-370 1.75 0.35 <0.0001 (****) 
LYMP419-528 2.13 0.34 <0.0001 (****) 
 
PF3D7_1476200443-512 2.50 0.57 <0.0001 (****) 
PF3D7_0402000305-428 1.73 0.40 <0.0001 (****) 
PF3D7_1201000292-397 1.42 0.45 0.0016 (**) 
 
MESA850-1147 1.38 0.20 0.0062 (**) 
 
KAHRP363-428 1.49 0.21 0.0007 (***) 
 
PF3D7_011420097-240 0.92 0.04 0.9845 (ns) 
 
PF3D7_1149100.1120-416 0.92 0.05 0.9917 (ns) 
 
Hyp12297-381 2.31 0.33 <0.0001 (****) 
PKNH_1325700303-445 3.12 0.67 <0.0001 (****) 
PF3D7_1102300 (FL) 4.08 1.06 <0.0001 (****) 
GEXP12 (FL) 1.97 0.44 <0.0001 (****) 
PF3D7_0402000 (FL) 3.73 0.80 <0.0001 (****) 
PF3D7_1201000 (FL) 1.09 0.20 0.2920 (ns) 
 
PF3D7_01142001-302 0.99 0.08 0.6517 (ns) 
 
PF3D7_1149100.1 (FL) 1.05 0.17 0.4333 (ns) 
 
Hyp12 (FL) 0.94 0.08 0.9064 (ns) 
 
Hyp1251-381 1.00 
 
0.10 
 
1.82403 (ns) 
 
Hyp12158-381 0.65 
 
2.35 
 
<0.0001 (****) 
PF3D7_1102300 (+ 
promoter) 
4.01 
 
1.82 
 
<0.0001 (****) 
Appendix Table 1 - Quantification and statistical analysis of GFP fluorescence at 
the periphery of infected erythrocytes. See materials and methods section 2.3.7 for 
details. 
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Gene Name 
Location of Potential 
Error 
Nature of Potential Error 
PFCD01_GARP 
360 Frame shift (Insertion) 
766 Frame shift (Insertion) 
PFGN01_GARP 781 Frame shift (Insertion) 
PFML01_KAHRP 1020 Frame shift (Insertion) 
PFML01_MESA 3030 Frame shift (Insertion) 
PFCD01_MESA 1190 Frame shift (Insertion) 
PFGN01_PF3D7_1102300 978 Frame shift (Insertion) 
PFSD01_PF3D7_1102300 1013 Frame shift (Insertion) 
PFGA01_PF3D7_0402000 1082 Frame shift (Deletion) 
PFML01_PF3D7_1201000 995 Frame shift (Insertion) 
PFTG01_PF3D7_1201000 995 Frame shift (Insertion) 
 
Appendix Table 2 – Annotation of introns and location of potential frameshift 
mutations in PACBIO sequencing. (A) Sequences containing frameshift mutations in 
PACBIO sequences were restored. Where multiple sequences were found (for 
PfML01_KAHRP, PfML01_MESA, PfTG01_MESA and PfTG01_1476200), the 
sequence containing the fewest frameshift mutations was used (either one or zero 
mutations). 
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Gene Name 
Location of Potential 
Error 
Nature of Potential Error 
PI C922_04319 
110-295 Un-annotated intron 
365 Point mutation (Stop codon) 
749 Point mutation (Stop codon) 
1244 Point mutation (Stop codon) 
PI C922_02878 
112-243 Un-annotated intron 
74 Frame shift (Deletion) 
1003 Point mutation (Stop codon) 
1672 Point mutation (Stop codon) 
PFR AK88_04565 
112-256 Un-annotated intron 
996 Assembly gap (skipped) 
1625 Assembly gap (skipped) 
2737 Assembly gap (incomplete sequence) 
PCYB_001100 
109-284 Un-annotated intron 
3 Point mutation in start codon 
109-284 Un-annotated intron 
639 Point mutation (Stop codon) 
1217 Assembly gap (incomplete sequence) 
PCYB_127900 
97-246 Un-annotated intron 
46 Frame shift (deletion) 
PCYB_042840 
112-242 Un-annotated intron 
37 Frame shift (deletion) 
1080 Frame shift (deletion) 
1716-2157 Reverse complement 
2129 Frame shift (insertion) 
 
Appendix Table 3 – Annotation of introns and location of potential frameshift 
mutations in EKAL-domain proteins. Introns were annotated manually for all 
sequences indicated. For protein PFR AK88_04565, apparent assembly gaps were 
present in the protein sequence, which were skipped in accordance to the protein 
annotation within the European Nucleotide Archive (ENA). Assembly gaps within PFR 
AK 88_04565 and PCYB_001100 result in a truncated sequence with no stop codon. A 
section of gene PCYB_042840 appears to be reverse complemented within the 
assembled sequence, which was modified in-frame with flanking regions. All mutations 
may be caused by sequencing errors or may be true mutations. 
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Construct Name Primer Name Primer Sequence 
GARP1-174 HD1_GARP_174_R TCCTTTAGATCTTCCTGAATATAAAGACATCACTTCAC 
GARP175-523 HD4_GARP_HT_175_R (OL) GGTTTATGTTGACCCGTTTTTGTTTTTTTTAAATCCTGTT 
GARP524-673 HD5_GARP_HT_524_R (OL) TTTTTCTTATGATTATCTCTTGTTTTTTTTAAATCCTGTT 
REX3 HD6_HT_F TCCTTTCCTAGGTAAAAAATGCAAACCCGTAAATATAA 
GARP524-673 HD7_GARP_HT_175_F (OL) AACAGGATTTAAAAAAAACAAAAACGGGTCAACATAAACC 
GARP524-673 HD8_GARP_HT_524_F (OL) AACAGGATTTAAAAAAAACAAGAGATAATCATAAGAAAAAAATGGC 
Multiple GARP AO828GARP_F CTAAGCCCTAGGTAAAAAATGAATGTGCTATTTCTTTC 
Multiple GARP AO829GARP_R GTTTAGAGATCTTCCTGAAATTTTGGCATTTTTTCTCA 
GARP1-118 HD9_GARP6_118_R TCCTTTGACGTCTCCTGAATCTACAGAGTTTTCATTAT 
GARP119-163 HD23_GARP14_119_F ATAATGAAAACTCTCTCGAGAAAAAAAAAGATAAAAAAGAAAAAAAGC 
GARP119-163 HD26_GARP14_163_R ACTTCACTGTTTTCGCTAGCTTTTTTATCTTTTTTATG 
GARP253-340 HD27_GARP16_253_F CTAAGCCTCGAGCAAGAAGAAATGTTGAAAACACT 
GARP253-340 HD28_GARP16_340_R TCCTTTGCTAGCTTCATTTTCCTTATCATGTTTTTTC 
GARP372-446 HD29_GARP17_372_F TGACAGACGTAACTCTCGAGGAAGAACACAAAGAAGGAGA 
GARP372-446 HD30_GARP17_446_R TCCTTTGCTAGCAACATTTTTAACTACGTGTTTTTTTAC 
PF3D7_1102300 (FL) HD53_PF3D7_1102300_F CTAAGCCCTAGGTAAAAAATGAAAAATTGTAGGAATATATTAATCG 
PF3D7_1102300 (FL) HD54_PF3D7_1102300_R TCCTTTGACGTCTCCTGAGACATTTTCCATTTTCATTTTTTC 
PF3D7_1149100.1 (FL) HD55_PF3D7_1149100.1_F CTAAGCCCTAGGTAAAAAATGATGAAGCTTTTTAATAATTTTACATG 
PF3D7_1149100.1 (FL) HD56_PF3D7_1149100.1_R TCCTTTGACGTCTCCTGATTGAGCTCTTCTTAATTTATCATTTG 
Hyp12 (FL) HD57_PF3D7_1301400_F CTAAGCCCTAGGTAAAAAATGTTTTCTTCTACAACAAATATATTTTTTTC 
Hyp12 (FL) HD58_PF3D7_1301400_R TCCTTTGACGTCTCCTGAGTGTCTTAAGCTAAGAAGCTTATTTCTTC 
PF3D7_0402000 1-302 HD59_PF3D7_0114200_1-302_F CTAAGCCCTAGGTAAAAAATGAAACACCTTCTGTCACTTTTTAAG 
PF3D7_0402000 1-302 
HD60_PF3D7_0114200_1-
302_R 
TCCTTTGACGTCTCCTGATACAAATTCTGGTGAAAAAATACCTC 
GEXP12 (FL) HD61_PF3D7_1148700_F CTAAGCCCTAGGTAAAAAATGAAGCAACATATAACCTTTAAGAAG 
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GEXP12 (FL) HD62_PF3D7_1148700_R TCCTTTGACGTCTCCTGATTTGCTTGGTAATCTTTTTTTTTC 
LYMP419-528 HD63_LYMP_419-end_F GGCGCTTCTGACGTCTTAACTGAAAATCAGATAAATGAAG 
LYMP419-528 HD64_LYMP_linker_F CTAAGCCTCGAGTCAGGATCTGGTACGGGCGCTTCTGACGTC 
LYMP419-528 HD65_LYMP_419-end_R TCCTTTGCTAGCATTTTTTTTTTTATTTTCTTTTCC 
PF3D7_0402000305-428 
HD66_PF3D7_0402000_305-
428_F 
CTAAGCGACGTCGATACCAGTAAGAAAGATATGAAG 
PF3D7_0402000305-428 
HD67_PF3D7_0402000_305-
428_R 
TCCTTTGCTAGCATTGTTTTTTTTTAATTCTTTTTTC 
KAHRP540-600 
HD70_KAHRP(3'repeats)_540-
600_F 
CTAAGCGACGTCACTAAGGGAGCAACTAAAGAAG 
KAHRP540-600 
HD71_KAHRP(3'repeats)_540-
600_R 
TGTAGTTGAGCTAGCAGTAGTACTTGCTCCTTTAG 
MESA850-1147 
HD72_MESA(lysrepeat)_851-
1146_F 
CTAAGCGACGTCAAAGATAAAGTGACAAAACAGG 
MESA850-1147 
HD73_MESA(lysrepeat)_851-
1146_R 
TCCTTTGCTAGCGTTTACTCTTTTGTTAACTTCTTTG 
GARP119-163 (+linker) HD80_GARP39_119-163_F ATAATGAAAACTCTGACGTCAAAAAAAAAGATAAAAAAGAAAAAAAGC 
GARP134-163 and GARP149-
163 
HD81_GARP40_134–163_F CTAAGCGGATCCTAGGATGCAAAC 
GARP134-163 HD82_GARP40_134–163_R1 TTTTTTCTTTTTTTTCGACGTCAGAAGCGCC 
GARP134-163 
HD83_GARP40_134–163_R2 
(OL) 
TTTTCTTTTTTATCTTTTTTTTCCTTTTTATCTTTTTTTTCTTTTTTTTCGACG 
GARP134-163 
HD84_GARP40_134–163_R3  
(OL) 
TTTATGTTTTTTTTCTTTTTTATGCTTTTTTTCTTTTTTATCTTTTTTTTCC 
GARP134-163 and GARP149-
163 
HD85_GARP40_134–163_R4 TCCTTTGCTAGCTTTTTTATCTTTTTTATGTTTTTTTTCTTTTTTATGC 
GARP149-163 HD86_GARP41_149-163 _R1 TTTATGTTTTTTTTCTTTTTTATGCTTTTTTTCGACGTCAGAAGCGCC 
PF3D7_1476200443-512 
HD105_PF3D7_1476200_443-
512_F 
CTAAGCGACGTCGATCAAGCAAGCAAGAAAAAAAAAAAG 
PF3D7_1476200443-512 HD106_PF3D7_1476200_443- TCCTTTGCTAGCTTTCCAAGTTTTAATTTTATTTTTAGTTTC 
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512_R 
PF3D7_1102300121-415 
HD115_PF3D7_1102300_121-
415_F 
CTAAGCGACGTCGATAGAGAAAAAGATGATCAAAACG 
PF3D7_1102300121-415 
HD116_PF3D7_1102300_121-
415_R 
TCCTTTGCTAGCGACATTTTCCATTTTCATTTTTTC 
PKNH_1325700 HD134_PkKahrp_full_R GTACCAGATCCTGAGACGTCTATTTTATTTTTCTTAGATTTGTCATTTTT 
GEXP12231-370 
HD143_PF3D7_1148700_C-
term_F 
CTAAGCGACGTCTCTGATAAAATATGCAAAGAAAATAAC 
GEXP12231-370 
HD144_PF3D7_1148700_C-
term_R 
TCCTTTGCTAGCTTTGCTTGGTAATCTTTTTTTTTC 
PKNH_1325700303-445 HD145_PkKahrp_C-term_F CTAAGCGACGTCCCCACCGTAGGTCAATACTC 
PF3D7_1201000292-397 HD146_PF3D7_1201000_F CTAAGCGACGTCAAAAAAGAAACGGAAACGG 
PF3D7_1201000292-397 HD147_PF3D7_1201000_R TCCTTTGCTAGCGCTCTGAGATTATTTTTAATATTGCTTAC 
PKNH_1325700 HD148_PkKahrp_full_F (OL) GGTTCCTAAATTGTTCTAATTACGAAAAATGTGATAGGAGGAGTG 
PKNH_1325700 HD149_PkKahrp_full_R (OL) CACTCCTCCTATCACATTTTTCGTAATTAGAACAATTTAGGAACC 
PKNH_132570075-232 HD150_PkKahrp_cons_F CTAAGCGACGTCCTTAGAACCCGTATAGTAAAGGAAGTTACC 
PKNH_132570075-232 HD151_PkKahrp_cons_R TCCTTTGCTAGCTCTTGGACTATCTGGTCCTCC 
PKNH_1325700 HD152_PkKahrp_full_F2 CTAAGCCCTAGGTAAAAAATGGCTATTCTTAAGGGATACAG 
KAHRP363-428 HD165_KAHRP5(2)_F CTAAGCGACGTCTCTAAAAAGCATGAAGGAAATG 
KAHRP363-428 HD166_KAHRP5(2)_R1 (OL) TCCTCGTTATCCTTATGCTTCTTAGATTTTTTCTTTTCACAATCGTGG 
KAHRP363-428 HD167_KAHRP5(2)_R2 TCCTTTGCTAGCTGCGTCCTCGTTATCCTTATGCTTCTTAG 
GARP50-118 HD223_GARP50-118_F CTAAGCCTCGAGAACGAAACCGAATTAGAAAAAAATAAAG 
GARP50-118 HD224_GARP50-118_R TCCTTTGCTAGCATCTACAGAGTTTTCATTATCTTTATCATTAAC 
PF3D7_011420097-240 HD225_PF3D7_0114200reps_F CTAAGCGACGTCAATAATATGGAAAAGGAGATGGG 
PF3D7_011420097-240 HD226_PF3D7_0114200reps_R TCCTTTGCTAGCTTTCAATATATAGTCCATATATTCTTTCG 
PF3D7_1149100.1120-416 
HD227_PF3D7_1149100.1reps_
F 
CTAAGCGACGTCATCCAAAATGAAGATTCTGAAAAAG 
PF3D7_1149100.1120-416 HD228_PF3D7_1149100.1reps_ TCCTTTGCTAGCATCATTCGTTGAATTTTTTGTAG 
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R 
Hyp12297-381 HD229_PF3D7_1301400reps_F CTAAGCGACGTCAGAGAAAAAAAAAAGAAAGAAAAAC 
Hyp12297-381 HD230_PF3D7_1301400reps_R TCCTTTGCTAGCGTGTCTTAAGCTAAGAAGCTTATTTC 
GARP (+ promoter) HD242_GARPpromo1kb_F CAAAAAGCTAAGCTATACATAGAAATATAAATAATTCTAATCCCATAG 
PF3D7_1102300 (+ promoter) HD244_FOGpromo1kb_F CAAAAAGCTAAGCCTCTATACATGATAATATGAAGATCATTTC 
GARP535-673 HD254_ GARPCterm_F TAAAAACTCGAGGAGGAAGCTGAACTTCAAAAAC 
GARP535-673 HD255_ GARPCterm_R TAAAAAGCTAGCAATTTTGGCATTTTTTCTCA 
Hyp1251-381 HD256_ FulllengthHyp12_F TAAAAAGACGTCGCAGAACCATCTTCACATGGCTC 
Hyp12158-381 HD257_ WOacidicHyp12_F TAAAAAGACGTCTTAATACCTATTCTACCAAATAGCTCG 
P. reichenowi GARP71-130 HD258_ ReichafterGFP_F GAAACGTTGGACGTCGATGAAAAAGATGAAAC 
P. reichenowi GARP71-130 HD259_ ReichafterGFP_R TAAAAAGCTAGCTTTTTTTTCTTTTTTCTTTTTTCCAC 
P. gaboni GARP381-412 HD260_GaboniGARP_R1 (OL) 
TTTTATGTTTTCCTTCCTCTTTCTTTTCTTCTGTTTTATGTTCTTGGACGTCAG
AAGCGC 
P. gaboni GARP381-412 HD261_GaboniGARP_R2 (OL) 
ATGTGTGTTTCTTCTTTTTCTTTTTCTTTTGTATCTATTTTATGTTTTCCTTCC
TCTTTC 
P. gaboni GARP381-412 HD262_GaboniGARP_R3 TAAAAAGCTAGCAAAGTTTTTAAGTATGTGTGTTTCTTCTTTTTCTTTTTC 
GARP372-446 (+linker) HD263_Falciparum GARPlink_F TGACAGACGTAACTGACGTCGAAGAACACAAAGAAGGAGA 
 
Appendix Table 4 – Primer sequences for all constructs used in this project. The protein name and cloned fragment boundaries are displayed in 
the first column. Most primer names also contain details of the gene. F and R denote forward and reverse primers, respectively, and OL designates 
primers used for overlap PCR. Forward and reverse primers are mainly adjacent but may be separate where new primers were required. Some 
primers may be used for multiple constructs. Restriction sites are coloured red. 
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Appendix Figure 1 – Western blots of all GFP-tagged constructs not shown in 
main text. Anti-GFP western blot (top panel) of transfected parasites expressing GFP-
tagged GARP constructs. Approximately 2 x 106 percoll-purified schizonts were loaded 
per lane, with anti-HAP used to confirm equal loading (lower panel).  
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Appendix Text 1 - ‘exportfind.pl’ perl script - Subroutines are included below. Input 
sequences were generated by PlasmoDB  as well as MPEX and SignalP. Comments 
are in red. 
 
#!usr/bin/perl 
 
# File:  exportfind.pl 
# Version 1 
# This script takes output from the MPEX JAVA program and the SignalP 
web server. 
# Output must be copied from the JAVA applet and web servers and saved 
as a .txt file. 
# The script predicts proteins which are exported into the host 
erythrocyte by Plasmodium parasites. 
# it extracts protein sequences from a FASTA file (e.g. malaria 
proteins downloaded from Plasmodb.com). 
# It counts how many transmembrane (TM) domains there are from an MPEX 
output file for the same gene set. 
# If there are less than 4 TM domains, it checks the SignalP output 
for a signal sequence (SS). 
# If no SS are present it looks for an N-terminal TM domain in the 
MPEX file. 
# If either a SS or N-terminal TM domain is present, a regular 
expression checks for a PEXEL motif by looking for an RxL motif  
# within 100aa of the SS cleavage site or TM. 
# Proteins containing a PEXEL are considered likely to be exported and 
printed out. 
# Both of these are printed out with the name of the protein and the 
length of the repeat sequence. 
# The number of sequences selected is printed at the end (multiple 
sequences may be from the same protein). 
# If scoring is turned on, more positively charged proteins are 
printed first (highest score first). 
 
# Date: 16.07.2015 
 
use strict; 
use warnings; 
use Data::Dumper; 
use get_mpex; 
use get_sigp; 
use Getopt::Long; 
 
my $count = 0; 
my $genename; 
my %genes; 
my $length = 30; 
my $score = ''; 
my $help = ''; 
my $name; 
my @data; 
my $repseq; 
my $repscore; 
my $fullseq; 
my $replength; 
my $psim; 
my $seqlength; 
my %result; 
my $cut; 
my $start; 
my $end; 
my $pexel; 
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# Open list of proteins from PlasmoDB, as well as the output from MPEX 
and SignalP for the same gene set. 
 
my $file = 'allproteins.txt'; 
my $outfile = 'allexported.txt'; 
 
my $mpexinfile = 'mpexresults.txt'; 
my $psiginfile = 'sigpresults.txt'; 
     
open(INFILE, $file) or die "can not open $file:$!\n"; 
open(OUT, ">>$outfile") or die "can not open $outfile:$! \n"; 
 
# Stores all gene sequences within a hash. 
while(<INFILE>) {    
    chomp; 
    if (/^>(\w{2,7}_\d{7})\s.+/) {  
        $genename = $1;  
    } 
    elsif (/^([AILMFWYVSTNQCUGPRHKDE]+)/i) { 
        $genes{$genename} .= $1;     
    } 
} 
# Loops through each protein sequence, calling subroutines to check 
for TM and SS. 
# get_mpex checks the number and position of all TM domains. Proteins 
with <4 TM are selected. 
# get_sigP checks for the presence of a signal sequence; if present 
the cut site is noted. 
# If no SS is present, it checks whether the first TM domain is within 
the first 100 aa. 
foreach my $protein ( keys %genes ) { 
    if (length($genes{$protein}) >100 ) { 
        my $mpexref = get_mpex($protein, $mpexinfile); 
        if (${$mpexref}[0] < 4) { 
            my ($sigpos, $sigyes) = get_sigp($protein, $psiginfile); 
            if ($sigyes =~ /Y/) { 
                $cut = $sigpos; 
            } 
            elsif ($sigyes =~ /N/) { 
                if (${$mpexref}[0] > 0) { 
                    if (${$mpexref}[1] < 100) { 
                        $cut = ${$mpexref}[1]; 
                    } 
                } 
            } 
        } 
# If a SS or TM was found, a RxL motif is searched for within 100aa of 
the cut site/TM domain. 
# Proteins containing the motif are printed out with their protein 
sequence. 
        if (defined $cut) { 
            $start = $cut + 5; 
            $end = $cut + 100; 
            print "$start, $end\n"; 
            if ($genes{$protein} =~ /^\w{${start},${end}}R\wL.+/ ) { 
                print "pex\n"; 
                print "$protein\n$genes{$protein}\n"; 
                print OUT "$protein\n$genes{$protein}\n"; 
            } 
        } 
    } 
# Parameters are undefined for the next protein. 
    undef $cut; 
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    undef $start; 
    undef $end; 
} 
             
Subroutine get_mpex 
 
#!/usr/bin/perl 
 
# File: get_mpex.pm  
# Version 1 
# A subroutine to analyse the output of the transmembrane-domain 
prediction program MPEX. 
# Genenames are passed from the exportfind.pl program and are searched 
for in the output file. 
# If a TM domain is found, the number of TM domains present and the 
position of the 1st is returned to exportfind.pl 
 
# Date: 16.07.2015 
 
use strict; 
use warnings; 
use Data::Dumper; 
 
sub get_mpex 
{ 
    my ($ID, $file) = @_;   
    open(INFILE, $file) or die "can not open $file:$!\n"; 
 
    my $genenamem; 
    my %genesm; 
    my $match; 
     
    # The number of TM domains and the position of the first TM domain 
are recorded for each gene. 
 
while(<INFILE>) {    
    chomp; 
    if (/^Results.+\:\s(\w{2,8}\_\d{7}.+)/) { 
        $genenamem = $1;     
    } 
    if ($genenamem =~ /$ID/) { 
        $match = "yes"; 
    } 
    elsif ($genenamem !~ /$ID/) { 
        $match = "no"; 
    } 
    if ($match =~ /yes/ && 
/^Number\sof\stranslocon\sTM\spredicted\ssegments:\s(\d+)/i) { 
        push @{$genesm{$genenamem}}, $1;     
        } 
    if ($match =~ /yes/ && /^(\d+)\-(\d+)\s\(.+/i) { 
            push @{$genesm{$genenamem}}, $2;     
        } 
} 
 
for my $valuem (keys %genesm) { 
     return \@{$genesm{$valuem}}; 
} 
}        
1; 
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Subroutine get_sigp 
 
#!/usr/bin/perl 
 
# File: get_sigp.pm  
# Version 1 
# A subroutine to establish whether a gene contains a signal sequence. 
# Genenames are passed from exportfind.pl and the output from SignalP 
web server is searched. 
# The presence and position of a signal sequence is returned to 
exportfind.pl. 
 
# Date: 16.07.2015 
 
use strict; 
use warnings; 
use Data::Dumper; 
 
sub get_sigp 
{ 
    my ($ID, $file) = @_;   
    open(INFILE, $file) or die "can not open $file:$!\n"; 
 
    my $genenamep; 
    my $position; 
    my $yesno; 
    my $geneID2; 
    my @split2; 
     
# The signalP output file is searched for the gene. 
# The position and presence of a SS is extracted from the same line 
and returned to exportfind.pl. 
 
while(<INFILE>) {    
    chomp; 
    if 
(/^(\w+)\s+0\.\d+\s+\d+\s+0\.\d+\s+(\d+)\s+0\.\d+\s+\d+\s+0\.\d+\s+0\.
\d+\s+([YN])\s+0\.\d+\s+SignalP.+/i) { 
                $genenamep = $1;     
                $position = $2; 
                $yesno = $3;         
            if ($genenamep eq $ID) { 
            return ($position, $yesno); 
            last; 
        } 
    }    
} 
 
} 
         
1; 
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Appendix Text 2 -  ‘chargesearch.pl’ perl script. Input was generated by 
‘exportfind.pl’. Comments are in red. 
 
#!usr/bin/perl 
 
# File:  chargesearch.pl 
# Version 1 
# A script for detecting regions within a protein which are rich in 
certain amino acids (e.g. highly charged regions). 
# It begins by extracting protein sequences from a FASTA file (e.g. 
malaria proteins downloaded from Plasmodb.com). 
# A sliding window of a certain length (default = 20 aa) scans each 
sequence in turn. 
# The number of certain predefined residues (e.g. lysine, K) within 
the window are counted by regular expression. 
# A threshold can be set for the desired number of a certain residue 
in a window (e.g. 4 lysines out of 20 aa). 
# If above this threshold the sequence within the window is 
temporarily stored, and the window moves forward 1 aa. 
# Each subsequent window which is also above the threshold adds to the 
growing sequence as it iterates. 
# Once a window does not contain the requisite number of residues, the 
current sequence is then considered complete. 
# If the complete sequence is above a certain length (e.g. 30 aa), the 
sequence is stored in a hash for that protein. 
# The sliding window will continue to scan the sequence, ignoring any 
windows which do not pass the threshold. 
# Any number of sequences can be picked out of a protein, all stored 
in an array within the protein's hash key. 
# These are printed out in FASTA format with each of the sequences 
within the same protein numbered. 
# This output can then be used for further processing (e.g. T-Reks for 
finding tandem repeats within the sequences). 
 
# Getopt::Long is used to allow users to change the values for all 
parameters through the command line.  
# Options for Getopt::Long: (single letters can be used for each 
option, e.g. -w instead of --window) 
 
#   infile = select input fasta file (filename) 
#   outfile = select name for output file (filename) 
#   window = modify window length (integer) 
#   residue = type of residues to be counted (string) 
#   count = threshold of residues within the window in order for that 
window to be added to the sequence (integer) 
#   length = length of the sequence required for it to be stored and 
printed (integer) 
 
# Date: 16.07.2015 
 
use strict; 
use warnings; 
use Data::Dumper; 
use Getopt::Long; 
 
my $genename; 
my %genes; 
my %lyscount; 
my $regseq; 
my %region; 
my @res; 
my $parameter; 
my $score = 0; 
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my $help = ''; 
 
# Default options are set for window size, residue count and length of 
sequence.  
 
my $winsize = 20; 
my $count = 4; 
my $lengthcount = 30; 
 
my $file = 'allexported.txt'; 
my $outfile = 'resreg.txt'; 
 
# Default options can be modified through the command line (see intro) 
 
GetOptions ("infile=s" => \$file, 
            'help' => \$help, 
            "outfile=s" => \$outfile, 
            "window=i" => \$winsize, 
            "count=i" => \$count, 
            "residue=s{0,3}" => \@res, 
            "length=i" => \$lengthcount) 
            or die ("Error in command line arguments\n"); 
                         
# If no option is entered for "residue", the default is set to 'K' 
 
if (not defined ($res[0])){ 
    $res[0] = "K"; 
    } 
     
# To look for residues in a row, inputs will be passed into an array 
which can then be used to create a search parameter. 
# The parameter will be inserted into the regular expression later on. 
 
if ((not defined $res[1]) && (not defined $res[2])) { 
    $parameter = "[$res[0]]"; 
} 
elsif ((defined $res[1]) && (not defined $res[2])) { 
    $parameter = "[$res[0]][$res[1]]"; 
} 
elsif ((defined $res[1]) && (defined $res[2])) { 
    $parameter = "[$res[0]][$res[1]][$res[2]]"; 
} 
 
# The name of the protein and its sequence from the FASTA file are 
held in a hash. 
# The sequence may span several lines in file, and will be 
concatenated.  
  
open(INFILE, $file) or die "can not open $file:$!\n"; 
open(OUT, ">>$outfile") or die "can not open $outfile:$! \n"; 
 
while(<INFILE>) {    
    chomp; 
    if ((/^>(.+)/)) { 
        $genename = $1;  
    } 
    elsif (/^([AILMFWYVSTNQCUGPRHKDE]+)/i) { 
        $genes{$genename} .= $1;     
    }        
} 
# The sliding window moves along each protein sequence in turn. 
# $score counts how many instances of the chosen residue occur within 
the window. 
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# If $score is greater than the predefined threshold ($count) the 
sequence qualifies to be stored within $regseq. 
# In order to capture the whole sequence, the first instance of a 
qualifying window stores the first half of the sequence. 
# Subsequent qualifying windows add one residue (the center) each, 
whereas the final window adds its latter half. 
# Once a window which does not qualify is encountered, the qualifying 
sequence up to that point can be stored. 
# A sequence is stored in the %region hash if it is over the 
predefined length ($lengthcount) plus half the window size. 
# Sequences can be stored either once a non-qualifying window is 
encountered or on the last window within the protein. 
 
foreach my $protein ( keys %genes ) { 
    my $sequence = $genes{$protein}; 
    my $lengthseq = length($sequence); 
    my $regseq = undef; 
         
    for(my $i=0;$i<=($lengthseq-$winsize);$i++) { 
        my $window = substr($sequence, $i, $winsize); 
        $score = 0; 
             
        while ($window =~ /$parameter/gi)  { 
            $score ++; 
        } 
         
        if ($score >= $count) { 
                $regseq .= substr($window, $winsize/2, 1); 
            } 
        elsif ($score < ($count)) { 
            if (length($regseq) >= ($lengthcount)) { 
                push(@{$region{$protein}}, $regseq); 
                $regseq = undef;                 
            } 
            elsif(length($regseq) < ($lengthcount)) { 
            $regseq = undef; 
            }                
        } 
         
        if($i ==($lengthseq-$winsize)) { 
            if(length($regseq) > ($lengthcount)) { 
                push(@{$region{$protein}}, $regseq); 
            } 
            $regseq = undef; 
        } 
    }            
}                   
     
# The regions of the protein high in certain amino acids are stored 
within the %region hash, and are printed out. 
# A number is added to the name of each protein to represent multiple 
sequences within the same protein. 
 
foreach my $value (keys %region) { 
    for my $i ( 0 .. $#{$region{$value}} ) { 
        print OUT ">$value $i\n$region{$value}[$i]\n"; 
    } 
} 
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Appendix Text 3 - ‘pickrepeats.pl’ perl script. Subroutines are included below. Input 
file is the output of the TREKS java program. Comments are in red. 
 
#!usr/bin/perl 
 
# File:  pickrepeats.pl 
# Version 1 
# This script takes output from the T-Reks JAVA program.  
# (T-reks: identification of tandem repeats in sequences with a k-
means based algorithm. 
# Jorda J, Kajava AV(2009). Bioinformatics 25 (20), 2632-2638)  
 
# Output must be copied from the JAVA applet and saved as a .txt file. 
# See example output in 'repeatexample.txt'. 
 
# The script creates a hash of the protein name, and the length of its 
longest repeating sequence. 
# (multiple repeating sequences must be separated before inputting 
into T-Reks using 'chargesearch.pl') 
# The hash is cycled through, printing out repeating sequences which 
are longer than a predefined threshold. 
# The subroutine 'get_rep' accesses the full length repeat from the 
'resreg.txt' file - the input for T-Reks. 
# The subroutine 'get_full' then gets the full length protein sequence 
from the initial fasta file. 
# Both of these are printed out with the name of the protein and the 
length of the repeat sequence. 
# The number of sequences selected is printed at the end (multiple 
sequences may be from the same protein). 
# If scoring is turned on, more positively charged proteins are 
printed first (highest score first). 
 
# Getopt::Long is used to allow users to change the threshold repeat 
length through the command line.  
# Options for Getopt::Long: (single letters can be used for each 
option, e.g. -l instead of --length) 
 
# Date: 16.07.2015 
 
use strict; 
use warnings; 
use Data::Dumper; 
use get_rep; 
use get_full; 
use get_repscore; 
use Getopt::Long; 
 
# The default threshold length is set to 30 residues. 
 
my $count = 0; 
my $genename; 
my %genes; 
my $length = 30; 
my $score = ''; 
my $help = ''; 
my $name; 
my @data; 
my $repseq; 
my $repscore; 
my $fullseq; 
my $replength; 
my $psim; 
my $seqlength; 
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my %result; 
 
my $file = 'repeats.txt'; 
my $outfile = 'replistr.txt'; 
 
my $repinfile = 'resreg.txt'; 
my $fullinfile = 'allexported.txt'; 
 
# Default options can be modified through the command line.  
 
GetOptions ('help' => \$help, 
            "length=i" => \$length, 
            'score!' => \$score, 
            "infile=s" => \$file, 
            "outfile=s" => \$outfile, 
            "repfile=s" => \$repinfile, 
            "fullfile=s" => \$fullinfile) 
            or die ("Error in command line arguments\n"); 
             
# Bring up usage instructions if --help option is entered, and end 
script.       
     
if ($help) { 
    die ("\nUSAGE: 
[-h or --help]      bring up usage instructions 
[-i or --input]     filename of T-REKS output file for input 
[-o or --output]    filename for output 
[-r or --repfile]   filename of input to the 'get_rep.pm' subroutine 
[-f or --fullfile]  filename of input to the 'get_full.pm' subroutine 
[-l or --length]    the threshold length for a stored sequence  
[-s or --score]     turns on scoring by the 'get_repscore.pm' 
subroutine 
[-nos or --noscore] turns off scoring by the 'get_repscore.pm' 
subroutine\n 
See README file for more details on usage with examples\n"); 
} 
             
# The input file 'repeats.txt' contains the output from the T-Reks 
JAVA program.  
         
open(INFILE, $file) or die "can not open $file:$!\n"; 
open(OUT, ">>$outfile") or die "can not open $outfile:$! \n"; 
 
# The full name (and any other information contained in this line) is 
stored in a hash. 
# Multiple repeating sequences may exist for one input sequence - only 
the length of the longest is stored. 
 
while(<INFILE>) {    
    chomp; 
    if ((/^>(.+)/)) { 
    $genename = $1;  
    } 
    elsif (/^Length:\s(\d+)\sresidues.+Psim:(0\.\d+).+Length:(\d+)/) { 
        $replength = $1; 
        $psim = $2; 
        $seqlength = $3; 
        if (defined $genes{$genename}) { 
            if ($seqlength > $genes{$genename}[2]) { 
            undef $genes{$genename}; 
            $genes{$genename} = ["$replength", "$psim", "$seqlength"]; 
            } 
        } 
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        elsif (not defined $genes{$genename}[2]) { 
            $genes{$genename} = ["$replength", "$psim", "$seqlength"]; 
        } 
    }    
} 
 
# Repeating sequences over a certain threshold length ($length) are 
printed out. 
# The 'get_rep' subroutine sources the repeating sequence while 
'get_full' sources the full protein sequence. 
# Both these are printed along with the protein name and the length of 
the repeat. 
# If no files are submitted for the subroutines, no sequences are 
printed out - just protein names. 
# the 'get_repscore' subroutine scores each sequence according to 
percentage positive charge.  
# If scoring is turned off, sequences are printed out randomly (all 
scores are set to 1). 
 
foreach my $protein ( keys %genes ) { 
    if ($genes{$protein}[2] >= $length) { 
        if (defined $repinfile) { 
            $repseq = get_rep($protein, $repinfile); 
            if ($score && $repseq) { 
                $repscore = get_repscore($repseq); 
            } 
            else { 
                $repscore = "1"; 
            } 
        } 
        elsif (not defined $repinfile) { 
            $repseq = "Sequence input file not supplied - See README"; 
            $repscore = "1"; 
        } 
        if (defined $fullinfile) { 
            @data = split ('\s', $protein, 2); 
            $name = $data[0]; 
            $fullseq = get_full($name, $fullinfile);         
        } 
        elsif (not defined $fullinfile) { 
            $fullseq = "Full protein input file not supplied - See 
README"; 
        } 
        $result{$protein} = ["$repscore", "$genes{$protein}[2]", 
"$repseq", "$fullseq"]; 
        $count ++;       
    } 
} 
 
# Sequences are printed out highest score first. This may be disabled. 
 
foreach my $name (sort {$result{$b}[0] <=> $result{$a}[0]} keys 
%result) { 
print OUT ">$name\nLength of Repeat 
sequence:$result{$name}[1]\nScore:$result{$name}[0]\nRepeating 
Sequence\n$result{$name}[2]\nFull Sequence:\n$result{$name}[3]\n"; 
} 
# The number of repeat sequences in the output is printed at the end 
of the file ($count). 
 
print OUT "Count: $count"; 
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Subroutine get_rep 
#!/usr/bin/perl 
 
# File: get_rep.pm  
# Version 1 
# A subroutine to get the protein sequences entered into T-Reks 
program. 
# The input file is the output of 'chargesearch.pl' which is in the 
FASTA format. 
# Protein names and sequences are collected into a hash. 
# Repeat sequences which pass the threshold length from 
'pickrepeats.pl' will have their names  
# searched within the input file. 
# The full repeat sequence is returned to 'pickrepeats.pl'. 
 
# Date: 16.07.2015 
 
use strict; 
use warnings; 
use Data::Dumper; 
 
sub get_rep 
{ 
# The full protein name as well as the number given by 
'chargesearch.pl' is passed from  
# 'pickrepeats.pl', and also the input file name. 
     
    my ($ID, $file) = @_;   
    open(INFILE, $file) or die "can not open $file:$!\n"; 
 
    my $genename; 
    my %genes; 
     
# A hash is built of protein names and sequences. 
     
    while(<INFILE>) {    
        chomp; 
        if (/^>(.+)/) { 
            $genename = $1;  
        } 
        elsif (/^([AILMFWYVSTNQCUGPRHKDE]+)/i) { 
            $genes{$genename} = $1;  
        }        
    } 
# Protein names within the hash are searched for names passed from 
'pickrepeats.pl' 
# If a match is found, the full sequence for that repeat is returned. 
 
    foreach my $value ( keys %genes ) { 
        if ($value eq $ID) { 
        return $genes{$value}; 
        } 
    } 
} 
         
1; 
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Subroutine get_full 
#!/usr/bin/perl 
 
# File: get_full.pm  
# Version 1 
# A subroutine to get a full protein sequence from the FASTA file used 
as input for 'chargesearch.pl'. 
# Protein names and sequences are collected into a hash. 
# Repeat sequences which pass the threshold length from 
'pickrepeats.pl' will have their names  
# searched within the input file. 
# The full protein sequence is returned to 'pickrepeats.pl'. 
 
# Date: 16.07.2015 
 
use strict; 
use warnings; 
use Data::Dumper; 
 
sub get_full 
{ 
    # The protein name (first word only) and the input file name are 
passed from 'pickrepeats.pl'. 
     
    my ($ID, $file) = @_;   
    open(INFILE, $file) or die "can not open $file:$!\n"; 
     
    my $genenamef; 
    my %genesf; 
     
    # A hash is built of protein names and sequences. Multiple lines 
are concatenated. 
 
    while(<INFILE>) {    
        chomp; 
        if (/^>(\w{13})\s.+/) { 
            $genenamef = $1; 
        } 
        elsif (/^([AILMFWYVSTNQCUGPRHKDE]+)/i) { 
            $genesf{$genenamef} .= $1;   
        } 
    } 
    # Protein names within the hash are searched for the first word 
passed from 'pickrepeats.pl' 
    # If a match is found, the full sequence for that protein is 
returned. 
     
    foreach my $valuef ( keys %genesf ) { 
        if ($valuef eq $ID) { 
        print "YES\n"; 
        return $genesf{$valuef}; 
        } 
    } 
} 
         
1; 
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